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Abstract 
The present study clIlIlI1ined the life historie, of individuals In Western 
Arntrnlin with a d)ngnosis of Angelman or Prader-Willi syndrome. Angclman and 
Prnder_Willi syndrome, are phCflotypically diverse disorders both of which result 
from the failure of imprinting at the chrlSqll-q13 locus. In most cases, loss of 
the maternal imprint from the region lead!; to Angelman syndrome, while lack oh 
patem"1 pattern results in Prnder-WilIi syndrome. Betwoon 4-14% of Angelman 
cases have a mUllltlon in a single genc, UBE3A. 
Subjects fnr the study were identified from the Disability Services 
Commission of West cm Auslmlia. Dntn on Ihes. individuals were oblllined from 
Ihe eliCflt files held by Ihe Commission, and supplcmenttuy datn were added by 
linkage to n number of daln5cts via the Western Australian Dam Linkage Unit. 
The information was Ihcn compiled into a database to provide informalion to 
physicians, families, and carers on the life histories and ageing patterns of people 
with either disorder. 
Fifty-six of Ihc 90 s ubjects identified had a diagnosis of Prodcr_Willi 
syndrome. Ten of Ihe individuals clinically dingnosed with Prndcr-Willi 
syndrome wen: analysed separately (Pruder-Willi-likc), as they had return"" a 
normal mcthylDllon test Md therefore were unlikely to have the disorder. This lell 
a group of 46 individuals in the Pruder_Willi cohort, and 34 pc,",ons with 
Angelmou syndrome. Nine individuals were deceased by the time of dntn 
collection. 
Both disorders are now diagnosed at an earlier "ge thou WIlS CIlmmon ten 
years ago, allhough there was still some degree of delay in diagnosing AngcImou 
syndrome when compared to Prndcr-WilU syndrome. In addition, the majority of 
recent diagnoses were confirmed by genetic Icsling, as opposed 10 the lack of 
genetic verification for earlier cases. 
The clinical presentation of both syndromes was gCflernlly similar to the 
eKpected profiles. lbroughout their lives, individlUlls with Angclmou syndrome 
eKhib ited most of the major clinical features; nowever epilepsy llSunlly did not 
appear until after the age of three years. Conversely, the Proder-Willi cOSes 
lended to presenl different churnctmstics nl vnrious ages. During Infancy, feeding 
m 
difficulties and hypotonia were almost universal, but these symptoms became less 
rommon in later life. By age three to four years most of the Prnder.WiIli children 
had an insntiable appctilc, leading to obesity unless the diet was strictly 
controlled. Some features, such lIS hypogonadism, were present from hinh, but in 
females it was not always obvious until puberty. There were some diagnostic 
clinical criteria which were unreported for many cases, c.g., microcephaly or 
prognathia in Angelman syndrome, and hyperphagia Or the chllllleteristic fneies in 
Proder-WilIi syndrome. 
For many suhjects either no genetie test had been requested, or klll)'otypc 
or banding tests only WeIC undertaken, many of which were uninformative. The 
incideJlcc of uniparental disomy in Prndcr-WilIi syndrome was around half that 
expeded, although the rate for Angelman syndrome was within the expected 
moge. 
On overuge, individuals with Angelman syndrome had been admitted to a 
hospital on aine occasions, Md those with Pradcr-Willi syndrome on seven 
occasions. Denwl work Md respimtory disorders well) �le main reasons for 
hospital admission for both groups of patients. However, significantly more 
AngclmM syIldrome patients were admitted with epilepsy than Prnder.Willi 
enses, Md treatment for undescended testes was needed only hy those with 
Prader-WilIi syIldromc. 
InteUox:tual function ranged from normal to profoundlydisnhled, with 88% 
of the Angelman group within the modcrnte-scvere categories, Md 72% ofPrnder. 
WiUi cases with a mild-moderule disability. There were many fewer than 
expected Prndcr-Willi patients with an IQ>70 (9% vs 40%). But sin"" Disability 
Services Commission does not ncccpt individuals with an IQ>70, case 
IlStcrtainment was effectively biased to ClIcl�de such people. This may explain 
the low rat� of uniparental disomy in the Pmder.Willi group, since such cases 
have a less severe phenotype than those with any other disruption of c1tr15qll. 
q13. 
In many cases the Disability Services Commission files contained only 
limited infonnation on the clini",,1 nod behaviourul presentation of these 
individuals. Oflen this was due to a lock of conwct with the Commission, for any 
of a number of possible reasons, c.g� dislWlce from services, reduced need for 
" 
services, or migmtion into or out of Westem AUsInIlia. The clinical criLcrla for 
bolh S)'IIdromes have only been published wilhin Ihe l!lSt 10·]2 yeam, which 
meant that reporting of some characteristics was lacking !IS th. relevance of these 
fealures WIIS unknown prior to lhose publications. 
Previous reports on ageing in people with lntellcctual disability have 
indicated that many of their ageing issuC5 mirror those in the geneml population, 
e.g .• visual or henring impalnnent, loss of mobility, and meDllI1 health disorders. 
Since the oldest member of the study group WlIS aged 48 yeam, it was nOl possible 
to produce a comprehensive picture of the age·associated morbidity typical of 
eilher disorder. However. the study does provide 8 valuable compnmtivc baseline 
for ongoing investigations into bolh syndromes. 
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I. INTRODUCTION 
1.1 The aigaifleao(e o!tbls project 
The World Health Organization hns Cillled for re=h into practices that 
succesjfully promote longevity nnd healthy ageing in persons with intellectual 
disability (ID) (Hogg el 0/., 2001). In terms of life expectancy, the population 
promes of both developed nnd developing countries ditTer greIIUy from those of 
one hundred years ago. For example, the median agc in Australia io 1901 was 
22.6 years, but by L999 It had risen 10 34.9 years (Australinn Bureau ofSlnti,tic!, 
2000), because of the increasing ratio of older people 10 those middle-aged and 
younger. People with ;n!eUechlaI disabilities arc also living significantly longer 
thnn in the past (Eymnn Cl a/., ]981; lanicki et 0/., 1999; Binles cl 0/., 2002). 
Those with mild ID have approximately the SilIIIe mean life eKpeclallcy as the 
general population, olthouglt severe ID decrcnses life expec\aJ1cy by as much ll5 
20% (Patjo el a/., 2000; Patja el al., 2001: BinI"" et al., 2002: Sutherland.1 0/., 
2002). 
The Intemot/onal P/a" of Action on Ageing (United Nations, 199B) 
suggested thol da'" relaling 10 older people were criticnl far the ""ccessful 
development of processe, and policies mimed at improving the langevity and 
quality af life af an ageing pop1llation. There arc a number af identified 
predictors of chronic disease that lead to m limi"'tion of funClional abilities in the 
older population, including poverty, being female, having a lower cducnlion level, 
and redm:ed aocess to health services (Walsh, 2002). These predictors apply 
equally to those with!D, espct:ially as members afthe ID population oflen fall 
into two o r  more af those categaries (Holland, 2000). However, onc of the ,"ain 
difficulties io the provision of heaIthcnre for people with ID is the communication 
barrlcr thst often CKis!5 between the patient and the dootor, and the difficulty 
experiem:ed by an individual with !D in recognIsIng worrying symptoms or 
conveyIng relevant Information to the physician (Evenhuis, 1991; Luru;ky & 
Rciss, 1998: lanicki ct al., 1999; Hogg, 2001). On average, indIviduals with!D 
have leSOl access to preventotive health Cil1C prognuns, have morc sedenlaly 
lifestyles, and an: le,s likcly to complain af ill-health, althaugb those with 
mild/modernte ID CIlI\ and do make Independent healthcarc decisions (Allan, 
1997), 
1.2 The Datu..., or Angelmao syodrome ami Pntde ... Willl syodrome 
Angelmnn syndrome (AS; M!M 105830) and Pradcr.WiIIi syndrome 
(PWS; MIM 176270) !Ire specifie ohromosomal disorders IGCated in the ql !-q13 
region of chromosome 15, They both involve abnormalities of genomic 
imprinting, i.e., the process by which genetic material is differentially expressed 
according to ils  parental origin. Angelman syndrome occurs when the maternal 
imprint is absent from the region, while Prader·Willi syndrome results from 
absen�e ofth. paternal imprint. Imprinting is One of the mechllnisms involved in 
epigenetics, i,e., chnnges In gene activity UllIt occur without variation of  the 
underlying DNA sequence (Riddihough & Penn;si, 2001; Wu & Morris, 2001). It 
is thought that epigenetic processes, such as DNA methylation and RNA· 
mediated silencing, evolved in port as defence mecl1anisms against pnmsitic DNA, 
trnnsposon damage or virus invasion (Falls el ai" 1999; M.1zke el al., 2001; 
Bestor, 2003). CIlm:ntly there are 47 humnn genes listed in the Imprinted Gene 
Cntnlogue, with a relatively eVen distribution between malemal and paterna! 
expression (Monson ., al., 2001; Moriso", 2004). However, as the roles and 
actions of the estimated 25,000·27,000 genes in the human genome arc funher 
clarified, the number of imprinted genes may be expceted to rise accordingly 
(NHGRl, 2004). To date, most of the known imprinted genes arc involved in 
either pro-- or post·n.tni growth and development (Moher el 01., 2003a). 
Although the two syndrome, are similar in terms of their basic genetic 
mcchnnis,"" they differ significantly in clinical presenlalion. AngelmllD 
syndrome OCCnrs in I per 10,000·20,000 births (Hou et al., 1998; Slromme, 2000). 
The disease pbenot)IpC is chlll<lcter;,ed by sC\lere ID, limited speech, an \IllSbJ.ble 
jerky gait, and seizure,. While AS WlIS fllSl clinically dC$oribed by Aogelmao in  
1965, the underlying genetic defect WlIS not rccogaised until the l.te 1980s, with a 
consenSllS opinion on the clinical criteria for dillgl10sis of the syndrome published 
in 1995 (WilIiamsetal., 1995). 
Prader.Willi syndrome has n sImilar p ...... nlence rote to AS ofbetwccn 1 
per 10,000·25,000 births (Slrommc, 2000; Wbinington et 0/., 2001; Smith et al., 
, 
2003). The phenotyplc characteristics include mild \0 severe ID, short stature, 
hypogonadIsm, an insatiable appetite and resultant obesity. It was originally 
described in 1956, a n d  clinical diagnostic criteria wen: developed in 1993 (Prader 
et al., 1956; Holm et al., 1993). As with Angclman S)IlIdrome, Ibe genetic basi, 
was WIly elucidated in Ibe I.te 1980s. 
There is considerable phenotypic heterogeneity among people with each 
S}'I1drome, possibly related to the nature of the underlying defect. The relatively 
recent description and diagnosis o f l b e  syndromes mcnns thot information on their 
clinionl progression is still very limited, and th.re may be many older, 
Institutionalised individuals who have remoined undiagnosed throughout their 
adult life. In "ddilion, little infoneDlion is ovoil"ble on the relationship between 
the disease phenotype and the specific genetic anomaly, or on the medical and 
health obstacles faced by people with either S)IlIdromc in adulthood. This 
knowledge is of prirnary importance in improving our underslar)ding oflbe nature 
and progression of the di�rdCl'S. It is olso needed for oppmpriotc family 
cnunselling and health care services, and ICI incn:ase basic knowledge of Ibe 
influence of imprinting in the chr15qll-q13 region on the ovemU fimction of the 
human genome. 
1.3 Tbe purposeoflhc .Iudy 
The presenl project aimed t o  establish a dodlC8lCd database of people in 
Western Australia (WA) di.gnosed with AS or PWS. The PWJl(lse wllS to allow 
estimotes of the population prevalence of each di,order to be made, and 
compllrisons dmwn between individlll ls within each group. The dalabll5e also CDn 
b: used lIS a resource for further research into the syndromes and the ageing ofthc 
study cohort. 
Descriptions of the sUlVivai and mortnlity patterns of people with AS and 
PWS arc recorded, together with hospital morbidity histories, so that infomllltion 
on the lif""",urse and sUlVival of people with AS IllId PWS CIIIl be provided 10 
flll1lilies, clinicilll s an� genelie wunsellors. Infonnalion of this nature will aid 
Individuals and their families in predicting future health needs and in plWllling 
appropriate inlervl.Tltio",. As the life eKpectancy of people with ID has increased, 
Ibe age of their plltCnlal carers has similarly extendod. This re,ulu In families 
3 
facing a range of probJems, includIng diminishing he�lth of the ageing c�,"" the 
possibility of a sudden end to the carin�. relationship due to InCllpacity or death of 
the Cllrer, and fewer options for employment ilI\d/orsocial activity forthe middle­
aged or older ID indIvidual (Holland, 2000; Bigby % /., 2002). More frequcnUy, 
ammgcmcnts for gtlardianshlp for adults with ID may be necessmy when parents 
are no longer ovoilable to fulfil this role, in a manner slmillll' 10 the increase in 
guardiill\ships for adults with dementia that hO!; occurred in Japan since 1980 
(Mizuno & Nanba. 2003). 
Detailed information on the lifc-courses of poop le with AS and PWS hO!; 
been ""nated and analysed. This project is onc of the frn;! in Australia to 
investigate health IUld ageing issues pertnining 10 AS ilI\d PWS in a defined 
population, and the data can be expanded by the continued future collection of 
informalion o n  these individuats. 
1.4 R""""n:b'lu",,11008 
1. Whal arc the prevalen"" mtes of AS and PWS in Western Australia? 
2. What life-time momid!ti .. W'C COmmOn and/or .pecific to each syndrome? 
3. What ageing issues are relevanl lo people diagnosed with each syndrome? 
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2. REVIEW OF LITERATURE 
2.1 The human genome 
2.1.1 Overview 
The information collected as pari of the Human Genome Project (HGP) 
has hnd a major imJl4c\ On previously held views of the genctic code. it was 
fonnerly believed that each gene encoded a specific protein, Md therefore the 
humM genome would conmin more thnn 70,000 genes (the smnllest estimated 
number of human proleins). However, to dale the HGP has identified only some 
25,OOO-27,()()O gencs, indicating much greater complexity in terms of gene 
interactions and Vllfiations of expression than were previously believed (National 
Human Genome Rosel!rCh Institute, 2004). On avcmge, each human gene can 
produce three different proteins, simply by changes in the initiating sites for 
transcription and to the splicing points (Pennisi, 2001). Almost 50% of the human 
haploid genome, approximately 3 billion base pairs, is composed of repent 
sequences. it is not yet known if these atCa5 perform a particulllf function, 
perhaps as regulators of gene expression. According \0 the director of National 
Human Genome Research Institute (Collias er 01., 2003), the alms of the HOP 
now include: 
J. Identification oran stnJctural and functional componcnts (genes or 
regulators) encoded in the genome; 
2. Investigation ufthe structure of the preleln pathways and genetic 
interactions within the genome, Md establishment of the role of each 
component in the phenotype; 
3. ldentifieation of the range of heritable variation found within the human 
genome, espccinlly the more common variants, e.g., single nucleotide 
polymorphisms (SNPs), smoll deletions, and insertions. 
The role of individual genes In the productiun oh specific phenotype Is 
complicated by the very lorge number of SNPs, which may add many small 
e[feets to a single phenotype. Alternate mutations or mutations at different sites 
en the same gene can result in different disorders. For Instance, n disruption of 
the dystrophln gene at one point leads to Oucheone muscular dystrophy while a 
, 
similar mutalion at a different point results in the clinically less severe Becker 
muscular dystrophy (Gilohrist el 01., 2000). In nddition, the expression pat1cm5 of 
vnrl""t alleles can be Dffected by a wide range of faclors, e.g., environmental 
internctions, s10cbastic events, IIlld intergenetic interactions (Hartm"" cl al., 
2001). 
In S<.lme cases, a nllmber of diffo:rent genes can produce a phcnolypically 
identicnl disorder, suoh as 8utasomal dominDl1t polycyslic kidney di= 
(Gilchrisl el al., 2000), Md different forms of imprinting foilurewithin chrlSql l­
q13 can result in PWS or AS. Continued progress on the delineation of these 
interactions by the HGP ""d similar organisations will increase knowledge in 
these 1Il"CIIS, Md provide expllll1ations for the variations in phenotype between 
individuals with the same syndrome, but differcntgenotypc" It is 01.0 envisaged 
that detailed knowledge of the differences between genotypes will allow precision 
matching of medications 10 act optimallY for th"t individWlI, e.g., a specific 
epilepsy drug which will be effective for tr .. ting individuals with Angelman 
syndrome caused by 0 deletion (Prows & Prows, 20(14). 
21.2 
2.1.2.1 
Genomk imprintillg 
Normaloffem oflmprlllllng 
The process ofimprinling is thoughl to involve the differential methylation 
ofCpG isla n d s  «:yto.sinefguonlne-rich region!! of DNA) in genes located close to 
the imprinting centre. Gene-rich segments of the genome tend I(} have higher 
concentrations of CpG isl""ds than areas with a lower gene density (Pen n l !! ll 
21l(1). If methylation occurs within a promoter region of a gene where 
tnmscripticn is initiated, then transcription ofth� particulor gene is blm:ked. This 
form of silencing is evident in imprinted genes, during X-chromosome 
illllctivntion, ""d when parnsitic or l1lII1'posable sene elements are silenced (Falls 
0101., 1999;Jones &TDkai, 2001; Pork & KurodD,21l01; Best(}r, 2003). 
11 has been hypothesised that genomic imprinting is a ",Iution to the 
conflict of interest thot is presumed to exist between the pDlemnl and motcmal 
genomes, in which the paternal role I. to incn:asc the fitness of progeny, 
irrespective of matemal cosl. In contrnst, the maternal objective is to lImit 
offspring fitness by an amounl sumc;enllo prevent overuseofm"ternal re!!ourocs 
, 
while continuing 10 mrnnlnin relnl health (Haig & Wharton, 2003). The miK\ure 
nf pntemally and maternally imprintod genes found throughout the genome is thus 
likely to represent a compromise between the two po�itioru, especially lIS most 
known imprinted genes affect pro- or posmatnl growth (Falls el al., 1999; Haig & 
Wharton, 2{!o3; Milher et al., 2003a). 
Methylation has beon shoWII to alter the interactions between proteins and 
DNA. These interactions can lead 10 chMgos in chromatin S\nJcture and 10 an 
increase or decrease in the rate of transcription, which is sometimes linkod t o  
cancerous growth patterns (Beliruky el al., 1998; Morison el al., 2001; Martincz­
Delgndu el al., 2002). For example, a tumour suppressor gene (pJ6) is inacti�ated 
by hypcrmelhylatio
.
n of the promoter region in a number of tumour types, 
including lung cancers and squ.nmous cell carcinomas. The degree of methylation 
within the region increases as the IC'lcl of abnolTl1ll ity of the cells increases, 
indicative of a po .. ible link between methylation of the promoter, 10 .. of 
expression, and development of the carcinoma (BeHnsky el al., 199B). 
Hypermethylation of hlstones, especially histone3 on Lys9 (H3L9), has 
been linked to the formation of stably-silenced chromatin regions on the maternal 
chromosome 15 at  the Pmder-Willi syndrome Imprinting centre (PWS-IC). 
Conversely, the methylDlion o f h lstone3 Lys4 (H3L4) has been associatod wlth 
the paternal chromosome IS in the same area. (Xin 01 al., 200t; Lau el al., 20M). 
The chromatin modifieations which result from thIs selective histone methylation 
are proposed epigenetic markers, as the chMges persist throughout development 
and are parent-specific (Xin et al., 200!; Rougeulle el al., 2003; Lac eta/., 2004). 
In addition, noelylated histones have bcen Identified on the unmethylatod Md 
active patcrnul CpG island of the SNURF-SNRPN (SNRPN upstream reading 
frame-small nuc!eolar ribonucleoprotein N) region, wheJ"ellS the inactive maternal 
copy is net associatod with ncetylation (S.iloh & WOOD, 2000). The silenced 
genes have been experimentally reactivated by treatment wlth a DNA 
methyltmnsferasc inhibitor which induces hypomethylation of the SNURF_ 
SNRPN CpG island. However, i t ls not knoWII if this !eChn!que could be used 
therapeullcally 10 help alleviale the symptoms of those with imprinting disorders 
(Sailoh & WadD, 2000). 
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The epigenetic imprint markers that idenlifY the pDl'Cnt of origin are erased 
during early gamelogenesis, and thon reset with the new pm:nt-of-origin mark at 
0, before meiosis U (Talla el a/., 1998; Keljenn cl a/., 2000; Fellluson-Smlth &. 
SUrnni, 2001; Coxe/a/., 2002; Kclly & TlllSler, 20M). In mnle mice an imprinted 
gene, H/9, which produces n fetal liver mRNA, has been shown to be funy 
methylated on the male strand by day 15.5 post-coitus, i.e., lhe pDlcrnal imprint is 
fully es(nblished by the early spem!ntocyte s(nge of gametogenesis, before lbe 
complction of meiosis [ (Lucifcro el al., 2(02). Similarly, in hum"" males the 
HJ9 imprint is acqu ired by the spermatogonia slage of gametogenesis (Kelly &. 
Trnsler,2(04). 
Likewise, in Ule female mOUSe a nlIIge of imprinted genes have been 
,bO\\1l to undelllO methylation at a variety ef times and speeds. Most of the loci 
investigated by Lucifao el al. (2004), i.e., SlV'pn, insulin-like growth factor 2 
rcceptor (Igf2r), paternaily e�p=d gene 3 (Peg3), and mesoderm-specific 
lmIlscript CMes,), arc completely methylated by 25 doys postpartum, nlthough Ule 
process occurs 11\ different stages of oogenosis for each gene (Lucifcro e/ al., 
2002; Lucifcro el al., 2004). In humans, mDlemal methylation ofth. SNURF­
SNRl'N exon I n onnally is fuUy esmblished during late ovulation or aner 
fertilillBtion (EJ-Maarri el al., 2001). The chromosomes iu a female mouse also 
gain methyla!ion asynchronously, i.e., the mntcmally-contributed strand of Snrpn 
ucquircs t h e  imprint earlier in development than the pDlemal strand. Thi. 
discrepancy between the timing of methylation indicates that some form of 
re«lgni!ion process i. available in primordial germ cells which forms a means of 
differentiating betwccn !h. origins of eaoh chromo.ome, even in !he absence of 
hypermcthylation (Davis et al., 2000; Keljean e/ al., 2000; Kelly & Trusler, 
2004). Selective oct:tylation of histones mny be such a means of identification, 
although there may also be other epigenetic changes yet to be identified (Saitoh &. 
WadB,2000). 
2.1.2.2 Fal/�re a/Imprinting 
Loss of effective imprinting can be due to: 
1. Deletion ofa portion of either the pntcmal Or maternal chromosome which 
includes the rel evan! gene/so 
• 
2 .  Unip=1II1 diromy (UPD), i.e., tile inh.ritam:e nftwo chromosom� from 
onc pllI'enl Drld nonc from the other. This may be Dll isodiSllmy (two 
identical chromosomes), or a hcterodlsomy (two different chromosomes). 
The effect of UPO on gene ellpression can VIII}' greatly, depending on the 
nannal role of ,,"ch nllele at thot 1""u5. For genes !hot are not imprinted, 
UPD has usually no effect on expression, nlthough there are = where a 
recessive allele is 'unmasked' due to the present. nrtwo copies from one 
p!lnm� iDstowi of one from each pnn:nt (Hitch in. & Moorc, 2002). Any 
imprinted gCllc which is hypenncthyJoted On both alleles due to UPD will 
not be expressed (nulIisomy), but it would be CKPectcd that imprinted 
genes whlch ore non-methylated on both nll.!es will both be expressed, 
leading to a diploid overdose effect (Smith, 1996). In situ"lions where 
there is phenotypic variation betwoxn UPD and deletion patients, it i s  
possible thot the difference results from 0 gene dosage effect. 
3. Mutatlon by deletion or substitullon within the imprinting centre (IC) that 
leads to disruption of the imprinting process and hence silencing of the 
imprinted gCJIels On both chromosomes (Jiang et al., 1999; Clayton-Smith, 
2001). 
Methylation u s\llll1y acts to silence the relevant gene, thereby limiting ilS 
expression to the al1o1e from the other parent. The importnnce of the contribution 
of both parents to nonnal development is shown by the production of modified 
mouse embryos. Androgenetic embryos, conlllinlng paternal genes only, suffer 
from reduced folllI growth and exhibit a Ven" high growth rate for the extra­
embryonic tissues (plnccnta and amnion). Parthenogenetic embryos, with only n 
maternal gene ccntribution, show normal folll  growth but gICally reduced extra­
embryonic growth. Neither type of embryo is viable t o  term (Falls el al., 1999). 
The delay In resetling the epigenetic marker on specific chromosome 
.<lrnnds, (Section 2.1.2.1), may help to Cltplain the recently reported Increase in the 
risk of imprinting disorders found in cbildren conceived by inlracytoplasmie 
spermatozoa injection (lCS!) Or other assisted reproductive technologies (ART). 
It is possible that the oooytc may fnil 10 complete its nonnal post-fertilisation 
maturntion, which includes the resetting of the epigenetic mnrlt, when undergoing 
the laboratory processes involved in leSl or other type. of ART (Fcrguson-Smith 
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& SUmni, 201!l, Coxel al., 2002, DeBaun el al., 2003, Orstavik el al., 2003). In 
addllion, defe.:;:tivc Hl9 methylatlon hllS been shown to be lIS,\ociatcd with 
abnonnal spermalogenesis aud a consequent low sperm <:ount (Ml1I"ques el al., 
201l4), which may DI"" have implications for the long-term outcomes of =isled 
reproduction techniques. 
A report on the safety of lesl found no abnormal methylation effects in 
infants conceived by this method, although the !;ample site was quite small (n � 
92), ond subscqucntanalysis of sperm smnpl,,s (n �  90) collected for ICSI showed 
no imprinting abnorm.alities (Manning el a/., 2000, Manning el 01., 2001). A 
Danish investigation into the outcomes of ART hnd concluded that the slight 
increase in perinatal mortality and congcnitnl malformations was most likely due 
to the effects of multiple births (WestcrgWlrd el al., 1999). More recently, 
however, infanlS <:onceivcd by ART in Western Austmlia have been shoWII to be 
twice os likely to suffer from a major birth defect as natunllly conceived infants, 
and to have tower birth weights (Hanscn cl 0/., 2002), nnd simill1l"ly conceived 
infants in Finland hnve higher rDtes ofeongenilal heart malformation (Koivurova 
d al., 2002). Both sets ofresulls were significant even after controlling for the 
effects of mUltiple births, which ore more commOn in ART conceptions, and there 
are specific morbidity problems associated with such birtlts (Sutcliffe, 2002). A 
subsequent review of the literature on leS! indicated an increased risk of 
congenital and genetic abnormalities, although the authors concluded that the 
Imoreose could be ",Iated III the underlying cause of inferli1ity in the parents 
(Retzloff & Homslein, 2003). 
Assisted "'prodUctive technology may also alTcct the incidence of 
imprinted disorom. Both Angelman syndrome and Becl;with-Wledemann 
S)'lldrome (BWS, MIM 130550) havo been reported to occur2-6 times more often 
than expected in children conccived by in-vitro fertilisation (IVF) or ICSt 
(Hnnscn el al., 2002: DeBaun .1 01., 2003, Gicqucl el 01., 2003, Gosden el al., 
2003, Orstavik el al., 2003: Halliday el aI., 2004). BWS is an ovcrgrowth 
S)'lldrome chllnlcterued by macroglossia (palllOlogical and congenital enlargement 
of the tongue), pro- Or postnatal overgrowth, and abdominnI wall defects (paulsen 
& Ferguson_Smith, 2001). Almost half of all BWS cases have been associated 
with nbnonnnl imprinting of the KCNQJOT gen. at clIrllpl5. This leads to 
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demethylation of the KvDMRI region of the gene and subsequent biallene 
expression of insulin· like growth factor !I (lGFII), whioh appears to contribute to 
abnormal developme!lt of the hypothalamic·pituitwy·ndrenal axis and subsequent 
growth accelemtion (Cole, 1998; Gicquel et al., 2003; Mnber et �I., 2003b). 
Despite an eAAaustive selll'Cb of onlice dntabascs, there aplXl!lt \0 be uo published 
reports ofPWS in artifieia!Iy-coneeived cbiI�n, which may be due to the fully 
functional patern.l imprint by the time fertlllsation lakes place, in IlOntrast to the 
sub-fimctional malCrnal imprint (Geuns et al., 2003). 
In addition to Angelman, Bockwith·Wiedcmann and Prnder-Willi 
s}'lIliromes, transient neonatal diabetes (TND; M1M 601410) and SlIvcr-RusselI 
syndrome (SRS; MIM 180860) hove been identified us imprinting disorders. 
Paternal uniparental disomy of chromosome 6 (UPD6) has been linked with the 
development of TNO, IIIId two imprinted genes are known 10 be located in the 
eltr6q24 region. These arc inferred to bave some effect on the diseru;e phenotype 
(Arima �t al., 2001). Similarly, maternal UPD7 is implicated in 7·10% of SRS 
casus. In Silver-RusseIl syndrome beth pre· and postnatal growth retardation are 
presen� seemingly caused by either under-cxpression of p.temal growth. 
promoting genes, or over-expression of motemol growth·inhibitors. There are 
also a rnnge of dysmorpbie feature.s associated witlt the SY,ldrome (Hitehins & 
Moore, 2002). 
2.J.2.3 The role of Imprinting/ailure in the development o/PWS and AS 
Angelmoo ond Pmder·WiIIi syndromes differ phcnotypically, altltough 
they both result from failure of imprinting or gene mutation within the same 
region of chrI5qll-q13. In genel1ll, if the affected chromosome is maternally 
derived tIlen Angelmnn syndrome occurs, wberens Pmder-Willi syndrome results 
if the paternal cbromosome is altered. Usually there Is nO obvious gender bias in 
either syndrome, olthough more boys thnn girls are identified with PWS before 
adolescence, possibly due to tile more subtle pbenotypic changes in prepubescent 
Sirls (Smith et al., 2003). 
Genetic testing for PWS or AS commonly begins with methylation 
analysis. There are " number of sites within the chrlSqll·ql3 region tIlat are 
hypcnnethylnted on the maternal chromosome, e.g., 5'SNRPN, NDN, ZNF127, 
" 
8Ild PW71, and wme which are prefen:ntially methylated on the paternal strand, 
e.g., u ID, YL48E and SNURFISNRPN intron 7. Ofthesc loci, fSNRPN h..., bce:\ 
recommended ..., the most accurate ond reliable site for the assessment of 
hypermethylation and it h..., been adopted for prenatal diagnosis (Kubota el al., 
\996: Glcnn elal., 2000: GeullS el al., 2003). SNRPNis expressed from only one 
olle!. by the 4...,.U, i.e., pro-implantation, stage of embryonic development 
(Huntriss et al., 1998). The other hypcnnethylation sites (NDN, ZNF127, PW71, 
uID, YU8E and SNURFISNRPN intron 1) have been found to be less infonllotive 
than 5'SNRPN, and to give highcr rates of incorrect diagnoses (GeullS et al., 
2003). Comprehensive methylation Molysis of both PWS Md AS cases with M 
imprinting defect showed that u variety of loci were affected, with methylation 
ahnormal on both chromosom� S\rnr,ds (Runle el al., 200Ia). 
The presence of a single band on methylation testing indicates uniparcntrJ 
methylation, Md the size of the bond identifies which parental pattern is prcsen� 
I.e., 4.2kb for the mntemol band and 0.9kb for the paternal at fSNRPN (Kubota el 
01., 1996). The chonges in methylation may re due to deletion, UPD or an le 
defcc� therefore further testing is neccssury to delemlinc which of these specific 
mechanisms is present (Wi!llams el al., \99&). The discovery of two bands 
(biparcntol methylation) is sufficient to exclude the diagnosis of PWS in most 
cases, but not \0 exclude AS (Buchholz el aI., 1998: Fridman elaf., 2000b: Glenn 
el al., 2000). Biparental methylation in AS can re an indication ofu single gene 
(E6-AP ubiquitin-plotein ligl!l;e: UBE3A) mutation (Mal5uum et 01., 1997: 
Monela er al., 1999a), but there also is a proportion of clinlcaIiy-diagnosed AS 
patients with no eUITeJI!ly identifiable genetic defect. 
2.2 AageIman-'Yudrome 
1.2.1 History and hat:kground 
Angelmll!l syndrome w..., first described in 1965. The pbenotypo was 
cbll!llcleriscd as a combination of SC'Iere lcaming disability, seizures with a 
specific electroencepbalogram (EEG) pattern, absent s�ch, jeJky alalllc 
mevements, and a happy sociable disposition (Angelman, 1965). ConsellSus 
diagnostic criteria, listed in Table 2.1 (p.l3), were subsequently published in 1995 
(Williamselol., 1995). 
Table2.1 Diagnostic criteria for Angelman syndrolDe 
Coruistenl (100%) 
Functionally SCVere developmental delay 
Speech impainnen� nO or minimal use of words 
Movement Or b.l""ce di.5o,der, 115ually ataxia of gait andlor tremulous movement 
of limbs 
Behavioural uniquencs�: any combination of frequent laughter/smiling; apparent 
happy demeanour; easily excitElble pcl'SOnality, often with hEll1d-flapping 
movements; hypennotoric behaviour; short attention spon 
Freqaent (>80%) 
Delayed, disproportionate growth in head circumference, usually resulting in 
microcephaly (absolute or relative) by age 2 years 
Seilllres, oruet llSually <3 years of IlJlc 
Abnonn.l EEG, ehoracterlslic pattern with large amplitude slow-spike waves 
(usually 2-3Is), facilitated by eye dosure 
Assoclaled (2l1-li0%) 
Flat <xx:iput; occipital groove 
Protruding tongue 
Tongue thrusting; suck/swallowing disordcrs 
Fceding problems during infancy 
Prognathia; wide mouth, wide-spaced teeth 
Frequenl drooling; excessive chewing/mouthing behaviours 
Strabismus 
Hypopigmented skin, light hair ""d eye colour (compared to famny), seen only in 
deletion cases 
Hype,,"ctive lower limb deep tendon reflexes 
Uplifted, flexed ann position especially during ambulation 
Increased sensitivity to heat 
Sloop disturbance 
Attraction tolfascinotion with water 
Adapl�dfrom IYilliamsel al. (J99J) 
The diagnosis of AS is usually based on clin;cnl findings, and it is nOW 
confinned in 80_85% of cases by cytogene�c or DNA testing (Loan "I al., 1999a). 
The flfS! diagnostic tests for AS were introduced in 1937 (Clayton-Smith & Laan, 
2003). Since that time, e!Torts have focused on further elucidating the genetic 
mecbanism underlying AS, and many dCSCIiplions of the variant phenotype and 
life-course orthe syndrome hove been produced. 
22.2 
2.2.2.1 
Th� Angelman syndrome phMOtype 
Developmental characterisllcs 
AngelmDII syndrome palients have been reported to be phenotypically 
normal during the prenatal and perinatal perioos, will, no diagnostic 
clmrncteristics in the newborn infant (Cassidy & SchwllriZ, 1998). Howev.r, 63% 
of the deletion patients seen by Smith (1996) showed hYPolOnia at birth, and even 
more (71%) had experienced fceding difficulties during infancy. D ....  !opmental 
delay is generally manifest by 6_12 months of age, when a delay in Independent 
sitting becomes .... ident (Willioms cl al., i995; Cossidy & SehwllriZ, 1998: Lean 
Cl al., 19998). Sitting is normally accomplished at around one year of age, and 
walking may be delayed until !be eighth year (Smi!b el al., 1996; Ln:m e/ aI., 
1999a). Males tend 10 ""hieve molor milestones al an earlier age than females 
(Leitner& Smith, 1996), al!bough the two non-ambuJ""1 individuals from a group 
of 1 1  patients s •• n by Sandmmm e/ al. (I997) were both male. Walking olien 
becomes more dimcult with increasing age, with as many as 42% of patients 
becoming wheelchair_bound in adul!bood due 10 a range of problems including 
obesity, an unwillingness to exercise, DIId scoliosis (Clayton-Smith, 2eOI). 
Delayed or absent speech is onc of the cardinal features of AS. Few 
patients ever learn to speak Md any who do generally a"'luire only a vcry limited 
vocabulary, although comprehension oflanguage is usually reasonable (Andersen 
el al., 2001). Small amounts of gestural or signed language may be learned 
(Wi11iwru; el al., 1995: Cassidy & Schwartz, 1998; L""" el al., 1999a). A 
vocab�lary of 4-10 words was used by halfoftl-.e UBE3,{ mutation palients Cn � 
14) studied by Monela Md co-workers (199�). These patients showed a higher 
level ofcomprebension and non_ve,b�l communication than is normal for people 
with AS. Clayton-Smith (2001) also reported improved non-verbal 
communication skills in a group of older patients (n D 28: ages 16-40 years), due 
to the improved coneentrntion span frequently found in older AS individuals. 
ID is present in all people with AS and is usually within the ScVere 10 
profound range, i.e., with measured IQ levels and an adaptive behaviour 
lISSessment of I.ss IbM 40 points (Smi!b el al., 1996; Clnyton_Smith & Lnnn, 
2003; Beckung cl 01., 2004). On averuse, patients with 1UI imprinting centre 
14 
disorder have been found to have less severe ID thM those with AS caused by 
other Genetic mcchanisms (Glllos.len_Kaesbach et al., 1999). 
2.2.2.2 Plrys Ical characteristics 
Thcjcrky, ntnxic movements nssoeialed with AS are appnn:nl III an early 
nge and continue into Inter life. When walking, the arms are commonly raised and 
held at o distancc from the body, with flCKed wrists and elbows. HMd-flapping is 
also often involved, and the legs are generally kepI stiff {Smith et al., 1996: LaM 
el al., 19990: Bcckun� et al., 201)4). Scoliosis develops in Dll estimated 40-70% 
of affected individuals (Lnan el al., 1996: SDlldannIn el al., 1997: Clayton-Smith, 
200 I), !I/1d tan contribute to a loss of mobility as the palients oge ('�Jnyton-Smith 
& Lann, 2003). Surgery for scoliosis has been performed on some p'tients, ollen 
with good results, and the o""",lion is quite well tolerated by most Individuals 
(Lassie et al., 2001). Hypertonicity (high muscle tone) of"'e lim')!, generally 
found in conjunction with truncal hypotonia (low mnscle lone), cu 1000d lojoint 
contractures and 0 stooping posture lIS patients become older, and it may have a 
demmentnl effcct on mobility (Cassidy & Schwnrtz, 1998; Clayton_Smith, 2001; 
Clayton_Smith & Loan, 2003). 
During the f!/"SI rew years of life AS patients often devetop a distinc�vcly 
shoped head, commonly either b/llchyccphaly (0 disproportionately wide head) or 
microcephaly (small head size) (Smith el al., 1996; SMdanum el aI., 1997; Lnan 
el al., 19990). Facial fentures that may OCCur include a long mouth with widely­
spaced teeth, flat occiput, mnndibular prognathia with a poinled chin, nnd a 
protruding tongue. These chllrllclerist;cs tend to become more pronounced with 
advMcing ogc (LIUIIl el al., 19990: Claylon-Smith & Lnan, 2003). 
Between 15-32% of adult AS patients become obese, although true 
hyperphagia, as found in PWS, isran: (Smith 01 al., 1996; Clayton-Smith l!:. l.aan, 
2003). ObesIty can lend to ocsoph�SOllI n:flux, and also contribute to loss of 
mobility. It is common for AS individuals to show hYJlOPigmr.ntation, i.e� with 0 
lighter skin, eye and hair colour than th.ir unaffccted siblings (Loan el 01., 1999n; 
Lassie et 01., 2001). However the halt may darken with age, as is common ill the 
general populntion (SandMWTI et al., 1997). Older AS paticn!!:U" ofien found to 
suffer from strabismus (37.57%), IUld keratoconns (TVa) (LaM el 01., 1996; 
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SnnWmam el af., 1997). There is no evIdence ofabnonnal genital development in 
AS =s, unlike the hypoplnsia found in PWS, Md puberty occurs at the eJt]ll>Cled 
age 8lld proceeds in a nonnal f,,-,hion (Williams el 0/., 1998: Clayton-Smith & 
Laan,2003). Females with sevcre ID mny, however, have difficulty dealing with 
menstruation DIld many ore prescribed conlrnceptives to control menstrual 
bleeding. 
2.2.2.3 Behavjoural aspecls 
Angelman syndrome was once tenned the 'bappy puppet syndrome', 
because of the chllrncleristic gait (Section 2.2.2.2) nnd behavioural troits of 
patients (L.nn et 0/., 1999a). innppropriatc smiling or laughter, a happy socIable 
disposition, short ottention span, and W1 easily excitable pcl"SOnnlity ore present in 
most individuals with AS (WilliDIl1s rl al., 1995: Smith el al., 1996; Lnan el al., 
1999a). Even babies bave been noticed loughing during the first fcw weeks ofHfe 
nnd this fonn of laughter genemlly continues throughout life, nlbeit at reduced 
frequencies (S8lldanDIl1 cl a/., 1997: Clnyton-Smith & LIl.IIlI, 2003). Hypemctivity 
nnd excitability are less common in older individuals with AS, who have a betler 
conceIltration span thDII YO\Ulger patients (Lnan el 0/., 1996; Clayton-Smith, 
2001). A significnnt proportion of AS cases su(fer from sleep disturbances, with 
either a reduced need for slccp or abnormal sleep/wake eydes. These abnormal 
sleeping habits oflcn improve with age (Smith cl 0/., 1996; SandanDIl1 el 0/., 1997; 
Willlams cl 0/., 1998: Ohta cl al., 1999n; Clayton-Smith, 2001: Clayton-Smith & 
Lnan,2003). 
Many AS patients ore reported to have a foscillation for water, reflective 
surfaces, and balloons (Williams el 01., 1995; Clayton-Smith & Lann, 2003), 
although the signIficance of this behaviour is unknown. 
2.2.2.4 Neur% gjcalj/ndlngs 
Seizures life present in npproximately 80% of AS cases during childhood, 
with OllBet nonnaUy within the first few years of life. The scizUftS W1l often 
difficult to <:entrol, especiaUy in patients where the causative abnonnality 
involves the deletion of genetic material (Leilner & Smith, 1996; Smith el al., 
1996: MinDssian " 01., 1998; Clayton_Smith & Laan, 2003). Some studies have 
reported a decrease in seizmc frequency during adolescence, but with mMy 
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individuals cxperj�"cjng a return oflbe seizures in adulthood (Lean er al., 1996; 
SDIldllIHlIII el al., 1997: Clayton_Smith, 2001). By com)lill"ison, other researchers 
have descrlbed 11 sllSlalncd decreo.se in seizure frequency 1010 adulthood (Bunlinx 
ellll., 1995). 
Almost all AS palients have an abnonnal EEG profile, even in the absence 
of,.,izure activity (Sandaomn el al., 1997; Smith e/ 111., 1997; MinOlS,ill1l el Il/., 
1998; GUlcsscn-Kocsbnch .101., 1999; Clayton-Smith & Laan, 2003; Valente e/ 
0/., 2003). A number of specific patterns have bccn identified which may 00 
present 01 different limes in the 5aIIle individual. Many AS children ,how 
persistent high amplitude 4-6Hz ,low-wave brain octivity which is nOl llSsocinted 
with drowsiness (1IIe delta paltern), although this will often disappear in later life 
(Mntsumolo e/ al., 1992; MinElSSi!lIl e/ 01., 1998; Lean el al •• 1999n; LWlII ", al., 
1999b; ValcnlC c/ al., 2003). In older AS patients, prolonged runs oftriphnsic 2-
3Hz rhythm, primarily over the frontal region, have been found to be more 
COmmOn (Loan e/ al., 1996), and spikes ns,oeiated with 304Hz waves across the 
posterior area have also becn idenlificd (ClaylOn·Smith & LlI3I1, 2003; Valenlc e/ 
al., 2003). 
2.2.3 Genetic basis of Angdman syndrome 
Table 2.2 Categories of AogelmnD and Prader-'h,lli syndrome by 
genolype 
Type ofmecbaDllim Persoosn(fectcd (%) MetbylaUoD Rccurnmce 
AS PWS 
Deletion 65-75 70-74 Abnonn .. 1 Very low 
Uniparental disomy �7 24-28 Abnonnlll Very low (Ul'D) 
Imprinting centre �1O 1-3 Abnonnnl Significant (IC) defects 
UBEJA gene 4-0 ., Normal Significant 
Unknown 10-20 <I Nonnnl ... 
Adap/edjromJiange/al. (1999) 
" 
As shown in Table 2.2 (r. 17), the genetic basis of AS has been sub­
divided into four main m""honisD�, described below. However, there is also a 
signifiCllnt proportion of cases in which no specific aetiology has been dermed, 
Md some of these may be eonfu:,ed with n rnnge of mimicking conditions, such as 
Rett syndrome or LClUlox..(lnstDut syndrome. 
2 U.J De/Cl/an 
Tnble 2.2 (p. 17) indicates that the most coll',mon cause of AS is a--lMb 
deletion in the chrlSql l-ql3 region of the malemally-derived chromosome, found 
in 6S-75% of AS cases (Jiang el a/., 1999). In oddition 10 this large-scale 
deletion, there is a small group of Individuals with unbalanced tnmsl()CDtions and 
smaller deletions In chrlSql l-qI3. The deletions are detooted either by high 
resolution banding, or by fluorescence in-situ hybridisation (FISH) after n 
unipnrentnl methylation pooem husbeen Identified (Williamselu/" 1998). 
The region of chromosome IS CQmmonly deleted in AS isshown in Figure 
2.1 (p 20). It involves two centromeric break_points (BPl & BP2), and one 
!elomeric break point (BP3), with approximately SOOkb between BPl and BP2 
(Butler el 0/., 2004). The deletions are thought to result from unequal crossing­
over between either complete or truncated CQpies of the HERC2 gene, which fonn 
one set of low-copy repeats at the tclomerie end of the region, and another set at 
the ccntromcric end (Ca.rrozzo elol., 1997; Ji el 01., 1999; Mnnn & BnrIOlomei, 
1999). The Herc2 gene in the mouse hus no repents, bUI mutntions in this gene 
lead 10 a rnnge of defects, i.e., neuromuscular, =retory vesicle and spenn 
acrosome defects, andjuvenile lethality (Ji e/o/., 1999). 
A recent study found thol a heterozygous inversion between BP2 and BP3 
wru; relatively commOn (67%) in the mothers of AS patients with a BP2-BP3 
deletion, but a similar inversion was not present in the mothers oflndividuals with 
BP1-BP3 deletions or with UPD (Gimelli cl 0/., 2003). It is SUll&ested that the 
Bn-BP] inversion, which is present in around 9% of the general population, 
could predispo;e to breakage at these specific points. However, lIS the risk of 
recum:noe for AS deletions is less than 1% (Jinng el 0/., 1999), the pcnctrancc of 
the increased risk of chromosome breakage is likely to be very low at 0.1_0.2% 
(Glme11i e/ 0/., 2003). 
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The common telomeric breakpoint and two centromeric breakpoints are depicted as vertical jagged lines and are separated by 4Mb (distances not to 
scale). The imprinting centre (IC) is bipartite, with the cis element required for maternal-to-paternal switching shown as a blue oval overlapping the 
SNRPN promoter (deletions in this region cause PWS). The more upstream element of the IC required for switching from paternal-to-maternal is 
shown as a pink oval ( deletions in this region cause AS). Genes or transcripts known to be paternally expressed are blue, and maternally expressed 
transcripts or genes are shown as pink. Transcripts that are not imprinted, or those for which the imprinting status is unknown are not given any 
colour. Transcription direction, if known, is indicated by arrows. 
Adapted from Jiang et al. (1999) and Meguro et al. (2001) 
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1.1.3.1 UnlparenJaJ d/somy (UPD) 
Paternal UPO accounts forbetweeD 2%and 7% of AS cases (Glenn el aI., 
1997: llang el al., 1999: Lossie el al., 2001; WilIillII\S el al., 2001). The pr<:SCJIOC 
of two paternal and no malernw copies of chromosome 15 is oRen a result of 
monosomy rescue, i.e., llIe inherilanoc of one paternal chromosome 15 and no 
malemnl copy (due 10 n malernal meiolio error), followed by po:<t-zygotic 
doubling of the paternal chromosome to correct the IOto] chromo,ome number. 
This reS\llts in identi""l pnternal chromosomes (isodisomy) (Robinson el al., 
2000). UPO may wso result from meiotic non-disjunctioD during 
spennatoge"esis, leading 10 a trisomIc conceptu,. Loss of the maternal 
chromosome 1S (trisomy rescue) then leaves only two different paternally-derived 
chromosomes (hetcrodlsomy) (GyRodimou el al., 1999). 
A parcntal tmnsloCl tioD Or other structural rearrnngemenl within 
chrl5q I 1-q13 increase, the likelihood ofrccurrence, due 10 the higher probability 
of 0 non-di,junction event (Smith .1 al., 1997; Robinson el al., 2000). 
Microsntellitc annlysis of the probruld and parents, using markers from outside the 
PWSlAS area, will differentiate between UPD and a deletion. That is, if markers 
from both parents arc pr<:senl, the patient h", a deletion, if not, then UPD is 
indicated (Willi""" el 0/., 1998; liang el a/., ]999). The type ofdisomy can also 
be di:<tingui'hed In this manner, e.g., if only one type of allele from the father is 
found atcaciJ marker, then i,odi,omy is indicated. 
1.1.3.3 ImprlnJing <:enJ/"/! (le) defects 
As shown in Figure 2.1 (p. 20), the imprinting centre spans the section of 
chrISqll-q13 centromeric ofllle S/I'RPN gene (Farber et al., 1999). There are 
two components of the le in the cbrlSq] 1-q13 "'gion, with the more upstream 
component, the AS smallest region of overlap (AS-SRO), approxim.tely 900bp in 
size. This element Is involved in changing the imprint from palernw to maternnl. 
Any mutation or delelion that offects this element will lead to a malernwly­
inherited chromo.<ome llIat has patcrnw marking, and so will nCI as 0 paterna! 
chromosome (Sailoh et 0/., 1996; Farber et Ill., 1999; Ohta el 01., 19990). 
Imprinting mutations, caused either by the deletion of 011 or part of the le, or 
some other mutation, are found in 2-10% of AS cao:es (Rougeulle & lalande, 
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1998: liang el aI., 1999: Lossie cl a/., 2001: Willimn! el a/., 2001: Duitlng et a/., 
2003). 
The pres<:nce of an abnormal methylation pattern and biparental 
inheritance ofmicrosntellite markers within the PWSfAS region is indicative ofan 
le abnormality (JiDJIg e/ aI., 1999). Almost halfofindividuols with an IC defect 
have hud no mutation identified, and It has been suggested thot these defects are 
abnormal epigenetic state.!, or epimulatio"s. It also h!lS been hypothesised that 
epimutations arise from spontaneous events during the fertilisation proce,. 
(Buiting et al., 2000: Builing .1 aI., 2003). 
2.1.3.4 UBEJAgcno 
The UBEJA gene has been described as the 'AS gene', and point 
mutalions within the gene on the mnlemat chromosome hove been found in 4-14% 
of AS potients (Kishlno .1 aI., 1997: Jiong el al., 1999: umie el al., 2001: 
WlIIiwns el al., 2001). The UBEJA gcne is located downstre.lm of the IC and the 
SNRPN gelle (Figure 2.1, p.20), and the gene product is a ubiquitin·protein ligase 
(E6-AP), which is involved in the degradation ofo nmge of proteins (Jiang el al., 
1999). In UBEJA patients Ille methylation pattern within Ille PWSIAS region is 
normal, i.e., biparenlol, and the ,,"alysis of micro satellites also shows biparental 
inheritance. Testing for UBEJA mutations is indicnted whenever there is an AS 
pilellotypc, including an abnormal EEG, with normal methylation and biparental 
chromosomal inheritance lIS evIdenced by genetic testing (Lnnn el 11/., 1999b). 
The IlliIjority of UBEJA mUllltions nrisc d� nova (Matsuum et al., t 997), although 
there is some evidence for somatic mosaicism of UBE3A mutations in 
phenotypicn1]y normal carriers (Moncla et 01., (9990). 
In vnrious cells of the body, such lIS !ymphocytes, fibmblnsts and cells 
from the kidney and heart, UBE3A is expressed from both Ille maternal and the 
paternol nIJelcs, although the imprint marker is still present and Ille paternal 
expression is reduced compared 10 (hat of the motemal allele (Vu & HolTman, 
1997; Herling el al., 2002). However, in parts of the central nervous system nod 
Ille brain, especially Ille hippocampal nod Purkinje neurons, UBEJA is expressed 
only by the maternal copy (Albrccht et al., 1997; Rougeulle el a/., 1997; 
Rougeullecl al., 1998: Ruugculle& Lnlandc, 1998: Mann &. BlU1o!ome� 1999). 
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Two altemative UBEJA RNA transcripts have boon identified. One, the 
UBE3A sen.., transcrip� was expressed biallcHcally in glial cells in the embryonic 
brain, but from only the materna l  chromosome in neurons. The other Mtisensc 
transcript (UBE3A-ATS) was only expressed from the poternol chromosome, and 
only in neurons (Yamasaki er al., 2003). As sholm in Figure 2.1 (p. 20), the 
UBE3A-AlS eX!eIJds downstream from the imprinting centre, through the 
SNURF-SNRPN Md IPW loci, and ovorlops UBE3A (Runtc er Ill., 2001b; 
Rougeulle &. Heard, 2002). There are two alternate splice ""nfigurations of the 
UBE3A-ATS, both of which appear to function as suppressors of the expression of 
UBE3A from the paternal chromosome (Chamberlain &. Brannan, 2001; Landers 
el Ill., 2004). As yet the role played by UBE3A and UBElA_ATS in the 
development of the AS phenotype has not been detcnnincd. It is, howC'l.r, 
nnticipated that as more gene products and the interactions between them nre 
identified, the infonnotion mode available will improve understanding of the role 
of UBE3A in the aetiology orAS. 
2.2.3.5 Unknown 
In npproximately 10-20"10 of clini<:ally dlagnosod AS patients [fable 2.2), 
none of the above genetic abnormalities have been identified using current 
laboratory t\l\:hniques. For this reason, cases with biparental methylation and no 
identifioble UBEJA mutation nre classoo lIS 'Unknown'. It bas been suggested by 
WilIiams and co-workers (2001) that some of these cases may DCtually be 
dilTerent disorders that mimic the AS phenotype. Possible candidate disorders in 
thi, category are Reil syndrome, a-thalasSilemia retardation syndrome (ATR-X), 
nuti'm spectrum disorders, any one of a variety of chromosomal defects, Lcnnox­
Oastaut S)IIIdrome, Gurrierl S)IIIdrome, and general dC'leiopmental dol.y 
(Williams �I al., 2001; Clayton-Smith &. Loan, 2003). 
There is also the possibility that mutations in other, as yet unidentified, 
genes which form part of the ubiquitin pathway could lead to either the non­
expression of UBEJA or blockage of the pathway at some other point, and thus 
result in the AS pbcnotype (Lossle 0111/., 2001; Clayton·Smith &. Lann, 2003). In 
addition, there may be genes within chrlSqll-q13, unconnected to the ubiquitin 
pathway, that affect the AS phenotype. One such candidate gene is ATPlOC, 
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mapped to 230kb distal of UBEJA (Figure 2.1, p 20), which produces an 
aminophospbolipid·transporting ATPase, and is preferentiolly expressed from Ibe 
maternnl cbmmoscme in the brain (Hening el al., 2001: Mcguro ct w., 2001). 
ATPJOCmay be Implicated in chromosome IS-associatcd aulism, and it may also 
influCllce Ibe development of AS, as Ibe gcne product is postulaled to be involved 
in cell signalling (Herzing el al., 2001). However, in ;lIlmans no e�idence of 
mulll ion wilbin Ibis gene has yet bc<:n produced (Claylon-Smilb & lnan, 2003). 
MOSllicism hilS been identified in some AS palients. On investigation wilb 
FISH, n ca.e of clinically typical AS wilb biparenrnl melbylatIon WIlB found 10 
hove .omatic mosaicism for a deletion ofchrISqll-q13 (Tekin el al., 2000). It is 
possible that funber cases of mOSllicism may remain unidentified because of n 
lack of FlSHlesling afier the discovery of a bipnrenllll melbyl.tion pattern. 
2.2.4 Genolypdphe1lotyJUl correlations 
The phenotype of AS may vary according to the underlying genetic 
mechanism. In general, patients wilb UPD or an le defect have Ibe least 
deleteriollB phenotypes, while do!etion = are Ibe most .. verely affected 
(lossle et al., 2001). 
Aogelman syndrome individuals wilb chr1Sql l-q\3 doletions have been 
shown to hove lower body mass indice., earlier oruet ofBeizures, and more .. Vere 
epilepsy Ihan Ibose wilb UBE3A mUllllions, followed by Ibose wilb UPD and [C 
defects (Smilb et al., 1997; Minassian el al., 1998; Gmessen_Koesbnch et w., 
[999; Moncloet 01., 1999b; Ohta et aI., 1999n). It nllB been hypolbesised thol lbc 
more severo seizure activity found in deletion cases may be due to Ibe loss oflbe 
GABRBJ gene which is situated downstream to UBE3A (Figure 2.1, p. 20). 
DeletIon cOSe. are al.o more likely to walk �I a 1.ler age than indivldunls wilb 
UPD, 1-8 years for delelioa vS <3 years for UPD, allbough Ibe number ofUPD 
patients sampled hllBbeen small (Smilb el 01., 1996; Smith elal., 1997). 
Microcephaly is le�s common in UPD DIld UBEJA polients thDII in 
deletion cases (Smllb el al., 1996; Smilb el al., 1997; Monel" et al., 1999a; 
Moncla et al., 1999b). UPD or IC palicnts are more likely to achieve a larger 
vocabulary IbDII tho.e wilb deletioru, UBEJA abnurmalitIes, or wilb AS of 
unknown ''<lliology (Moncla e/ al., 19990; Monela cl al., 1999b; FridmDII Cl al., 
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2000a; Lossie e/ al., 2001). le patients are more liable to be hypotonic and/or 
obese, and to have a mild/moderate intellectual disability. They are less utaxie, 
less prone to epilepsy, and have a nomml head circumference (GiUessen_ 
Kaesbach e/ aI., 1999). 
The nge at dingnosis d()Os not seem to be greatly affected by the 
underlying genetic mechanism of AS. Deletion patients have been reported with a 
mean age at diagnosis of 8.8 years, and UPD cases nt6.6 years, a non-significant 
difference (Smith et aI., 1996; Smith el al., (997). Other studies confinn that 
then:: is no substantlDl discrepMcy in the ages at dingnosis between delction and 
non-deIelion patients (Monela el al� 1999b). 
It Is thought that loss of the maternal allele of the P gene from the 
tclomerie end of chrl5qll-q13 (Figure 2.1), coupled with the presence of a 
mutation in the remaining paternal allele, Is responsible for the lock of hair, eye 
and skin colouration found mainly in deletion cases. Mutation in the P gene has 
been shown to lead to oculoeutancous albinism type 2 (OCA2), an antosomal 
recessive disorder in which melanin production in the skin, h.ir and eyes is 
defective (li • llg e/ al., 1999: Snitoh et al., 2000). UPD patients with 
hypopigmentation may have had n palemDl recessive aUele 'unmasked' when it is 
present in both isochromosomes. 
[n deletion CIlSes it has been suggested that haplo-insumciency, i.e� 
deficient gene expression by the lone allele, of any non-imprinted genes in the 
PWSlAS region could magnify the effects of the lossofcxpression of UBE3A. In 
turn, this would lend to the more seVere clinical mEUlifesl.lltion observed in these 
=s. Simil.,.]y, the extnl dosage ofp.ltemally expressed genes found in UPD 
and le eases may ameliorate the effecta of the loss of UBElA expressIon on the 
disease phenotype (Lossie e/ al., 2001). However, there is no obvious renson why 
le p.ltients, who have two paternal-type thromosomcs, have PWS-likc fcature, 
(obesity and hypotonia) when these Imits occor in PWS patients who have no 
paternally mO/ked thromosome ]S (GIll�.ssen-Kne,bao:hel al., 1999). 
An even milder phenotype than that generally described for AS pntients 
has been reported in n sincle AS CIlSC with UPD, and an additional small 
supernumerary marker (SMC) chromosome IS. This patient showed less ataxia 
than more typical eases, better communication skIlls, milder seizure activity 
(confined to infnncy), and nononl pigmentation (Thomp"'" & Bolton, 2003), The 
SMC may have contained genes that were nol present in an active form On the 
chromosomes, thus supplying the products absent In those with the classical AS 
phenotype. 
2.3 Prader-WlIIill)'Jldrome 
2.3.1 His/ory and hacAground 
This disorder Was first described by P/'IIder, Lnbhart and WilIi in 1956. 
Symptoms common to all palients were learning disability and behaviour 
problems, hyparphngin and obesity, nnd delayed sexual development (Stale & 
Dykens,2000). The genelic basis ofPWS was c1nrified in the late 1980., with 
consensus diagnostic criteria published by Holm and othen In 1993. 
A mod.1 for PWS has been proposed which represents PWS as a 
starvation syndrome, ",ther than one of ove.....,ating as i. commonly accepted 
(Hollnod er ai" 2003). The thOOI)' supposes that the body falsely perceives a state 
of starvation when th<: hypothalElIllic pnthwnys thot signal saliety are disrupted. 
This lead!i to a similar drop in metabolic lUte nnd gonodotropin release to that 
appnrent in !,"ople suffering from nnoroxia nervosa. At the sume lime, n high rate 
of ghrclIn secretion ClIllSes desensitisation of the growth hormone secrctol)' 
response, suppressing growth hOl1l1one production. 
It is likely thal mutations in any genes within the PWS region that disrupt 
the functIon of the hypotholornus could nccount for the main features ofPWS, i.e., 
ove�ting, growth deficiency, and hypogonadism (HolInnd er al., 2003). In fllC� 
a number of genes offeeting the development of the paraventricular nucleus in the 
hypothalamus have been Identlfied. These include NDN on chromosome t5 and 
SlMJ on chromosome 6, which are both Imprinted genes (NlchoUs, 2000; 
Michaud, 2001; Michnud et al., 2001). As yet there hllS been no positive link 
between any specific gencls and the development of the PWS phenotype. 
2.3.2 The Proder-WllII syndrotm phenotype 
Tnble 2.3 (p. 28) lists the PWS diagnostIc criteri ... which are divided into 
eight major nod 11 minor clements. Most of the major clinical signs Il/'C present to 
v8I)'ing degrees ot all "!les, wherens many of the minor criteria an: found only in 
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older patients (Holm el 01., 1993). Lnle identification of the disorder was 
common in the past, with 36% of the = studied by Grcenswng (1987) 
diagllosed after 16 yelll'S of ugc. However, these IDle diaglloses wc� generally 
made prior to the publication of clinical eri!cria and the development of diagnosUc 
JabornlOry tests for the syndrome, so thot in general the age at diagnosis is now 
decreasing. A number of studies have recruIted only ehildren with genetically 
confurned PWS, indIcative of diagllosis prior to adolesCCIl<:e (Lindgren el 0/., 
1998; Houlfa el al., 2000; Wigren & Heimnnn, 2001; Trifiro et al., 2003). 
2.3.2.1 lkve/apme1l/a/ characleris/lcs 
Young PWS patients usually cxbibil poor suckling abilities, fceding 
difficullies, and developmental delay. Webb Cl 01. (2002) reported 100% 
occurrence ofthesc three crileria in their PWS subjects. Developmenta! motor 
delay is evidenced by the lalc;r average ElSe of siuing unsupported (12 monlhB) and 
of walking (24-29 months), although nol all cases are similarly delayed in their 
developmenl (Gillessen-Kaesbacll el 01., 1995; Cassidy & Schwartz, 1998). 
Speech acquisition is also somewhat belated, often inlu the third year of life 
(GilIcssen-Knesbach el al., 1995; Clayton_Smith, 2001; Wllliams e/ at., 2001), 
and speech articulation defects, found in 19-90% of patients, are common 
throughout life (GilIcssen-Kacsbooh el at., 1995; Webb e/ at., 2002; Whiltiugton 
el al., 2002). 
Mild 10 moderole ID occurs in the majority of cases, wIth assoc:ialed 
learning difficullies (Holm el al., 1993; Eiafeld el al., 1999; Fridman c/ al., 
2000b). Approximately 27-40"10 of PWS cases function at Iow average or 
borderline inlclligence JeveI" and 1-19% of ratients nre severely intellectually 
disabled (Cassidy & Schwartz, 1998; Einfeld el al., 1999; Slnte &. Dyken!, 2000: 
Clayton-Smith, 2001; Clarke et al., 2002). Across nIl IQ groups, PWS patients 
are found 10 pcrfonn ocademically below the expeclcd level. for their inlcl1!gcncc 
rating (Dcscheemaeker e/ al., 2002). 
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Diagnoslic "riteM ror Prader·WIW syndrome 
(scoreorS points needed) 
Major criteria (1 pt .mcll) 
Neonntnl and infar,dle hypotonia, wilh poor suckling, improving wllh age 
Feeding problcms in infancy 
Excessive or rapid weight gain bctween ] and 6 ycars ofoge: centml obesity in 
the absence of intervention 
' 
Characteristic fociol fcab,":, with norrow face, almond-shaped eyes, small moulh 
wilh Ihin upper lip, down-turned corners of the mouth, micrognolhia (3 or more 
featun:s required to scorn) 
Hypogonadism: hypogonadism, Or delayoo or incomplete gonadal maturation 
Globol developmentnl deloy <6 years; mild-moderate ID in cIder per.;ons 
Hyperphagia/food obsession 
Deletion at ISql l-q13, maternal discmy or imprinting centre ,,"omnly 
Minor criteria (1/2 pt eacb) 
Decreasoo felnl mcvemen� infantile lethargy or weak cry 
Characteristic behaviour problems _ temper tantrums, violent outbursts; obsessive 
behaviour, tendency to be argumentative, appositional, rigid, manipulative, 
possessive and stubborn; pe=vemtion (stereotypical actions): lying and stealing 
(S or more realures needed to scorn) 
Sleep disturbance or sleep apnoea 
Short stnture for genetic background, in the absence of growth honnone lhempy 
Hypopigmentation - fair hair and skin compared to fomily 
Small hands or reet fcr height age 
Narrow hands with straight nlnar border 
Eye obnonnalities 
Thick viscous saliva 
Speech articulation defects 
Skin p!cking 
Snpportlve nod logs (Dot scored) 
High pain threshold 
Decreased vomiting 
Tempemture instability in infancy, Or altered tempemture sensitivity in older 
children and adults 
Scoliosis and/or kyphosis 
Early adrenarche 
Osteoporosis 
Unusual skill withjigsaw p�les 
Noma! neuromuscular studies 
Adaptedfrom Holm et 01. (1993) 
" 
2.3.2.2 Phy£ical ciwraclerlslic£ 
The poor suckling and fceding difficulties found In most PWS Infants 
(Section 2.3.2.1) are u result of the muscu11l1' hYJl!ltonia gentrally asSOl'iated with 
this syndrome (Gillessen-Kaesbach el al., 1995: Fridman el al., 2000b: Webb ot 
al., 2002: Trifrro el al., 2003). HypotonIa in PWS is normally observed in 
infancy, but some adults continue to suffer frem low muscle IOnc throughout their 
lives. Eating ability improves with uge and pronounced weight gain between the 
uges of [2 months and 6 years is a common chlU'llcteristic of people with PWS. 
Without intervention, excessive weight gain is one of the major diagnostic criteria 
(Hohnetal., 1993). 
MIlIIY PWS patients, children and adults alike, have an unusually low 
resting metabolic ratc which appears to be related to the obnorma] fat mass to lean 
moss mtio found in the disorder (Carrel cl al., 2002). Young underweight PWS 
patients hove a greater proportion of body fat thllIl healthy children at W1y 
p'lrticullll' body mass index (HMI), and this is 01,0 apparent in older, obese PWS 
children (Brnmbilla e/ al., ]997: Eiholzcr ct al., ]999). In fact, the ratio of lean 
body mass to fat mass is lower in PWS cases of aU ages than in both obese 
controls IlIld normal weight controls. 
The unusual oody composition In patients with PWS can be improved with 
growth hormone th�rapy, which decreases the percentage of body fat SlId 
increases that of lean body moss, thus resulting in an ineTCllSed resting mClabolic 
rate (Davies el 01., 1998; Lindgrcn et al., 1998: Lindgren & Ritun, 1999: Myers 
Cl al., 1999: Carrel el al., 20D2: Hoyby. et al., 2003; Paterson & Donoldson, 
2003). The combination ofhypotoni .. low metabolic rate and lack of activity, 011 
of which arc associated with PWS, mny help to explain the apparent low caloric 
requirement of patients. Extremely re,trictive diets have been found necessary to 
control weight goin in many PWS patients (Hoffman el al., 1992: Cossidy & 
Schwartz, 1998: Gold'tone el al., 2002). 
The obesity that gencrrJly results from uncontrolled eating can 
significantly inc=e morbidity and mortnIity mtes in PWS paticuts (State & 
Dykens, 2000: Clayton-Smith, 2001). However, with effective weight control, 
patients with PWS can survive inln thuir gib decade (GreenSWDg, 1987; Cnrpenter, 
1994). Among the morbidities associated with excess weight DIe limited mobility, 
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cardi"'pulmonory disease, leg ulcers, and diabetes mellilus, any Or all of which 
can lead to increllSoo hospitnlisation and earlier deo.lh (Grcenswng, 1981; 
Goldberg el a/., 2002: Hoybyc cl a/., 2002). Diabetes was fonnerly thought to be 
p=nt as a major health risk for PWS cases, bowever, there have been more 
re""nl reports which suggest thal the preYulen"" of diabeles in PWS mny nOI be as 
bigb as previously belleved (Greenowas, 1987; Goldberg c/ of., 2002: Hoybye el 
0/.,2002). 
Most PWS palients are reduced in stalure when compared to relatives. 
This Is thought to be primarily due to the absence of 11 nuturally-occurring 
pubenal growth spurt, although birth weights and lengths haye been n:ported \0 be 
lower in PWS cases than in healthy infants (Gillessen-Kncsbach el a/., 1995: 
Cassidy cl of., 2000: Slate & Dykens, 2000). Growth hormone (GH) treatment 
hllS been used to inc","",e the growth velocities of PWS children, with partial 
success (Dov!.s cl a/., ]998: Lindgrcn el 0/., ]998: Lindgrcn & RlIzen, 1999: 
Mycrs el a/., 1999: Carrel el a/., 2002). This therapy CM also minimise Ibe 
de .... lopment of the ch!lnlcteristic facies, improve respiratory Dlld musele fUoction, 
and reduce depressive symptoms, especially in individuals over 1 1  years of age 
(Lindgren elof., 1999: Myers el al., 1999: Whitman el 0/., 2002). In addition, 
children younger than 1 1  year.; \end to show less deterioration of he ha vi our after 
treatment ibM is expected ofPWS patients (Whitman el al., 2002). 
Specific facia] features arc often present in individuals with PWS. These 
fOlllUres include dolioccpbaly (a relatively long head), almond-shaped eyes, small 
bifrontal diwnetcT, a thin upper lip in 0 smoll mouth, and/or down_turned corners 
oflb. mouth (Laumncc .1 0/., 1�81; Holm.1 a/., i993). Howtver, one study 
found thal only 49% ofPWS cases had the characteristic facies, making this onc 
ofthe least sensitive major criteria for the disnrder (Gunay-Aygun e/ al., 2001). 
[n Itnly, 57% ofPWS ncanal.shad thrc:c ormore of the cr.miofanial features, with 
a further 28% of cam showing two features (Trifiro el 0/., 2003). 
Genitnl hypoplasia and/or delayed or incomplete gonadal matumtion nrc 
commonly found in PWS palients. Male cases frequently exhibit undcsxndcd 
testes and/or a small penis (Grecnswae, 1987: Wcbh el 01., 2002: Trifiro el 0/., 
2003). The presence of these highly vi"ible signs of hypogonadism in moles 
fncllitates dingnos;; in childhood, unlike fem.les who often lack visible signs of 
genil.Eli hypoplasia (Smith er al., 2003; Trifiroel 01" 2003). Primary nmenorrhoea 
is the most commOn sign of hypo go nod ism in remoles, with 60% of WOmen never 
reaching menarche. Individuals of both gender generally undergo delayed and 
incomplctc secondary sexual development (Crioo elal., 2003). 
In \\'(lmen with some history of menses, Ule majority report delayed or 
irregular periods (Greensw'g, 1987). There have been several pope .. r"""rtmg 
fertility In female PWS cases. although only two of the five mother.; had an 
nnequivocal genetic diagnosis (Hockey el al., 1987; Akefeldtel al., 1999; Schulze 
el al., 2001). Of these two women. onC hod a maternal UPDand her child showed 
no nbnormality, due to the transmission of a nonual maternally-imprinted 
chromosome from the mother (Akefe1dt el al .• 1999). The other individual was a 
deletion case who save hirth to DD infant with AIlgelman syndrome, because the 
deletion was inherited 00 the motemal chromosome (Schulzc elal .• 2001). 
Strabismus occurs in 58-75% of PWS cases (Gillessen_Kae,baoh ef al., 
1995; Cassldy & Schll'llrtz, ]998; Cassidy el al .• 2000; Whitlington elal., 2002). 
Hypopigmenl.Eltion also is found in m3JIY PWS patients, especially those with the 
COmmOn deletion in chrl5ql ]-q13 (Gillessen-K.esbach ., al., ]995; C!l5Sidy & 
Schwam, 1998; Cassidy elal., 2000). In similar fashion L lbe AS deletion., the 
PWS deletion also includes the P gene (Figure 2.1, p. 20), associated with the 
pigmenl.Eltioo of hair, skin 1lJld eyes. A single mi,sense mul.Eltion in theP gene on 
the m.tema! chromosome in a PWS patient thus affects the functionality of the 
gene product DIld results in DCAl (Lee el al., (994). 
Scoliosis has been found in 34-75% ofPWS cases entering adulthood, and 
its progress appears to be unresponsive to OH therapy (Lourance el al .• 1981; 
Cussidyel al., 2000; Cnm:1 el al., 2002). In addition, o,teopoenio or o<teopolOsis 
oetllfS in 75% of adults with PWS, possibly as a result of hypogonadism which is 
o known risk faclor for ost""polOsis (Hoyhye elal., 2002). It has been established 
that bone mineral density (BMD) tends to be lower in PWS patients than in age­
and BMI-matched obese individuals (Brambilln el al., 1997). Although initial 
studies reported no chEUlge in BMD after one year of GB therapy, an improvement 
has been achieved In PWS children after a 4-ycar course of GH treatment 
(Lindgren tlal., ] 998; Carrel el ai., 2002). The widespread incidence of scoliosis 
oodfor os\Coporosis in PWS contributes to the reduced mobll!ly found in m.'IIy 
adults with the syndrome. 
A number ofth. ciJlI/'llcteristic features ofPWS arc thousht to result from 
the intemJplion of correct hypotha]amic function. Growth hormone production is 
regu]ated from the hypothalmnus, lIS is the satiety signa] which appears III be 
dysfunctional in PWS p.ltlenlS with hyperphagia. It has been hypothesised that 
the complU'lltivc lack ofl= body tissue, which ilsclfrelates to GH deficiency, is 
associated with the development of many of the features of PWS, i.e., the 
proscnce of hypotonia, low resting melabolic rate, poor fcoding in tnfWlCY, Md the 
law calo;ic requirement that appears to be typical ofPWS patients (Brambilla el 
a/., 1997; MorIin el al., 1998). Further research into the effects of OH therapy 
should aid understanding of the role played by the hypothalamus in the production 
efth. PWS phenotype. 
1.3.1.3 Behm>ioural aspec/s 
A]though hypotonia, low metabolic rate ""d inactivity oil contribute to 
obesity in PWS, ultimately the weisht gain is caused by hyperphagia, i.e� 
compulsive eating and food obsession, which is present in most PWS patients 
(Einfc]d el al., 1999; FridmM el al., 2000b; Gnnoy-Aygun cl a/., 200]; Russcll & 
Oliver, 2003). Food and other [css paiotable materials, such as dog food or food 
scraps, oflcn need to be locked out ofreo.ch in no effort to control patients' eating 
urges (Lnlll"lll1ceel 0/., ]981). 
Tests of the eating behaviourofPWS pntienlS compaled to those ofobcse 
and norma] weight subjects have revealed that PWS individuals tend to eat for a 
longer timc thnn either of the other two groups nod with no diminution of eating 
1lIte, probably due to a rook of satiety response. The rote of food comumption 
exhibited by the PWS individuals was less varied, with no difference between the 
IlIte of eating at the beginning of the session nod the rate at the end of the session. 
It therefore appear.; that PWS individllllls do not exparicnce the snme intensity of 
hunger signals as control subjects (Undgnm 01 al., 2000). Simil.rly, PWS 
subjects are likely to cboose a larger qunolity of food, regardless of their 
preference rating for thnt food, even when the lalger quantity comes only after a 
limc-<lelay (Joscph el al., 2002). These results support the theory that PWS 
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patients suffer from lack of satiation rnther than hunger pe� se (Holland �I al., 
2003). 
A Food-Related Problems Questionnaire (FRPQ) hllS been developed in 
the U.K. which can help 10 ehnrncterise ,,"oh individual's responses to food 
(Russcll & OHVCf, 2003). The three mnin nrCIIS covcred are preoccupation with 
food, impairment of satiety, nnd composite negative behaviours (i.e., taking 
nndlor storing food, the eating ofincdiblc items, Md inappropriate respon� when 
food is not occ:essible). When the FRPQ is used there is slgnifiCDllt variability in 
the rerolling scores between individuals with PWS, which may help thernpists to 
provide appropriate programs to alleviate the specific behaviour patterns of each 
person (Russell & Oliv�r, 2@3). 
The range or minor criteria often seen in PWS subjects is listed in Table 
2.3 (p. 28), and include, both biologicn] Md behav;ourol troits (GreensWllg, 1987; 
Holm e/ al., 1993; Einfcld e/ 01., 1999; Fridman cl al., 2000b; Webb cl aI., 2002; 
Whillington cl aI., 2002). Daytime sleepiness is reported in many PWS enses, and 
this is genernlly unaffected by weight loss. However, both sleep opnoea und 
obstructed breathing are onen relleved when body weight is reduced (Gillessen­
Knesbach el al., 1995; Hanis & Alien, 1996). Skin picking is common in 
individll.ll s with PWS, often commencing before the oge of 7 years. The 
behaviour mny be episodic, i.e., occurring once or twice a year, or it may be more 
frequent. In either case the behaviour nsually persists throughout life. 
Complicntions such lIS cutaneous infections mny occur, and similar behaviours, 
e.g., hair or clothes picking, are oncn found in conjunction with skin picking 
(Wigren & Heimann, 2001). 
PWS patients, csJ=ially those with UPD Md/Or with modcralC to severe 
ID, are prone to the development of psychoses Md other mental disturl!aJlccs in 
adulthood (Clarl<e el al., 1998; Verho.vcn el al., 1998; Boor ./ a/., 2002; 
Dcscheemackcr e/ al., 2002; Verhooven cl al., 2003b, 2003a). Psychotic episodes 
tend to be preceded by a specific event, c.g� loss or the threat of loss, a change in 
life situation, or the introduction oh strict diet regime (Vogels er al., 2004). It 
has been suggested that there moy be a mnlCmnlly CKplCSsed gene within 
chrlSqll-ql3 that results in a gene dosage eITeet when present in two ReliVe 
copies, as is found in UPD. There is, however, no identified gene in the region 
which tall be prediclcd to affect the bmin chemistry sufficiently to Induce 
psychosis (Smith, 1996). 
2.3.2.4 pws·/ike phenotype 
In the U.K., PWS-lik� patients with no genetic <:onfilT11lltion of the 
syndrome were lISSesSed and comporcd to those with a genetic diagnosis of PWS 
(Wcbb el al., 2002). The results showed that most oCthe minor criteria ofPWS 
and some of the major eriteria were present in slmilEIT proportions in both groups. 
Hypotonia at birth, feeding difficulties in infEll Cy, and genital hypopia5i" were all 
more frequent in true PWS than in those with a PWS-likc phenotype. This would 
suggest that these criteria are of greatest application in diffel'e!ltinting PWS from 
other disorders associated with develcpmenl:l! delay, hyperphagia, and obesity 
(Webb el al., 2(02). 
2.3.2.5 M�r/allty In Prmler-Wil/i syndrome 
The m.in causes of mortality in 8 series of PWS cases varied with age at 
deall! (Sehrander·Slumpel el al., 2004). In the younger oge sroup « S  yoars, n � 
13), six children died from ncute rospimtory infections, three from 
hypoventilation. two from gostrointestinal problems associated with fever, one 
from a parapharyngcal abscess, Md onc from accidental cnuses. None of these 
disorders are normally associated will! obesity, as would be expected at the 
younger ages where typically there is no huge increase In weight. Among the 
group of 14 subject. aBed nine years or older, the causes of death for four 
Individuals Were respiratory complaints, four had cardiac disenscs, three had 
gastrointcstinal disorders, and onc each were due to carcinoma, a stroke and spinal 
myelitis. There is a credible link between obesity and some of these causes of 
death, notably Cllrdiac complaints and stroke, as PWS cases in this age gronp are 
very likely to be overweight (Palcrson & Donaldson, 2003: Schrander.Stumpel el 
al., 2004). 
2.3.3 Gonl!l/c baslsfor Prader-WIIII syndrome 
2.3.3.1 DeletiDn 
The vast majority of PWS cases show an abnonnnl methylation pattern 
when tested (Fridman el al., 2000b: Glenn el al., 2000; HMe! & Wevrkk, 2001b). 
As is the = with AS, the major mulntion associated with PWS Is 11 deletion in 
chrISqll-13, although in PWS the affected chromosome Is Inherited from the 
father (Tablc 2.2, p. 17). Between 70-74% of PWS subjects have the - 4 Mb 
deletion which shares the common break points (Figure 2.1, p. 20) wllh the 
deletion thllt cauSe,j AS (GilIessen-Kaesbach d al., 19%; G!enn el a/., 1997; 
Cassidy el al., 2000). At !east seven cases of somatic mosaicism for PWS 
deletion have been recorded in the literature (Matzoc 'l al., 1998), and there may 
be difficulty in identifying these cases, as the methylation pattern often appcllfS to 
be biparental. FISHtes!ing is most elTective at identifying somatic mosaicism. as 
wcll as more common deletions. 
2.3.3.2 Uniparental d/somy 
Mat.mIIl UPD!5 accounts for24-28% ofPWS = compared to 2-7% of 
AS subjects (Table 2.2. p. 17). reHecling the greater likelihood ofnondisjunetion 
during oogenesis than spermatogenesis (Gleon el al., 1997; Cassidy & Schwartz, 
1998; Cassidy el a/., 2000). The increased parental age lISSOCiated with matemal 
UPD could be related to the fact that older women ore more prone ta defects af 
oogenesis than younger females (Gillcsscn-Koosbach el al., 1995; Fridman el 0/., 
2000b). Almost a quarter cfthe maternal UPD cases investigated by Robinson el 
al. (2000) were shown to result from post-zygotic rescue ofa trisomic conceptus. 
resulting in heterodisomy. 
A similar case with mutemn! heterodisomic UPDIS was also fouod to 
hove 11 SMC IS. The phenotype WIIS typical of PWS, with the addition of early­
onset Type I diabetes (Horelina el al., 2004). Mosaic trisomy 15, in conjunction 
with makmal UPDI5, has been reported to produce a severe version ofPWS with 
an incrensed risk of congenital heart disease. Incomplete trisomic rescue is the 
mechanism that ha<; been proposed in explanation oflhis phenomenon (Olanderel 
a/.,2000). 
2.3.3.3 Imprinting centre de/ecls 
le abnormalities are present in 1-5% of PWS, including most of the 
families within which there have been two or more "lTected individuals. 
DeIelion" in the IC, which occur in 14% of PWS cases with IC defccts, hove a 
recurrence risk ofs()%, making correct identification of the genotype an important 
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genetic counselling 1001 (Sailoh el al., 1997: Cnssidy & SchwDrlz, 1998: 
Rougeulle et Lalande, 1998: Builing el al., 2000: Buiting el al., 2(03). The PWS 
section oflbe le is localed just upstream of SNRPN (Figure 2.1, p. 20), and any 
disruption of Ibe le eliminates rescUing of the imprint from matemol to palcmnl 
in Ibe male germ-line (Snitoh el al., 1997: Buiting el al., 2000). The PWS-SRO 
has been narrowed to a 4.3kb section of chromosome which contains both SNURF 
Md the promoter region for the SNRPN gene (Saitoh el al., 1996: Ohta el al., 
1999b). 
2.3.3.4 Single gone dc/eels 
As shown in Figure 2.1 (po 20). then: nn: seve/ll  genes in the chr15q]]. 
ql3 region thot ore solely expressed from the paternal gene in some tissues, and 
SNRPN, JPW, MAGEL2 (NDNLI), NDN and ZNFJ27 (olso known os MKRN3) 
have all been considered as candidate genes for PWS (Snitoh dol., ]997: ClISSidy 
& Schwnrlz, 1998: Cossidy el 01., 2000: Lee .1 al., 2000: Hanel & Wcvrick, 
200]b). 
There is some evidence that CIlmplete transcription of SNRPN will prevent 
development of the PWS phenotype (Kuslich cl al., 1999). Experimental 
treabnent of SNRPN with 5-IWI·dcoxyeytidinc, an inhibitor of methylation, has 
resulted in reactivation of expression from the previously silent allele (Falmer­
Smentck& Francke, 200]). However, the dcmethylation wos not accompanied by 
acetylation of the H3 and H4 histones in the region, contrnry to the findings of 
other wOIkers who hove successfully reactivatod the nllele (S"itoh & Wad., 
2000). Asyc� reactivatIon ofSNRPNhM not bcen tested In vivo for suitability as 
a thc/IIpeutic measure to alleviate the PWS phenotype. 
Th� SNURF-SNRPN locus i.o; compl.", and III least four functions are 
em:oded within this area, including part of the PWS imprinting centre whieh is 
overlapped by SNURF. ExoM 4-10 of SNRPN encode a core spliceosomal 
protein (SmN) that hosan active function in brain ti.o;suc involving mRNA splicing 
(Gray cl aI., 1999). In addition, there arc a number of altemotive splice sites 
within SNURF-SNRPN, including many within the nnneeding exons lOa-20 
(Wirth elnl., 2001). The alternate 3' transcripts produced from these sites moy be 
the soun:e of other proteins, such lIS th.t producod by the HDII·8S snoRNA (smat! 
3S 
nucleolDl RNA) gene cluster, the HBIl-438A snoRNA gene, IUId theJPW cene (de 
loo Santos el al., 2000; Gallagher el al., 2002). Fnrther elucidation of the roles of 
these different transcripts will be of potential interest to researcher.; ofPWS. 
The 2.2kb sillgle""on gene NDN encodes a protein, NECDIN, from the 
MAGE family (Figure 2.1, p. 20). This protein is in�olved in the regulation of 
cell proliferation, ond it can bind to a number of differenl transcription factors. It 
is imprinted in humDll.S ond mice, with the mmemol ollel. lelativcly 
hypermethylated in all lissues, and highly methylated in the blllin (!..au et al., 
2004). The result is that NDN is prefercntially expressed from the paternal allo1e, 
with high levels ofnctl�ity in the developing hypothalamus, which is llSsocioted 
with a number of phcnotypic features of PWS, e.g., hyperphDgia and lack of 
growth honnonc (Sutdiffe el 01., 1997; Lee & Wevrick, 2000; Nicholls & 
Knepper, 2001). Disruption of necdin production in mice leads to the 
dcvclopmlmt of reduced number.; of oxytocin-producing cells in the 
pamventricUlar nucleus of the hypothalamus, a region that contains 0 critical 
regulator of appetite (Michuud, 2001). 
In a similar f..,hion, MAGEL2 is monoallelically expressed from the 
]II ternol chromosome in tissues of the central nervous system (Hnccnccio Cl al., 
1999). During development, high levels of exprcSiion are found in sites thut 
include the hypoLhalnmus, the first branchial arch and tongue, the gcoilll  
tuhereule, the limb buds, and the otic vesicle. Characteristics of PWS that arc 
connected to these areas of exprcsslon include, hyperphagia Md shor! stnture 
(hypothaJamus), lIItlculntion defects IUld thick salivo (tongue), hypogonadism 
(genilal tuberoule), small hands and feet (limb buds), and eye abnormalities (olic 
vesicle) (Lee el al., 1000). 
ZNFI27 encodes . zinc-finger protein which may have a function as a 
ribonucleoprotein, IUld is cxpressed only from the paternal Dllele. Figure 2.1 
shows thal ZNF127 overlaps a second gene (ZNFI2AS) which is transcribed from 
the antisensc strand, producing a dilTerent protein albeit of unknown func!!on 
(Jong cl al., t999). 
None of the mollSC models that possess only a single, patcrnally_inherited 
Snrpn, Ipw or Zfpl27 gene have shown an identifiable PWS phenotype. 
However, Ndn-deficlent strnins hove givlm variable results; one showing no 
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abnormal phenotype, the other exhibiting a failure to thrive and a lethal 
respiratory cefcct (Hanoi & Wevrick, 2001 a; Michaud, 2001). Since no speciilc 
gene ha>; been positivdy identified as the cause ofPWS" i
,
1 is inferred that PWS is 
a contiguous r.,cne disorder, Le., there Is more than onc gene arreming the 
syndrom� phenotype (Nichol1s & Knepper, 2001). 
2.3.3.5 
A smal! minority of patie,lls with the PWS phenotype lack ."y of these 
three major forms ofchrlSql l-q13 defecl. In infancy, PWS shares some feature� 
with Down syndrome, trisomy 18, !lIld hypothyroidism. Simil!lfly, a number of 
different syndromes, e.g., Sot03, Wilson_Thmer, Cohen, and Bnrdet-Biedel, lIS 
well !IS hyperinsulinism and growth hormone deficiency, all have similar 
phenotypes to PWS as it manifesls in older children (Nolan, 2003; Delme & 
Mlchaud, 2004). Many of the PWS diagnostic criteria, i,e� neonnlnl hypotonia, 
infantile fceding difficulties, obesity after 2 years old, nod facial dysmorphism, 
arc also pre,;ent in persons with a deletion of the paternal allele of the SIMI gene 
at chr6qI6.2 (Falvro el 01 .. 2002). The SlMJ gene hllS been linked to the 
development of lhe parnventricular nucleus of the h)'pothalamus, nod mouse 
studies indicate tlw.1 haploinsufficiency of the gene leads to the PWS-Iikc 
phenotypo (Miehaud Cl (11., 2001; Delm. & Michaud, 2004). In addition, certain 
X-chromosome abnormDlities, e,g., Klinefelter's syndrome, Fragile-X, nod 
supemumerury X-rnmker chromosomes, also show some of the choractmistics of 
PWS (Monaghan el (1/" 1998; Stratakis, 1998; Delme & Michaud, 2004). 
Individuals with a PWS-likc plu:notype ."d normal methylation patterns should 
therefore be ellllltlincd carefully for any ofthcse mimicking conditions. 
The presence of a moternal interstitial duplication of chr15qll-ql3 has 
been linked to a separate phenotype which shor.s some features widl both PWS 
and AS. Indlvldllllls with these dUplications have developmental delay, 
intellectual hnodicap, speech delay, and some autism-like chamcteristics. MElIlY 
are prone to seizures, display unprovoked laughter, make involuntary hond 
movements, and arC hypotonic. Growth retardation and hypogonadism are, 
however, not features of this phenotype (Repollo �I al., 1998; Thorn", �I (1/., 
1999). Thesc choracteristIcs arc similar to those exhibited by individuals with 
SMCl5 (Webb elw., 1998), 
2,1.4 Gl!IIotypdphenotype corre/QtJlms 
It was believed that there were nO phenotypic differences between PWS 
patients with chrlSqll-q13 deletions and those with upn and IC defects 
(Greenswag, 1937). However, the mean birth weights and birth lengths ofinfants 
with adeletion moy be larger than of those with UPO (Gunay-Aygun et al., 1997), 
eVen though preVious re;earch had indicated larger birth weights for non-dcletion 
cases and similar birth lengths (Gillessen_Kacsboch et al., 1995). As the lalter 
study included both upn and IC patients, the conclusions drawn from the two sets 
of results were not necessarily contradictory. In fact, no significant differences 
have been identified between the standard deviations of measurements of height, 
weight or body mass lndeK in PWS patients diagnosed with the three different 
types ofPWS defect, deletions, UPOand lC (Haulfuet 01 .. 2000). 
Compared to pattents whh a deletion, especially femules, the mean age at 
diagnosis is significantly higher for individuals with UPO. This probably reflects 
the milder phenotype oJlcn reported for upn patients compounded by the 
difficulty of recognising femule genital hypoplasia prior to pubeny (Cassidy el al., 
1991: Gun"Y.Aygun clal., 1997: Cassldy & Schl'o'lllU, 1998). Speech nrticulation 
defects are olso more commOn in PWS cases resuiting from. ddetion (Cassidy cl 
al., 1997; Webb el 01., 2002). 
Two of the physical features of PWS that are mOre common in deletion 
patients are an increased frequency of the 'typical' fadal features, and of 
bypopigmentntion (Gillcssen-Kae,b.ch el al., 1995; Cas,idy & Schwnrtz, 1998). 
Individuuls with a deletion are more likely to present with bYl"'rphagia at an early 
age and excessive skin picking. They also exhibit n higher pain threshold than 
non-deletion cases (Cas,ldy el al., 1997; Cassidy & Schwnnz, 1998; Fridmilll el 
al., 2000b; Webb el al., 2002). Many PWS individual, with " delClion arc 
purported to sbow superior spatial skills, e.g., in solvingjigsaw pU7Zles, however 
these reports bave been largely confined to adults (Cossidy el al., 1991; Cossidy & 
Schwartz, 1998; Webb el a/., 2002). 
Patients with " deletion between BPI and BP] have been descnbed as 
having greater difficulty In control1lng their compUlsions, whether regarding foad 
intake, dully routines, or obsessive tendencies, than those with a BP2-BP] 
deletion. This observation has been interpreted as suggesting the presence of a 
gene in the region between BPI nnd BP2 whioh exerts some effect on compulsive 
behaviour:s (Butler et al., 2004), although no such gene hos been identified. 
Maternal UPO increases the probability of psychotic episodes in 
adulthood, with heterodisomy elevating the risk to a greater degree than 
isodisomy (Clarke et al., 1998: Vernoeven el al., 1998: Boer et al., 2002; 
Descheemacker el al., 2002; Verhoevcn el al., 2003b, 20030). The reason for this 
finding is unclear, although the hypothalamic dysfunction associated with the 
PWS phenotype hns been linked to the development of bebnviourul and 
psychopathologic.1 abnonnalitics (Vcrhoevcn el al., ]998; Vcrhoevcn el al., 
20030). ]fthis prove� to bethecase, theromny be ogene (or genes) that arlvem:ly 
affect the development of the hypothalamu" or a pathway that affects mentnl 
health. However, eKpression would only be observed when there were two 
different functional allele"� insleod of the single functional gene found in non· 
affected people, or in the CllSe of the total lack. of functionality found in PWS 
cases with a deletion or on IC defect, i.c., a gene dosage effect 
2.5 �ummary 
The dise .. e phenotypes of AS and PWS vary ccnsidernbly, both between 
and within the two disorders. The variety of physical and behavioural 
characteristies commonly found in individuals with AS or PWS may be attributed 
10 the differences between the specific underlying genotypes. There bos been only 
limited informallon available as to the effects of ageing on either disease 
phenotype or on the common morbidilie, fneed hy people with AS or PWS. 
There will, however, be some health Issues that are universal la many ageing 
people, enoompassing the wider ID populace and tho� with PWS or AS, 
including visual or bearing impairment, restricled mobility, ond co-morbiditles 
associated with obesity. In nddition,thcrc arc some conditions, commonly found 
in people with ID, thal are likely tu be frequent among those with AS nod PWS, 
e.s., high rates of respiratory diseases, seizure activity, psychiatric disorders and 
dementia. The existence of morbiditles specific 10 either PWS or AS ha.';, 
however, been R matter for conjecture. 
39 
,. 
3.1. 
METHODOLOGY 
The data sources 
The Disability Serviccs Commission (DSC) ha!. been Tespon.sible for 
providing services to Western Australians with ID .ir,c<: 1953. Any individual 
refemd 10 DSC during the IIlSt 50 years h .... nIl oleclronic record stored in the 
client database, which until June 2003 contained diognostic nnd demographic 
informalimt on over 15,000 persons. Clients are referred to DSC for initial 
assessment from a variety of sources around the stale, including hospitals, 
specialist physicians and general pmctilionets. Referrals also may be made by 
fllIllily members on behnlf ofpeopJe will! inteUectuBl lu!l1dioap. 
Historically. clients hove been offered regular appointments with DSC 
physicians who provide an assessment ofnced and oITer advice about disability­
reloted services. In addition to the DSC client database, paper records are kepi on 
each e1icn� including information on medical, ollied health care, w:commooat;on, 
und psychologicnl assessments, and geneml correspondence relating 10 each 
client's hcalth care needs. 
Demographic data recorded electronically at DSC Include se", dote of 
birth, contact details, type of residence (e.g., complete residential care, group 
home or family home), lIl!lIillll status, employmentsllltus and ethnici!), (Appendix 
I). Diagnostic variable! that are coded include the clinical dingnosis, level of 
severity of ID, and additional co-morbidities such lIS congenital malfonnations, 
SCnlDI)' disabilities, and any DSsociated physiCllI disability. lnfonnotion is also 
included ifo genetic aetiology is suspected, and whether any psychiatric condition 
exists (Appendix 11). This IlISt field tends to be limited in its interpretation and 
only indicates whether a person has 0 behaviouml, ncurotic or p,;ycitotic 
component to their presenllltion. 
The electronic Wld paper records for individuals are sometimes incomplete 
due to varied contact of the client with DSC-based health care workers Md the 
age of the client. The quality of data collection has also been otrcded by changes 
in infonnation col1ectlon prnctices since the inception of the database (Megahey, 
1996). 
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3.2 Record linkage 
3.2.1 Oven,iew of the Data Linkage Unit 
In addition to analysis of the DSC electronic and paper records, health 
information for each AS and PWS case was obtained by record I ink.age to the core 
datasets held in the Western Australian (WA) Data Linkage Unit. The Data 
Linkage Unit was established in 1995 and is supported by the Health Information 
Centre in the Department of Health, the Centre for Health Services Research at 
the Unjversity of Western Australia, the Telethon Institute for Child Health 
Research, and the Centre for Health Informatics at Curtin University of 
Technology (Figure 3.1). 
Figure 3.1 Truncated structure of the data-linkage system in Western 
Australia 
Core data sets Commonwealth Data Research databases 
Systems 
Hirth 
Registrations 
Busselton Surveys 1974-2003 1966-1987 
Hospital 
Road lnjury Morbidity Data System 
1970-2003 1987-200) 
Deaths 
Registry 
Red Cross Blood 1969-2003 Transfusion Service 
Mental Health 1995-2002 
Information System 
1966-2003 
Cancer Registry 
Disability Services 
Commission 
1981-2003 Other State data systems 1953-2003 
Midwives Notifications WA Electoral Roll 1988-2003 
1980-2003 Silver Chain 1993-2002 
WA Data Linkage System structure as of May, 2003 
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The method "",ployed fur record Ilnkol1e involve" the probnbilistic 
matohing IlIld clerical reviews of health records from the six con: dntasels listed in 
Table 3.1, using vital information such as names, addresses and daleS of birth 
(Holman ., al., 1999). There an: three basic Sleps 10 the process of linknge. 
Records that !mve 0 potential n:lntioru;hip are filSl col1ected into 0 block, IUld in 
the second SInge they are m&tched to determine if they an: likely to be rel.ted. In 
the third singe, the matched records an: linked for W1wysl s  of the information 
pertaining \0 o:nch individual (Holrrum el al., 1999). During the post ten years, the 
Data Linkage Unit has relined the system of linking the various health database" 
in W A, and the process is estimated to be at least 99% DCCumtc. 
Toble3.1 Time-.paD ot....,otd.'l trom tbe sb core datasets orlbe Data 
Uokage Uoit 
Mental Health Information System 
Cancer Registry 
Midwives' Notifications 
Adaplodfrr;m Holmonel al. (1999) 
3.2.2 Th� core dQlas�1!i 
1966·present 
19a1-present 
1980-present 
As pnr\ ofa wider project on ID, wl clients registered at DSC since 19SZ 
were linked to four of the core damsels (Hospital Morbidity Data System 
(HMDS), Ikath Registry. Menlol Health Informalion System (MH1S) IlIld Cancer 
Registry) 10 obtain infonn.!!on on health history. Extroction of the data from 
these datascts was completed in 2002. 
1.2.2.1 The H(JSpll�1 Morbid/I)! DaJa Sy$lem 
The Hospital Morbidity Data SySle� (HMDS) has been aclive in WA 
since 1970 10 monitor IlIld record moTe thari.,12 million episodes ofacule can: in , 
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public ond privnte hospital!, and free-standing day hospitals throughout the Stote. 
Information on the principal reason for admission ond 11 variety of co-morbi diti cs 
is sto� in the HMDS. The HMDS contains up to 21 diagnostic IIlId I I  
procedure codes for each admission, ond it is this information th"t w"-' used to 
identifY physical morbidity among the AS IIlId PWS clients. Diagnoses Il1C stored 
according to the coding sysk:ms of the Intem.tional Classification of Disease 
manuals, !ermed ICD·8, lCD-9 and lCD·]O codes (World Health Organization, 
]967; World Health Otgn is&tion, 1977-\97B; World Health Orglll ization, 1992· 
cl994). To fll.Cilita\e onalysis, records were updated from the earlier systems to 
their equivalent in the ICD·lO coding system. 
1.2.2.2 The DemJu &gir,ry 
lbe Deaths Registry provide. infona.tion on the dole, place Md cause of 
death of individuals whose death WIIS regIstered in W A since \969. The dol.!! for 
the Deaths RegislIy were obtained directly from the Office of the Registror 
Geneml, Md in the study the Deaths RcglslIy was used to supply additional 
infornllltion on mortnlity nmong the members ofth. study group. 
1.2.2.1 The Menial Heallh In/annallon Syslem 
The Mental Health Information System (MHIS) contains records of an 
contacts for WA residents with the Mental Health Service since July 1966. The 
System consists of !Wo separate datnbases - inpatients and outpatients. The 
inpatient data cover nU acut. public nnd private hospitnl admissions due to menta! 
health conditions, IIlId all admissions to designated psychiatric hospitnls, 
authorised psychiatric hospitals, residential progrums and units, and psychiatric 
host.ls and nu-sing homes. The outpatient datn encompass all public p,ychiatric 
outpatient ond community mental health �rvices in W A. 
The data stored 00 the MHIS thnl were used in the present study include 
the specific JlSYchintric diagnosis, the type of ndmission or ,ervice used ond the 
length of stay (inpatients) or length of use of ,crvi"". (oulpntlcnts). As with the 
HMDS, the data are stored in 0 mixture of ICD coding systems editions, which 
were updated 10 the ICD·IO rormat prior to analysis. 
3.2.2.4 The Cancer NIJI!ficallons Reg/slry 
The CDnccr Notificotions Registry 0115 been in existence since 198] und 
holds a list of a]] cases ofcnrcinoma diagnosed in WA from that lime. Owing to 
the relatively recent estahlisomcnt "fthis datnsct there were some members of the 
study group woose results Were nol recorded by the Cuncer Registry. 
3.1.3 Supplementary datuse! 
For the current project the databose at the Genetic Services of Western 
AustraI1a (GSWA) Was also sourced durinS 2003-2004. GSWA provides genetic 
hoalth services to individuals with genetic disorders or those at risk of carrying 
genetic disorders, und their families. A referrnl from a Medical Practitioner Is 
needed to book a consultation a\ GSWA, although the initial impetus for 
investigation may come from un individual or couple if they have rcnson to be 
concerned about hereditmy disorders. 
A range of diagnostic, <:<.lunseUing, and prediclive services are availnble 
through GSWA for those affected by, or ot risk of, genetic and congenita] 
disorders. Details of the specific molecular Md/or cytogenetic tests conducted, 
Md the results of those tests, ore maintained on the GSW A database. 
3.3 Daln collect!on protocol 
The casus were initially Identified by the selection from the DSC database 
of all individuals with 0 clinical diagnosis of AngelmWl syndrome (Heber cude; 
6759) or Prader-Willi syndrome (Heber cnde; 6715) (Hober, 1959). The poper 
files Were ordered from the Records Department of DSC. with a maximum oflen 
filesordercd 0\ Wly given time. Tne files wcereviewed Wld details of the clinical 
presentation of the coses were <:<.lnfinned. All of the data ,,){!rnction procedures 
werecondueted within the DSC prcmises in west Perth. 
The profonna used to "'<:<.lId the infonnation cxln\c\ed from Ihe paper files 
is reproduced in Appendix Ill. It included provision for recording the presence or 
absence of ciinicol sigru, especially those included in the diagnostic criteria for 
eoch syndrome, as well as demogrnphic data, dewiJs of any genetic tests 
<:<.lnducted, fW1lily history, and data on illness or medIcal condilions. 
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The types of data included in the DSC files v.uied from cnsc to case, but 
on the whole there Was a great dcal of consistency. EveI)' file contained basic 
data II.'i outlined previously (Section 3.1). In addition. most parents had provided 
information on fnmily background. ante· and postnatal hl!;tory, and the 
developmental history of their offspring (Appendix IV), and the referrals were 
accompanied by a Client Referral form Md a Clinicnl Information form 
(Appendices V & VI). It is usual for DSC physioiWL'l to conduct an initial 
physical c){llfIIination, followed by periodic updates where possible. The results 
of these cxnminations were recorded in the patient's file (Appendix VII). The 
l'C);ults and detoils of DSC specialist services, such as speech thempy, 
physiothelllPY, hwing tests or optical te!;tins were also included in the client 
files. As the individual continued to use DSC services, more <lnta were odded. 
including rel"'rts from non·DSC servIce providers.., nvallable. 
A database of extructed information pertaining to each individual was 
created in the Statisticnl Package for the S()Cial Sciences (SPSS) version 1 1 .5 for 
Windows. The list of variobles included In the datob= Is contoincd in Appendix 
Vlll. MMY of these variables were taken directly from the proform .. with oth"" 
being added ... further dolo were collected. Any clinical data which were not 
specifically mentioned in the files were recorded either as unknown or 'no data' 
within the datasel. 
Snppl�JOentruy information Was merged from the four other COre State 
SOu","s as d�'Scribed above: Hospital Morbidity Data System, Dcaths Registry, 
Mental Health Information System. and Cancer Registry . ... well .., the aenetic 
Services WA database. As can be scen from Table 3.1 Cp. 43), some of the data 
sets have been in existence for a shorter time than tile DSC !'I:cords, which meant 
that in cortain c= limited amounts of infommtion were available in tile other 
datnbascs. The Hospitnl Morbidity databnsc. for instance, only commenced in 
1970 and so 18 of the study group had no recorded hospitnl ndmiBSions between 
their year of birth and tile estnblishment of the dotob.sc. 
3.4 Data analysis 
The study was population·based, cslng comparisons between the two 
groups of patients. The data wcre analysed in a quantitntive manner, using the 
Statistical Package for the Social Sciences (SPSS) version 11.5 for Windows. 
Given the relatively low prevalence of AS and PWS, quite limited numbers of 
subjects were available for study. This was particularly the case for deceased 
subjects (AS, n '" 2; PWS, n "  6; PWS.like, n '" \) and for this reuson mortality 
and survival mtes Wcre not calculated. 
The project was primarily descriptive in its outputs, analogoll.S to 
international studies addressing similar research questions, and hence most ofth. 
findings are presented in the fonn ofsummruy statistics. 
3.S The study population 
The American Association of Mental Retardation (AAMR) criteria for 
intellectual disability shown in Table 3.2 are used by DSC to dclcqlinc client 
eligibility for rogistmtion and sclVices (Grossman, 1983). 
Table3.2 LcvcloHnlellcdual ruactlou lIS iudicated by IQ muge 
T,� IQmnge AAMRCodc 
Low nveragelbordcrlinc disability 71·84 
Mild intellectual disability 55·70 3 1 7.0 
ModC!llte intellectual disability 40·54 318.0 
SC'lcre intellectu"1 disnbility 25·39 318.1 
Profound intellectual disnbility <25 318.2 
Unspecified 318.3 
Arlaplcdfrom Grossman (1983) 
The specific criteria of ncccptancc for DSC rogistmlion include sub-­
averoge intellectual functioning (i.e., IQ<10) that has an onset before I B years of 
age, and evidence of significanl imp�innent (i.e., 2SD below the mean) as 
measured by un Adoptive Behaviour Assessment. Adaptive ,km, !IN asscssmllllts 
of learning, personal indepcndence, und soc!allsation skills, as Op(lfOpriote to no 
individual's age and cultuml background (Grossmnn, 1983). In pl1lCtice, persons 
with an IQ>70 but with significantly limited adaptive beIw�iollT skills arc 
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sometimes included in the DSC registIation process, due to their demonstrated 
level of overall disability. 
k; outlined in Section �.3, all individuals WWI a Hebcr diagnosis of either 
Angelman syndrome (n ,. 35) or Prnder-WiIIi syIldrome (n ,. 59) from the 
Disability Services Commission were selected for the study (total. n .. 94). After 
reviewing the patient files, it was appan:nt that two of these CllSes had been 
Incorrectly l.belled asPWS (Heber 6715). In another two cases the diagnosis had 
been changed; one from AS to Lenno)(-Gaslaut spectrum, n type of epileptic 
disorder, the other from PWS to Stein-Lcventhal syndrome, defined Il5 polycystic 
ovaries, obesity. hirsutism and llIIIenorrhoea (MJM 1&4100). These four cases 
were therefore Cltcluded from the analysis, reducing the !!llnl study sample 10 90 
subjects. 
An additional three people were identified from the GSWA dalnbase as 
hnving AS or PWS, although they had never been registered as clients of DSC. 
Sinee no further informal ion was available on these individuals, nonc was 
included in the cohort. A JlCI1lon identified from GSWA records with nbnormal 
methylation ofehrl5qll"'l13 had B male child registered at DSC, with a genetic 
diagnosis ofi>WS. This child was already included in the study group. 
Within the PWS group, a set of ten individunls who had normnl 
methylation patterns were annlysed sepnratcly (referred to as the 'PWS-like' 
group), since biparonlat met�ylation hllS been considered as sufficienl reason to 
exclude PWS as n diagnosis in >98% of eases (Buchholz cl al., 1998: Fridman �I 
al� 2000b: Gleon �I 01.. 2000). Hence there was 0 strong possibility that most of 
these people had some other as yet unidentified genetic abnonnality. The 
exclusion of these ten individuals left a central (lI'Oup of 80 cases for whom a 
specific genetic I\llomaly had been identified, or who had B robust clinical 
diagnosis of AS or PWS. 
3.6 Etbloal lssuCll and approval 
Ethical approval for the project was given by the Edith Cowan UnivWlity 
Ethics Committee. The Disability Services Commission of Western AustIalia 
(DSC) Ethics Committec also gave permission for use of the DSC client dalabase 
to conduct the reselU'l:h, and specifically gmnted permission for the project to be 
undenaken On DSC premises. The study was epidemiological in nature and 
analyses were conducted on a group Jevel. Individuals were not identified in any 
d!lCllDlents or reports. Subjects and their fumilies were not contacted for the 
research, and 115 previously noted, nO client files were removed from DSC 
premises. 
Ethical approvnl for the linkage of cH en Is to thc four DaIll Linkage Unit 
core datnbases was received from both DSC IUld the W A Confidentiality ofHcaltb 
Infonnation Committee at the Depllrtment of Health, which is responsible for the 
maintenance and linkages of these e1ttcmal datnbases. All DSC cases (n � 
15,000) were linked to obtain this edditional infonnntion, since it was expecled 
that not all AS and PWS diagnoses would be specifically entered into the DSC 
database, or conversely that they had heen retrospectively diagnosed during their 
contact witlt DSC. As stipulated under the lerms imposed by the Confidenliality 
of Health Infonnation Committee, !he data linkage was undcnakeD by the 
personnel responsible for record linkage within the W A Data Linkage Unit. The 
datascts conlllinoo within the Dntn Record Linkage Project are avnllable for 
rcsenrch purposes. They are a highly effective, proven 1001 for h""lth infonnntlon 
retrieval and nnnlysis, and are almost unique worldwide in the broadth and depth 
of coverage offered. 
The general and medicnl files for each DSC client were kept in SecUIC 
storage on DSC premises when not in use, and were Recessed only by !he 
candidlllc and her supervisors. Aller datn linkage and eJ(lroction, subjects 
contained in the database Were identified by an unique number, which was used 
for all recording of information relcvanl l0 the client, in�ludi"g medical detnils 
elClrooted from tile DSC filcs. Electronic infonnation Was proleCled by passwords 
and unique numbers, and any hard copies were kept in secure stornge at the 
Cenlre for Human Genetics, Edith Cowan University. 
The completed dlItabose will be held on a password'protected computer at 
the Centre for Human Genetics, and it is envisaged tha� subject to ethics 
approval, the infonnalion will be made avaUable to Medical Practilioners, carers 
and service providers for individuals with eilber syndrome. Genemlly, Ibe data 
will be available in !he form ofsnmmaries, allbough reports will be prepared for 
specific interested agencies, such as DSC. In oddition, Drlicie!! will be prepared 
and submitted for pnblication in specialist academic jonrnals. 
. 1  
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4. RESULTS OFTHE STIIDY 
4.1 prom .. oUhuludy cohort 
As shOWII in Toble 4.1, 34 of the 90 individuals seleded for study (19 
females and IS males) had a diognllSis of AS, 46 (23 femol." and 23 males) had a 
diagnosis of PWS, and there were SC'/en males and three femoles in the PWS-Jikc 
group lotolling 10 enses. On. oflbe PWS enses was of Indigenous Austrulian 
deSl'ent, but none of the AS or PWS.lik. cases. The ages at the censor dale 
(30.06.20!}3) or oge 01 death ranged from 10 months 10 4& years 4 months. All 
members of the AS group Were nged six years or older, but nine individuals with 
PWS were less than six years of age. The birth yearn for the palients in both the 
AS and PWS.lik. groups ranged between 1957 and 1998, whereas the PWS group 
were born belween 1954 and 2002 (Figure 4.1, p. 52). Nine oflbe 90 subj�cts (2 
AS, 6 PWS, I PWS·likc) were dc=d by the cenSOr date. 
Tablc4.1 Cbaradcrulk. of Ihe .tudy ""hart (0 � 90) 
AS PWS PWS-like Tolal 
Diagnosis: 34 46 " '" (number ofindividuols) 
Gender: Mole 15 (44) 23 (50) 7(70) 45 (50.0) 
number{%) Female ]9 (S6) 23 (50) 3 (30) 45 (50.0) 
Ages (in years): 21.6 21.0 24.7 
mOllll (range) (6.5-36.6) (0.9-4B.3) (15.1·33.1) 
Deceased: , 6 9 (number of individuals) 
M.l 
Of the 32 1!ving AS cases, 20 resided al home, nine Were resldenl in group 
homes or hostels, and onc each in foster care, an independent home, and 1!vlng 
with adoptive parents. The moan nge of individuals living in privole residences 
was slgnifiCDI\lly lower ibM Ibose in shellered accommodation (20.2 years vs 27.9 
50 
years: t = -2.255, p = 0.032). The majority of people were registered within the 
Perth metropolitan regions (90.6%), with the remaining 9.4% living in rural areas. 
Members of the PWS group were also mainly resident at home (n = 28) or 
in group homes or hostels (n = 6). Once again, there was a significant difference 
between the mean ages of individuals living at home and those living in 
residential care (20.2 years vs 32.6 years: t = -2.584, p = 0.015). The place of 
residence for six individuals was not recorded, and the remaining six were 
deceased. The Perth metropolitan regions were home to 70.0% of living PWS 
individuals, with a further 17.5% living in rural and remote regional locations 
throughout Western Australia. Five individuals were not in receipt of DSC 
services at the time of sampling and therefore were not allocated to a region of 
residence. 
The residences of the nine surviving PWS-like patients were recorded as 
home (n = 7) and group home or hostel (n = 2); three were from the Perth 
metropolitan regions, and the remaining six individuals lived in country districts. 
There was no significant difference between the mean ages of the cases residing in 
private homes compared with sheltered accommodation. 
Figure 4.1 Year of birth for the cohort at five year intervals 
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4.1.2 Level of intellectual function 
The level of intellectual function of the study group varied from ' low 
average' to profoundly handicapped, with 4.4% being unspecified, i.e., the 
subjects may not have been fonnally tested due to their youth or for other reasons. 
The range ofJQ scores reported for the study group are shown in Figure 4.2. 
Figure 4.2 Levels of intellectual function of the study group (n=90) 
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4.2 Angelmao syndrome 
4.2.1 Prevalence 
The prevalence of Angelman syndrome in the study group was 
approximately 1 in 40 000 live births. This figure is based on the numbers of 
patients with AS identified in the study who were born in WA (n = 26), and the 
number of births in WA during the 50 years that DSC records have been kept (n = 
1.05 million) (Australian Bureau of Statistics, 2003). The remaining members of 
the AS group were variously born in other parts of Australia (n = 6), Canada (n = 
1 ), and England (n = 1 ). 
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4.2.2 Age at diagnosis 
The diagnosis of AS was made for members of the study group at a mean 
age of 5.8 years (range, 1-27 years). On average, the deletion cases were 
diagnosed at a later age than those with other forms of AS defect (6.9 years and 
5.0 years respectively), and females were diagnosed earlier than males (5.2 years 
and 6.5 years respectively), although neither difference was statistically 
significant. There have been no AS cases registered in WA since 1999, even 
though prior to that date the numbers registered per five year period were 
gradually increasing, possibly in line with the increasing total population of the 
State (Figure 4.3). On the basis of the established clinical criteria, one individual 
was originally diagnosed in chiJdhood with PWS, but subsequent methylation 
testing confirmed a diagnosis of AS. 
Figure 4.3 Date of diagnosis for the study cohort at five-year intervals 
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4.2.3 Major AS clinical criteria 
Half of the AS patients were assessed with severely affected intellectual 
function, with more than a third (38.2%) within the moderate range of disability 
(Figure 4.2, p. 53). Developmental motor delay was not universally evident in the 
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group 11.'; a wbole, 11.'; shown by the lower boundlllJ' ofth. sitting/walklng nll ge 
which fell within the pnramelers for the general population (fahle 4.2). 
TabJe4.2 Frequeucies ofthe major dlnlcal ,Igo' of Angclmau syndrome 
withlo the.tudy .... mpl. 
Clinical criteria PoslUve(%) Negative (%) 
MoJor development (age in yOllU"S); sit, l.4y {0.5-4.9y} 
mean (nlllge) (n � 29, n �J3) walk, 4.4y (1.I-9.0y)' 
No speech orminimal words 82.4 Some delay (o"'34) 17.6 
Atnxia (n -34) 91.0 , .. 
Inappropriate laughter or smiling 76.5 23.5 
(n-34 ) 
Micnx:cphaly(n � 20} "' .. 15.0 
Scb:ures (n � 34) g8.0 12.0 
Abnonnal EEG (n '" 30) 82.0 , .. 
*Five subjects had never _lked 
o - number of subjects for whom data WII.'; available for cnch clinical symptom 
The majority of AS patients (0 '" 29134) walked at some stage of Clltly 
development The pailents who walked comprised 13 orthe IS males (mean age, 
3.5 years; nmge, 1.1-9 years), nod 16 or the 19 females (menn age. 5.2 yClll'S; 
nmge, 2.2-9 years). This difTcJCm:e in the mean ages at walking of male and 
female children was significant (1- -2.052.p '" 0.05) The three females who had 
neverwntked were aged 21 years. 6 yenrs, and 6.5 year.; (deceased), wbile the two 
non·ombulanl males were aged 11.8 years, and 12.8 yClll'S (deceased) respectivciy. 
All of the subjects had delay and/or imulea,uaoy of speech, with the 
majority acquiring few, if ""y, words. Ataxia Dnd inappropriate laughter also 
were present in most cases. Microcephaly WIlS diagno""d in 44% of 5lIbje<Jls, 
although the number of eases for whom dota were available (n '" 20) was too few 
for statistical comparisons to be m.de. A large proportion of eases (88%) wen: 
reponed to hove experienoed seizures, with 26% su/fering frequent episodes. In 
addition, the majority of mdividuals had at I� on. nbnormal EEG reading 
(82%), with only three subjects neVer having been tested (Tnbl. 4.2, p. 55). 
4.2.4 Minor AS din/col crit�rill 
Th. lh'"'.::iO"ce or absence of the characteristic facial features such lIS flat 
occiput, mandibular "I'IDgnnthin, drooling, mouthing, and tongue thrusting was 
rnrely noted in the p,�irnt files (Figure 4.4, p. 57). Strnbismus was recorded in 
almost half (47%) of the """'cs, Md hypopigmcnlation in 35%, although 
information on these eharactcnSlics was unavailable for significant numbus of 
patients. Few data wen: available On the presence of the mised, flexed arm 
position claimed to be chorneterutie of AS, or on sleep disturbMccs. A small 
number of subjects (n � 3) wcre recorded as having a fascination with water 
(Figun: 4.4, p. 57). 
4.2.5 OtherclinicalFmdings 
A number of additional clinicnl chnrocteristics were frequently reported 
within the study group. Most ",,",cs (79%) of AS were hypotonic, and half of the 
group were regarded lIS hyperactive. Over 38% were considered obese, and 50% 
of the group wcn: of normal stature. Skin picking II'DS reported in seven patients, 
mainly older individWlIs. Scoliosis was present in 33% of all pollents and in 56% 
of those more than 16 years old. Three of the moles had either undescended testes 
or a small penis. 
<1.2.6 LaimratorydiDgnos/s 
acnelie tcstmg was conducted on 88.1% of the cohort, although eight 
patients (23.5%) had received only karyotyplng or banding tests (Table 4.3, p. 
58), cf which half were JIOsitive. Two persons with a delelion, as indIcated by 
ohromosomal banding, had relurned normal bifllll"Jltal methylation tests and were 
therefore included in the 'inconclusive' group. Onc IcSl hod heen performed for 
UDDA. abnormalities (which wru; negative), but none at all for le defects. afthe 
19 methylation tests conducted, I I  were positive and eight were negative, and 
three of the four FISH tests were posItIve. Delctions accounted for 33.3% of the 
JIOsitive l"CSults, IIl1d UPD for a further 6.7% (Tnble 4.3, p.58). 
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Figure 4.4 Frequency of the minor clinical signs of Angelman syndrome within the study group (n = 34) 
Minor clinical criteria 
I • Positive • Negative D Unknown/no data I 
Table 4.3 {�etalls of dlagnOlltic lest( WlCd for Angelmlln !l)'adrome eases 
(0"'34) 
Typeofmoleo:ularlcits (%) 
Moleo:ular test re,ults: 
number (% of those tested) 
Kaxyctypellmnding 
FISH 
Methylation 
Unknown/no test 
Deleticn 
Uniparenta.l disomy 
Positive (not specified) 
No abnormality dete<.:ted 
Inconclusive 
4.2.7 HorpllllladmlsslollS 
"., 
11.8 
55.9 
11.8 
n �  10 (33.3) 
n � 2 (6.7) 
n m 2 (6.7) 
n - 1 3  (43.3) 
n = 3 (10.0) 
Individuals witb' AS bad been admitted to hospital on 11 totnl of 301 
oe<:aSions, with an average of 8.8 (SO - 8.6) inpatient episoocs. As sbown in 
Table 4.4 (p. 59), epilepsy nnd/or seizures were the most common reasons for 
admis.sion (14.3%), followed by gastrointcstinlll tract disorder, (13.0%), 
holiday/respite care (I ].3%), dental care (9.6%), and "" piratory. tract disorders 
(8.6%). The remaining admissions covered 11 wide variety of reasons, e.g .• eye 
abnonnalities, bums, congenital dcfonnities. Four pwple had no recorded 
hospital admissions. 
More than h�lf of the individuals with AS were admined one or more 
times for dental work (n = 18), rn.J .Imost as many for epilepsy (n '" 16). A 
fuMher 12 indIviduals were hospir.lIsed for f"ilure to thrive or developmental 
delay (rllble 4.4, p. 59). Admission for dental work was over-represenLed in 
patients with seVere or profound intellectual disability (62% of dental 
a�,"issions), even though this group comprised less than 53% of the AS 
;;;'pulatlon. 
Three individuals were admitted to psychiatric units fer up to tiuee doys 
durati!.'n. The reasons listed for their admIssion were developmental dday (1111 
three persons), and epilep.y (two persons). Three other AS patients atrended 
psychialric outpatient clinics on two, six and eighteen occasions respectively. The 
diagnoses reported for these persons were seven: ID, microcephalus, and 
psychosocial circumstnnl:CS (unemployment) respectively. 
Table4.4 Hospital admissions for Ibe ADgellnan syDdrome gronp 
Rouon foradmlssion 
Dental 
Respiratory disorders 
Ear pmblems 
Skin disorders 
Open wound, various sites 
Failure to thrive/feeding dimculties 
Foreign body Inserted, Ymous sites 
Congenilal anomaly 
Urinary tract disorders 
Fructured bone ± complications 
Other causes (various) 
4.28 M0r1111ity 
29 (9.6) 
16 (8.6) 
IS (5.0) 
]5 (5.0) 
13 (4.3) 
]2 (4.0) 
9 (3.0) 
8 (2.7) 
6 (l.0) 
5 (].7) 
47(15.6) 
of Numberof 
oHotal I 
I 
18 
10 
7 
4 
• 
12 
, 
, 
4 
4 
19 
There had been two deaths within the group of 34 AS patients. One 
person died of $/QIV3 epllcpllcw; al the age of 12 years 10 months, and the other 
p,tienl wos aged 6 years 6 months at death from pneumonia. 
4.3. Prader-WnU..yndrome 
4.3.1 Prevalence 
A birth prevalence of [ in approximately 29,500 was calculated on the 
bosis of the number of PWS cnscs identified for this study who well: born in 
'" 
Western Australia {n c 31} and the number of births were registered In WA over 
the lust 50 years (n � 1.05 million) (AustraliDll Bureau of Statistics, 2003). Ton 
Olher memben of the PWS group had been born in other parts of Australia, and 
one each in Hong Kong, Scolllll d, Soullt Africa and Spain. The remaining 
individual had no record of counlly of birth In the rclcvllIlt DSC files. 
The avemge age at diagnosis of PWS was 5.3 year,;, willt 34.8% of lite 
entire PWS group diagnosed before lite age orone year. Within the subset of 1 1  
individuals who were added to the database a!ler 1998, the mean age at diagnosis 
was 1.1 years (l'IIIlge, 0.1-6.0 years), while the 3S individuals who were included 
prior to 1998 had a mean age at diagnosis of 6.6 years (range, 0.2-17.0 years). 
This difference WIIS highly significant (I g -3.5, p a 0.001). Deletion taSCS WCre 
diagnosed at a slightly earlier but SIlItlstically non-significant "ge than those 
without a deletion (mean, 4.5 years and 5.9 years respectively; 1 = -0.90, nls), and 
males curlierthWl temales (mean, 4.6 years and 6.0 years respectively; I g -1.015, 
nls). The numbers of PWS cases diagnosed were appreciably higber in the five_ 
year periods of 1980-84 (n - 12) IUId 1995_99 (n � 13) than during any other time 
perioo (Figure4.3, p. 54). 
M.J Mojor PWS cllnlcol alierlo 
As indicated in Toble 4.5 (p. 61), the majority of PWS cases repolled 
hypotonia (96%), infantile feeding preblems (85%). nnd rapid weight gain at an 
early age, followed by obesity (87"10). HyperphagIa 11'85 described less often 
(61%). Repolling oftbe characteristic facinl features was poor, with over 90% of 
case files without mention oflhis feature. H)IpOgonodism and/or c!),ptorchidism 
were present in two--thirds (67%) ofPWS patip;ots, i.e., 91% of males ofa!1 ages. 
and 58% of females OVer IS yearn. t.il of the adult female patients with a 
""nfinned deletion had ubsc:nt oT delayed menses. but this feature was reported in 
only 300/ooffcmules of the same age in the group of patients without IIlI identified 
deletion. MOlOr devclopml:llwl delay WlIS found in many caseS (n -20), but there 
were some patients (n � 18) who did not show any marked delay in rcucbing 
physical milestones by comparison with the general population (fable4.5, p. 61). 
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Table 4.5 Frcquucle!l ortbe major diuital sign" ofPmde ...  WilLi 
syndrome "':\Ibiu tbe study sample 
CLiuic.oi criteria Positive (% of group) Negative (o,.\. of group) 
Hypotonia (o -46) 95.7 4.3 
Feeding problems{n-43) 84.8 '.3 
Exeessivewcighl gain (n "l 86.9 l3.1 
Ch"",eteris!ic facies (n ,. 2) 4.3 0 
Hypogon�dism (n -41) 67.4 21.1 
Hyperpi1agia (n g 33) 60.9 10.9 
Mo!ordcvcicpmcnl (nge in years): sit, l.Oy (0.5-2.5y) I subjc<:t unable 10 sit or walk at mean (range) (n �34, n '" 39) walk,2.8y{I-IOy) 0." 
n ,. number of subjecl! for whom data was available fer each clinical symplom 
4.3.4 Mlonr PWS clinical criterln 
Figure 4.5 (p. 62) Shows that more thllll halfofthc study subjects (57%) 
had exhibited some orthe charne!.ri,tie bchavioul'II  patterns lISS""ialed with PWS 
(tem;>er Irultrums IIlld violen! oulbursts), IIlld 72% were short in stature compared 
to fnmily member.;. Individuals who hod received growUl hormone th"ropy (n" 
4) were recorded lIS short, regordlcss of their current height Ocular abnormalities 
were reported in bolf of cases, IIlld a large percentage of PWS paliem.3 (85%) 
suffered from delayed speech development lIlld/or articulalion dcfecl!. Many of 
the remaining minor clinical signs were under_reported. with fewer thIlll 40'" of 
individuals having specific features record"" in their files; i.e., decreased Iclal 
movement (23%), sleep diSturbances (13%), size and sh';>e ofbandslfeel (3)%), 
pmenee ofthiok soIiva (O%) , IIlld skin picking behaviour.; (37%). 
'" 
Figure 4.5 Frequencies of the minor clinical signs of Prader-Willi syndrome within the study sample (n = 46) 
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4.J,5 Oilier dlnlcalfintllngs 
Scoliosis was reported in I I  ofthc 30 subjects (37%) who were aged I S  
y= Or more, but in none of those aged less than [ 5  years. Two individuals with 
scoliosis had received corrective surgery for the condirion. Osteoporosis Was 
identified in one female, aged 32 years. 
Al lcasI one episode ofepilcpsy or convulsions was reported in 28.3% of 
cases. Of the 13 persons who had an epileptic episode, five showed n deletion, 
One was diagnosed as UPD, four had nC'lCf been tested, nnd four had no genetic 
mechanism identified. Diabetes was reported in four adults, with no data 
available for the other 30 adult members of the PWS cohort. 
4J,6 Llrhofll/ory tllagnofis 
Tahle 4.6 shows that geJIetic testing was performed on 84.8% of the PWS 
cases. Almost n third of these people received only kruyotyping or handing, 
There were no lests for le defects. All of the FISH and methylation tests Were 
positiVe, Le., unipnrental, as the patients with bipare!ltnl methylation had been 
removed pre-annlysis 10 form the PWS-like group. A deletion was identified in 
43.6% ofle5k:d cases, and UPD in 10.2%. No genelic mechanism was identified 
in 23,1% of those tested, and the remainder had returned unspecified 'positive' or 
inconclusive tests, 
Table4.6 Diagno . . ic tests for Prader-' l1i syndrome""""" (0 - 46) 
Mean age al diagnosis (range) 
Type ofmolecul .. tests (%) 
Mole""l .. lest re,ults; 
number (% oftbose tested) 
KllI)'otypelbanding 
FISH 
Methylation 
Unlmownfno tcs\ 
D.letion 
Uniparental disomy 
Posilive (nol specified) 
No nbnonnality detecled 
In,,,,nelusive 
5.3y (0.1_17y) 
30.5 
17.4 
36.9 
15.2 
n � 17 (43.6) 
n�4 (IO.2) 
n - 6 (15,4) 
n = 9 (23.1) 
n - 3 (7.7} 
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4.3.7 Hospital admis�lo/1< 
As shown in Table 4.7, PWS patients had been hO);pitalised on n total of 
328 occasions (mean, 7.4; SO, 6.9). with respiratory truet infections accounting 
for the 11I1'S.st number of admissions (7.6%), followed by breathing difficulties 
(7.3%), dental = (6.4%). nndescended lestes (5.8%), gastrointestlnal disorders 
(5.5%) and an unspecified congenital wlOmaly (5.5%). In addition, a large and 
varied number of reasons were listed in the pallents' files for their Ddmis.sion to 
hospital. These Included ceUulitis, musculoskeletal discrders, congenital 
deformities, Md ingestion of toxic subst<mces. Nearly 37% of individuals 
sutTered from ut lellS! one respiratory infection, and 1 4  individuals .. ch had been 
admitted to hospital for dental work Or with breathing difficulties (Table 4.7). 
Table4.7 Hospital admissions for tbe Prader_Witti syndrome cases 
witbin Ibe sludy group 
Total nllmber of Numberor 
Reason for admwioD admissions (% of total Individual! 
admlMioDll) admllled 
Respiratory infections 25 (7.6) 17 
Breathing difficulties 24 (7.3) 14 
Epilepsy 15 (4.6) 9 
Gastrointestinal disorders 18 (5.5) • 
Holiday care 3 (0.9) 
"'""' 21 (6.4) 04 
Congenital anomaly 18 (5.5) 10 
Undescended testes 19 (5.8) 9 
Eat problems 11 (3.4) , 
Skin disorders 5(1.5) , 
fructured bone," compIicotions 16(4.9) • 
Failure ID thrive/feeding difficulties 1 1 (3.4) 6 
Urinary tract disorders II (3.4) 9 
Foreign body inserted, various sites 2(0.6) , 
Complications of pregnancy/childbirth 9(2.7) 
Open wound, various sites 2(0.6) 
Other causes (various) 118 (35.9) 
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Silt patients had been admitted to psychiatric units for an averng� of 24.S 
days (range, 2.96 days), on the groUllds of l�, developmental >:!day or, in one 
CIISC, nonoOrganic psychosis. One male PWS case, who recorded 1162 psychioWc 
outpatient visits, attended group theJllPY sessions for mixed disturban<:e of 
conduct and emotions over a period ofnln. years, ut an avemge of 10 visits per 
month. Further outpatient visits to psychiatric units wen: made by three persons, 
with the tolnl number of visits per person I'8IIging from 3 to 12. ID, 
developmental delay and disturbance of conduct Were the moin rellSons for 
attendance. Two individuals with PWS attended both as inpatients and 
outpatients (one person each with mod.mIC ID and schizophrenia). 
Three individuals had neoplasms roported in their files. One patient had 
been diagnosed with a benign tumour of an endoorlne gland, another had a 
molignant melanoma removed at 16 years of age, and the third person hod a 
thyroidectomy for malIgnancy at uge 35 year.;. The only onc of these Urree 
patients who was deceascd had survived for 20 years ofl.r removal of the 
melanoma and then died ofcnrdinc failure, aged 36 years. Only one of these cases 
was listed in the Cancer Registry, lIS the other two persons had been diagnosed 
before the Registry WIL< ""mmeneed. 
�.3.8 Mortality 
Of the silt deceased PWS cases, two had died from cardiac am:stI 
myoonnlia! infan:tion, onc from pneumonia, and in the remaining three cases the 
CaUSe of death w ... not recorde�. The case noles for onc individUIII had been 
referred to the Coroner, but nO notifiention had been received by the Deaths 
Registry at the date of dol.!! Hnuge. The other two people were not listed In the 
Deaths Registry, and nod.ta wcre inoluded in their DSC file!. Theiragcsat de.th 
rnnged from 2.3 years to 36.5 yeW'S. 
4.4 Metbylatlon Donnal 'PWS-like' group 
4.4.1 Oln/ca/flndlngs 
As previously describod (Section 3.5), this group comprised 10 people 
with a clinioal diagnosis ofPWS but who showed biparental methylation patterns 
(Toble4.I, p. SI). TheiravCnlgc age Was 24.1years (range, 15.1·33.1 years). As 
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can be Seen from Figure 4.2 (p. 53), the level of ID reportod was mild (0 D 6), 
borderline (n '"' 2), modemte (n '"' I) nnd ,evere (n = 1). Moan age ot dingnosi, 
was 10.6 years (range, 0.9-25 yClU"S). However, the age for two cases was 
l1I\JeCorded, and ,oth. dnte of first contaot with DSC was used as the upper limit 
of the age at dj.gIln,i, for those individllOl,. 
Half of the ,ubJects were reJlOrted 10 have hypotonia, and five individuals 
eJ<hibited feeding problems in infancy. Eight were obese, one was of normal 
weight nnd .w.lure, and one bad no dntn on body habitu,. Their uVrnlge age ot 
sitting was 0.8 y= (range, 0.7·],0 years), and it WlIS 1.6 years (range, 1.1·2.1 
yeur,) for walking. Of the ,even males, five were hypogonadal, whereas only one 
of the three femal .. hOO no menses. HypOIJlhogio was re(>Orted os present in 
,even of the subjecls, and speech delay or defects in nine cases (Table 4.8). Half 
of the group Were either of normal .w.1ure or were Inll. Skin picking behaviour 
was evident in two ;ndividUl!I,. None of the other features regarded as 
chorneteri";. ofPWS (Table 2.3, p. 28) were recorded with ,umc;ent frequency 
' :' to enable a valid ELlSCssmcnt. Fourofthe group had reported at least one epileptic 
episode. 
Table 4.8 Frequendell of various dhlical cbaracteristitll In the PWS-like 
subgroup (n = 10) 
Clinical criteria Poslll�e (Dumber) Negatlve(aumber) 
Hypotonia (n � 8) 4 4 
Feedi�g problems(n- 8) , 3 
Excessive weightgaln (n � 9) • 
Hypogonndism{n - 10) • 4 
Motor development (nge in yenn;); si� 0.8 (0.7-1.0) I subjedncver 
mean (range) (n �7, n = 8) walk, 1.6 ( l .t-2.7) walked 
Hyperphagia(" - 10) 7 3 
Stature compared to relatives (n � 9) shortm4 normal =4 tall�1 
Speech dclay/def,cts(n - 10) 9 
Skin picking (n � 10) , 
n - number ofsubjel'ts for whom daln was available for each clinical symptom 
., 
4.".2 H"rpIlJladmks/om 
Members of the I'WS-like group were admitted to hospital on a tolal of70 
occasions (rnenn, 7.0; SO, 10.3), but with a large proportion of these visits 
(32.9%) for epilepsy and ""ovulsions in a single individual. Re:;piralOry tract 
infeotions and gaslrolntcstin.l tract disorders accounted for ten (14.3%) and eight 
(1 1.4%) admissions respectively. Individuals (n � 4) were more commonly 
hospitalised ror sustrointes\inal disorders than for My other rellSOn within this 
group of patients (Table 4.9). 
As with the AS and PWS cases, there were vruious other reasons recorded 
ror hospital admission, including syncopc und collapse, disorders of the 
ligDlIUmUmuscie, and virnVChlamydiol infection. Four (>001'1. from the PWS-likc 
group accounted for one day ofinpalicnl llIld six visits to outpatient psychiatric 
services, ID, stress/ftI]xicLy disomers and infantile ccrebml palsy were I'I:cordcd as 
the main Teasons for Ibese ollClldOllces. One womon died at age 17.9 Y""". but no 
informalion on her caUse ofdealb was available from the Deaths Rcgisuy. 
Table4.9 Ho'pltal admission, ror the PWS-JJkc alses within iD tbe 'tudy 
group 
Totalnumberof Number of 
R .... Dn for admwloD admission. (% "flotal Individuals 
admissions) admllted 
RespiIatory disordcn 10 (14.3) 3 
Epilepsy 27 (38.6) 3 
Gasuolntestinnl disorders 8 (11.4) , 
"'""' 1 (1.4) 
Congenital anomaly I (1.4) 
Ear problems 1 (1.4) 
Skin disorders 1 (1.4) 
Frnclurcd bone ± complications 2 (2.9) 
Failure to thrivelfeedingdifficutics 1 (1.4) 
Urinary !met disorders 3 (4.3) 3 
Olber causes (various) 15 (21.5) 
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,. DISCUSSION 
A numb .... of diverse demographic, clinical, gelletic and technical factors 
need to be considered when ossessing the ovemll findings of the study, 
5.1 Potealial limitallno. of Ihe study 
5.1.1 ellSe IlScu(alnmenr 
Onc disadvantage of using the DSC database for case ascertainment is the 
Commission's requirement that a specific level orlD is idC'lltificd before a client 
is acccplCd for rcgistrntlon. This hus particullll" relevllIlCil for individuals with 
PWS, because an estimated 27-40% an: thought to have at leas! low-avcmgc 
inlelligence (ClISoidy et 01., 2000; Cimke el al., 2002). Therefore PWS 
individuals who have nonnaI or borderline intelligence arc unlikely \0 be 
regi!rtercd at DSC. In addition, a recent study of ID in WA found that a 
significant number of children with ID wen: identified either through the 
Department of Eduoalion, Catholic Education or the Association of indcp<mdent 
�chools, rather than vi. DSC (Leomml et al., 2003). Globally, the majority of 
pefSOll5 with ID fall within the mild/moderate mngcs of functional limillltion 
(ChristiWlson et al., 2002; leonnrd et al., 2003). Hence it is possible that 
additional people with AS Or PWS DrC living nndingnosed in lbe community Md 
could perhaps be identified if 1I1""e educatiolllll agencies were used as souroes of 
lISCCJlIIinmenL 
The orgMisation known as Irrnbccn .. which la!er became the Disability 
Servi""s Commission, was a centre originally eSlllbHshed by the Slow learning 
Children's Group (now the A"liv foundation) in 1954. The centre, which was 
used for the testing and diagnosis of ID, became the responsibility of the Menwl 
H .. lth Depllrtment of WA in 1964. Over those years of foundation Md change 
1I1cre were a number of different physicl!lllS involved in rccord·kccping, and mIIior 
chEUlgcs in public attitudes to ID occurred (GilIgrcn, 1996). 
The initial descriptions of PWS in 1956 und AS in 1965 were published 
during 1I1is period of development in the provision of services for lbe ID 
population in Western Australia. By 1I1c lime the consensus diagnostic criteria 
were published (Holm et al., 1993; WiIliams et al., 1995), a majority of the 
individuals in the present study cohort hod been dingnosed by the swffot DSC or 
by another Medical Practitioner. The "",!iest rocorded diagnosis of AS at DSC 
wns in 1966, and that ofPWS 'Has in 1968. In some cases the Heber code WIIS 
ndded reIrospectivoIy to the patient's file, and 1Ilere WIIS no way of ascenaining at 
whill precise date the coding hnd been perfonned. There also was no gunrantee 
that all cases of PWS Or AS hnd been identified from the registered client 
population and hurl the requisite Heber code appended to their file. 
Linknge of the GSWA records to 011 registered DSC clients ensured that 
all persons with 10 who had undergone cytogenetic testing of chromosome 15 in 
Western Australian public tabomtories were considered for inclusion in the study, 
thllS ensuring the creation of 0 databo.sc comprising most of the known cases in 
WA. By cleflllition, those cases identified ut GSWA but who were not registered 
with DSC could not be induded in the study, IlS no clinical data were available on 
thest.: individuals. However, only three individuols who were identified through 
GSW A IlS having PWS or AS were not included in the DSC files, so it is unlikely 
tIlat a signifiCllllt number of caseS were missed bc<:ause of this limitatioo. It is 
known that at an early stage of the development ofGSWA SOme individu.als had 
sumples for testing sent to Inbomlories in other States of Austratin. Unfortunately, 
it WIlS not possible to access tile records of these labomlOries tn get confinnotio" 
oflest results. 
It wns difficult 10 estimate the number of people with PWS or AS in the 
W A resident population who were not registered on the DSC databnsc. Given that 
some 1.05 million people were born in WA between 1950 and 2003 (Australian 
Bureau of Statistics, 2003), Md previous prevalence mtes for both AS and PWS 
bave been estimated at I in IO,OQ()"25,QQO births, it initially was expccted that 
between 84 and 210 people would be Identified as having one or other syndrome. 
As demonstrated in Section 3.5, 80 pcrsons born before 2003 were identified from 
the DSC database. However, only 57 of these people (26 with AS, and 31 with 
PWS) were born in WA. This leads to the possibility that at least 27 nod perhaps 
as many as 153 individUll s born in WA with either syndrome may not bave been 
diagnosed. If correct, several potenti"1 contributory cireumstances can be 
identified: 
I. The birth incidences for both syndromes are lower in WA than would 
seem probable from estimates derived for other population •• 
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2. A sizeable proportion of people with PWS or AS hnd migmted from W A 
before they were diagnosed. 
3. A slgnlficnnt number ofJ'WS or AS cases remnin undlagno!lCd In the 
general population. 
4. Indi�id\Ulls with one or other of the syndromes died before a diagnosis 
and/or ""n!net with DSC was made. 
Ofthcse four possible oulcomes, numbers 3 and 4 would ...em to be the 
most feasible. Worldwide then: appears to be compa!lllively liltle variation in the 
reported inddenre rotes for AS and PWS, therefore it is difficult to suppose 
credible grounds for their apparent low prevalrnce in this SlIIte (Hou 0/ al., 1998; 
Stromme, 2000; Whittington el 01., 2QOI; SmIth cl 01., 2003). In addition, the 
population of WA is considered to be demographically quite stable, with vCI)' 
limited permanent migration from the State (HotrnWl elol., ]999; Trewin, 2003), 
SO it is unlikely that many peo�le have moved out ofWA before being diagoosed 
wllh either syndrome. As 23 suhjects were born outside WA. there appears 10 
l�ave been n medy rate omet inward migr.>lion over the last 50 years (Trewin, 
2(103). It is acknowledged that the diagnoslic services offered by GSW A arc both 
comprehensive and of high quality, bu� no; was noled above, then: have beeJ\ 
periods when genetic tests were conducled In the laboratories of other Austrolian 
States, and the results were nol always availab]e in  the cllcnt files. 
There remains the possibility that n ,ubsUUltial number ofindividuals with 
ID nre registered nt DSC bul have not had a diagnosis of AS or PWS recorded. 
Over the lasl lS years there bas been n greater empbasls on community care for 
people wllh ID, '0 thut mOre oft;:n palien!S arc seen by a Geneml Practitioner 
talher than by the s[JeCialisl physioians at DSC (Stella, 1996). In these cases there 
probably is lillle chance that the individual, would have returned to DSC to have n 
retrospective dlagnosis recorded in their filos, eS!",cinlly if their level of ID Was 
borderline or mild. 
AS patients arc difficult 10 diagnose in the first fcw years of life, before 
the chlU'8Ctcristic patterns of developmontal delay and epilepsy bave become 
manifes� and some cases ofPWS are nol diagnosed until chlldbood areven tater. 
It i! therefore enlirely possible that some individuals in WA with either syndrome 
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have nol yet been identified. Du. to the relatively =nt development (post-
1995) of specific diagnostic laborolOry tesls for both syndromes, it seems likely 
that a number of older people with AS or PWS have nol i>ee'l recognised as 
having dther syndrome. In the Netherlands, for example, two middle-aged 
I"'tienls with PWS or AS WCre identified during a retrospective study of the 
residenls of a single l,mg-slny in;litution (VI1rl Buggenhout er �I., 2001). 
Similarly, fouredult AS cases wen: diagnosed after screening n sub-section of the 
population of a large Dcvclopmenlnl Centre in the U.SA (J.oobsen ., al., 1998). 
The large-scale deinstitutionalisation of the inlcltcctUll ly disabled pop"I,;!;"n in 
WA since th� 1970s makes it unlikely thut many of these putative PWS or AS 
cases will ever be specifically diagnosed (Stellll, 1996). 
5.1.2 Dalll avllilabUIIy 
Specific restrictions were effectively imposed on the study by the dala 
oollection meih<KI employed. As there was no direct or indirect palient or ClllCr 
oonlnCl, the daln ool1ected were wholly dependent 011 the quality and quantity of 
infonnntion recorded in the various datablo.Scs IUld in the client hard mpy files. 
These records have been compiled and mainlnined by a rel.tively small number of 
Medical Pnu:titioners, with the consequent expectation that they would b. 
internally t(lnsistent. Howcvor, under-reporting of mMY of the recommeroded 
diugnost!c sigm for both disorders WEtS apparent in a suoolnntial numlJ.er of the 
early patiCllt files, possibly du" to the relatively nxcnt specification of the 
diagnostic clinical criteria for the \Wo syndromes, allied to the retrospectiVe nature 
of some of the diagnoses. 
The volume of data contnined in eneh m<l also depended on the degree of 
utilisatio" of DSC assistancc IUld resources by individual clients. Some people 
were rarely in contnl:1 with DSC, especially those with a milder phenotype or 
whose pnrenl!;/canlJS mny have had more resourees available to them. In the 
ea:rlier years of what wm to become the Disability Ser;joes Commission there was 
considemble distrust of the 'professionals' expressed by some parents, and it was 
also difficult for clients who lived in more remote regions of the Slat. to access 
DSC services (GilIgren, 1996). The overall result was tluIt the records of certain 
indi�idua!s t(lntained relatively liUle information. In these cases, the 
supplementary data acccssed from the othel WCSlcm Australian dntabases w�re of 
plUticular value in establishing the morbidilY pallCtns of the patients. 
The del/clopmen!l\Ild use of record sheets specifically for AS or PWS has 
greatly aided th� collection of data pertaining to the major clinical signs of both 
disorders (Appendices IX & X). Howel/er, in the absence of professional help, 
the record sheets can only be completed with a level of accuracy dependent on the 
memory and opinions of the parents or <:arers of Ihe patients. Tenns such as 
'fceding difficulties' are often subjective and vague, nnd they may elicil a wide 
variation in response, dependen! on the perceplion ofth� meaning ofth. phrase on 
the part of the respondent [n addition, SOme oftbe characteristics, Le., hypotonia 
and weak cry in PWS, and feeding difficulties in either syndrome, are generally 
confined 10 infancy Md may not be rccnUed at a loter dale. Conversely, short 
slalure and hyperphagia in PWS IlfC normally fClllures of the older chUd and adult, 
mther than the infant. 
5.2 Prevalence estimates 
5.1.1 InlelleCf��f dis�bility find flhnlc origins 
A study from Western Australia covering the period 1983 to 1992 
estimated that 14.3 persons per 1000 births In WA had "" ID, with the mojorily 
(10.611000) showing mild/modemte ID (le<.>nnrtl et 01., 2003). The male 10 
female mlio Was J.�:I, and there was 0 disproportionately high number of 
[ndigenous AustraliM clients, with 2.3 Indigenous cases to each non-Indigenous 
patienl (Lconnrtl er al., 2003), even tllOUgh Indigenous people only comprise 3% 
of the Slate popUlation (Aust",H"" Bureau of Statistics, 2002). The gender ",tio 
Was similar to that recently calculated for a rural South African population, but the 
ovemll prevolencc in South Africn was much higher at 35.6 persons per 1000 
births, ofwhorn 29.1 per 1000 were mildly disabled (ChristillllSOn elo1., 2002). 
The presence of high mtes of specific morbidities in mothers, e.g., 
diabetes, hypertension and chronic rennl disease, or in the child, e.g., fetal alcohol 
syndrome, postnalal lcad poisoning, malnutrition and infanlile Maemia, may be 
implicaled in the increased occum:nce oflD nmong both Indigenous AustrnliMs 
and Indigenous So�th Africans, as these disorders IlfC indicative of the lower 
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socio-economic standing of many indi�idunls in �)CSC two populations 
(Grossman, 1983: Christillll50n el al., 2002; Leonard el aI., 2003). 
As mentioned previously (Section 5.1.1), in WA more children wilh mild 
ID Were identified through lhe Department of Education, CDlholic Education Md 
'the Association of Independent Schools lhM from DSC (Leonard cl al., 2003). 
n,. preVll ence of severe 10 profound [0 vlllies widely across studies Ilfld 
populations, llII glng from 0.64 per 1000 to [4.4 per 1000, ollhough some oflhesc 
figures refer 10 binb incidence while olh.rs signify prevalence in a surviving 
cohort, so thnt no over.l1l comp=ive conclusions can be rendily drown (Durkin 
., aI., 2000; Christinnson el al., 2002: Arvio & SiIIllflpaa, 2003; LeonDId el aI., 
2003). 
5.2.2 Angel""'n syndrome 
The relalively low prevalence mte for Angelmnn syndrome suggested by 
the data from the present study group could .. flect the problems in ensuring an 
ac:eumte clinical dlagnos[s of AS, especially in infancy, "Ilhough it is difficult 10 
understand why this would be more relevanl in WA thM in other I�gions of 
AustrnUa or intemotion.lly. The comparatively sleady rate of migration into the 
Stale would indicate thot there can be little ground for supposing n founder effect 
is opemtive, especially in the light of the ever-increasing ethnic diversity found in 
the migrant population. The apparent reduced incidence of the disorder is 
reflected in the obscnce of individuals diagnosed with AS within the losl five 
years, eVen though the various eytogenClic Md DNA_based diagnostic laborulory 
tests ha�e been available throughout this lime-period (WilIiwns ., al., 1995: 
Sailoh el al., 1996; Glenn cl aI., 1991). 
It would seem that there hos been a laok of di"gnostie testing in Weslem 
Aus\nllilll\ cytogenetic and moleculnr genetic labcratories for IC or UBE3A 
deft<:is, which were identir.ed os �i&llj(jCllllt causative mechanisms of AS in 1996 
nnd [991, respectively. Addition,,!y, the tests thnt were used proved 10 be 
uninfOlTlllltive for many patients, .Ilggcs\ing that a number of AS ca:;es rem"in 
undiagnosed in WA. For example, ancr a negative bllIlding test or kW)'otype, in 
the pasl individuals may have been listed either as nol having AS or been 
allocated some other diagnostic code (e.g., 'other unkllown prenatal influence'; 
n 
Hel>er 6900). lfso, they would nol�ave been selected forthe study from the DSC 
dalllbase. Ncvcrthele", there were four people who had ° negntive 
karyotypeibanding test but who were still considered 10 have Angelman syndrome 
based on clinical assessment, and were recorded as such. 
To date, there has been no reported voriation in prevalence of either PWS 
Or AS which could be attributed to membership of any specific ethnic group. 
Therefore, the absence of Indigenous Australians from Ihe AS co�ort could be 
i�dicalive of a lack of opportunity for idenlification due 10 remotene" from 
SCl'Viccs, Or of communilY'specific beliefs and aUitudes (Morgan el 01., 1997). 
Aboriginal people often prefer 10 care for individUElls with n disability within the 
community, ralher thWl seeking outside help (Brown. 2001). This means Ihat, 
despilc ovcr·represenmtion of the Indigenous communily (7.4% of cases) in the 
records of DSC (Glasson .' 01., !n !'re,,). there still mny h e .  significant number 
of individuals who have nol been given a causative diagnosis for their intcllcctunl 
disability. AI the sa!ne time, as [ndisenous Australians comprise just 3.5% ofthe 
lotal Western Au,tralian populalion, small number effects may also provide a 
part-e:<plEll1alion (AustraliEll1 Bureau ofStntistics, 2002). 
5.2.3 Prader_WllIIsyndrome 
In a similar m""ner to Ihe AS group, il was vITj difficult to estimate the 
birth incidenccofPWS in WA from the dam collected as part of the current sludy. 
E�clusion from the DSC n:coms of persons with no or minimal lD would have 
meant that some PWS individuals with borderline ID were almost ccrtllinly 
missing from the study. The possibility of ov.r-<lia�nosis wru; also a 
consideralion since, ru; previously discussed in Section 2.3.3.5, there is a range of 
condilions that superficially resemble PWS if elinicnl crilena are used as the only 
basis for assessment. This was onc of Ihe reasons for removing methyl.lion· 
nonnal individuals from Ihe main study cohort (Section 3.5), as there is a high 
probability thnt few of these people have PWS, despite their clinical presentntion 
being consi,lent with the symptoms of the syndrome. 
Most previous sludies have reported no gender bias amon� people with 
PWS, although females ore ollen under·represented in the groups investignted 
(Orecnswag, 1987; Akcfeldt & GilIbcrg, 1999; Couper & Couper, 2000; Fridman 
el al., 2000b). [t has been suggested that the probability of miHliagnosing PWS 
in females i� inrn:ased by the difficulty of identil}'ing female genital hypoplasia 
(Akef.ldt & Qil1berg, 1999; CriDO el 0/., 2003). In this study, then: wen: equal 
numbers of males and females with either a strong clinical Or a confurned genetic 
diagnosis of PWS, and the mean age nt diag�osis did nOI differ significantly 
between mal.,. and females. 
5.3 Denlnpmeotal characterislics 
5J.l Angdmansymlro= 
Although seven: or profound ID was common (S2.9%) in the AS study 
group, the frequency was nol a< high as ha< been suggested in other reports (Lnan 
., al., [996; Leilner & Smith, (996). h would be expected that most people with 
severe ID in the Slnte would be included in the records of DSC, as one of the 
primary functions of the CommIssion is to provide support for individuals with 
inldI.ctual difficulties. Thus there is no obvious explanation for the relalive 
paucity ofpl:ople with Seven: ID in the study. Both of the AS patients identified 
with UPD had moderate ID, which may be indicative of the less scverophenotype 
prevIously described in this su1H:las, of AS patient (Monela et 0/., 1999b; lossi. 
el al., 2001). 
Table 5.1 (p. 76) provides a comparison between the frequencies of a 
number of dingnostic features found in the presenl sIIldy and those .. ported by 
other authorn. A Ir.ljority of the observed rates of cIiniCII  f""tures did not vary 
greatly from those previously r,"oted, olti10ugh some minor discn:paneies were 
noted. Leilncr and Smith (19'!6) found rn�t males were mo .. likely 10 become 
independently ambulant, Md :\[ an eali
,
ii.( age, than females. This was supported 
In the prcsenlstudy, where thcinean og'� �fjndcpendent watking wassignilicnntty 
greater for females (5.2 years) than for mnles (3.5 years) (Section 4.2.3). Th� 
average oge or walking ror the whole group (4.4 years) was in close agreement 
with figum reported by other authors {wn cl a/., 19990; Moneln et 0/" 1999b}. 
CbaraderisUc AS Literatare Rcfcreac"" 
Oo:v<lopmOllIlll delli)': .�·\7mth ,I, 12_2Omth (Bunlinx., �I� 1995; Smith et �I .• 1996: !..aan" "J .• 1999; Moncl." "J .• 19990; 
(n�29;n�28) walk�53mth w.lk�33·72rnth Mo"cla" al� 1999b) 
Ab",ntlmiolmol.peech (%) " (n-34) �'OO 
(BUllri"  et al� 1995; MonclReI "J .• 1999.) 
Atnxia (%)(n a 34) " �, (!lUll!i""" al .• 1995: Smith ,I"J., 1996; LiIIIll el "J .• 1999; Sod!mg <I al., 2004) 
Beha>iotlr(%} (n -34) ,. 77_100 (Suntinx el "J .• 199�; Smilh <I "J .• 1996: !..aan <I aI., 1999; Monclo<1 "J .• 1999.) 
MicrocopholY (%) (n · 20) M 62-93 (!lunlinx tI 01., 199;; Monol. eI <J1� 19990; Mon'Ia""J� 1999b) 
Epilepsy (%) (n a 34) .. 79_8S 
(Buntirn: <I al .• 1995; !.eim", & Smith, 1996; Mi ..... l ... " al .• 1998; 
Monclaer al� 1999a; Clayton·Smith & LIIIIn, 200J) 
Abn<JmUII E E G  (%) (n c 27) " �,oo (!luntinx<1 al., 1995; Leit",,< & Smith, 1996: Moncl. <I<>1� \999n) 
Fe<ding diffiOll li .. (%) " (n �25) 21_77 (SmIth, "al .• 1996; Mond.<I"J; 1999n) 
Sln!bi",,", (%) (n • 27) " 21_57 (Bunlinx <I 01.. 1995; L ... et al. 1996; Sond""","." <>1. 1997; Monol. <I al .• 1999.) 
Hypoplgm=ion (%) " (n- 17) ". 
(Bunl;"" <1<>1, 1995; Moncl. <I<>1� 1999a; Moncl." cl .• 1mb) 
Hypotoni. (%) (n � 34) " 48-{;3 (Buntirn: et"J, 1995; Smith <I al� 1996) 
Salli",i,!",.) M 25_10 
(!luntin",' cl, 1995;!..aan <I al. 1996; 5"",IOIIom <I aI� 1991; 
(> 15)" n � D) Moncl." 01, 1mb; CloyWn-Smith, 200I} 
" Obesity (%) (n � 34) " IS_SO 
(Smi!h <I al .• 1996; Monel • •  , ai, 19990; M<IIl<I. <I aI� 1mb; 
Clll)'loo-Smlth & l=n, 2(03) 
The majority ofindividuols willl AS never acquire more llIan n few words 
ofspe«h (Buntinx eta/., 1995; Monela et ai" 1999h: Alldersen ctal., 2001), IlIId 
most of Ill. AS cases studied had cilller no ability 10 speak, or had only a very fcw 
words in their vocabulary. Many individuals from llIe AS cohort were reported 10 
be able 10 underslnIld some verbal communication from olllers. Commonly, AS 
cases arc reported to have a higher degree of speech comprchClIBion llIan of 
expression (Buntinx N al., 1995; Monela el al., 1999b). In 0 Norwegian study 
(Andcrscn cl al., 20tH), llIe median cognitive age for AS patients between the 
ages of two and 14 years was estimated to be [(} months (runge, 7.23 months). 
This cognitive oge corresponds to Slage 4 of the sensorimotor period of 
development as described by Piagel (CllIIIpbell, 1976), and onc of the 
characteristics of this singe of developmen� defined as 'pre-Iangunge', is that 
llIerc is a recognised ability to underslnnd verbal commUlliCDtion and show 
intelligent behaviours (Campbell, 1976). 
S.3.2 Proder·W/II/ syndmme 
The I'WS study group conlnined n much smaller percenlnge of nonnal or 
berderline intellectually disebled individuals than would be expected, i.e., <9% by 
comparison with the 3040% reported by other researchers (Cassidy & Schwnnz, 
1998: Wcbb Cl al., 2002). As previonsly indicated {Section 5.t.1}, ilia case 
asccrtoinm.nt method used in the present study was effectively biased to exclude 
those with a borderline level of ID. Unfortunately, the study design and ethical 
considerations precluded the use of the educational Sources described in Section 
5.1.1. as a mODnS of identifying additional cases. The number of PWS cases 
falling into the severe or profound ID categories (4.4%) did not differ 
significantly from that Eiven in most oilier reports (Slnte & Dykens, 2000; 
Clayton-Smilll, 2001), although one study did indicate that 18.8% of their group 
functioned nt lQ <50 {C!nrke et aI, 2002}. Therefore, it seems probable that most 
of the more severely affecled PWS patients in W A have been identified. 
" 
TableS.2 ComparUoD oftbe Prailer-Wil1i gTOopwitb tbe literature 
Cbaraderistic ,ws 
Hl'l"'tOtlia(%)(n m46) 96 
Weigh'�IIin{%)(n=46) 
HYl"'&"nadiom{%) 
(nmI5:nm I9) 
"' 
Literature 
liJ-l00 
81_100 
73-93 
mole-94_Ioo 
f<mol.-60-100 
D<>,:opm""al del")' 
(n-34:n-39) 
,it - 12mU. ,it - 12mth 
walk�31m!l> w.!lkm2'\_29mih 
Hyperphagia (%}(nm33) 85 
Short ,tnI\ll'e (%) (n = 39) TJ. 
Hypopigm."laIfun (%) (n" 20) 75 
Sooliosi, (%) (n _ 30) 
Epilep!i)' (%) (n =46) " 
S8_77 
32-75 
14-46 
Rerereuces 
(Oill<»<tl_K"""b<tch., al., 1995; fridmBn., al., 2OOOb; 
Webb., al., 2002; Whittingtoo.1 al., 2(02) 
(Giltwen-K ... b<tch tI al., 1995: FridmBn e/ al., 2OOOb; 
w.bb.t al., 2002) 
(GilI.<=I-)(u"b<tch .. al., 1995: Gun,y-Aygun tI al., 2001: 
Whittinglon., al., 2002) 
(GiU"".".Kaesboch tI al., 1995: w.bb <I al., 2002; 
Wh<ttingtml., al., 2(02) 
(Oillwen-K ... ba<h., �I .• 1995; W.bb., al.. 2(02) 
(fridmm et al .• 2000b: Whittington., al., 2(02) 
(Oill ... .,,·K ... boch et �I., 1995: FridmBn., al .• 2OOOl>; 
Whittington" al., 20(2) 
(GiU==-K ... ba<h., aI., 1995; OWidy ok Schwartz. 1998: 
WhittlngtD!l" al., 2002) 
(Gillcss""·K ... bach,, al., 1995: Fridman <I al., 2OOOl>; 
BUll"" al., 2002; Ylhinington tI al., 2002) 
(Oill=en-K ... ba<h" al., 1995: Whittington <I al., 2002) 
(La"""",,, al.. 1981: B.,I.,.., al .• :!OO2; Whinington "al., 2002) 
(OiU=en-K=ba<h <I al., 1995: FridmBn <I al., 2000b: 
Butl .... al., 2002) 
The frequencies ofselecled clinical fcalures within the PWS group were 
compared with previously published papers, and the results summarised in Table 
5.2 (p. 78). Speech artieulalion problems or delayed acquisition of specch lire 
listed as minor clinical signs ofPWS (Holm .' al., 1993), however, in the currenl 
study 85.7% ofPWS cases suffered from speech dcfccts. According to data from 
the U.SA., speech articulation defects and some of the other minor features 
appear la be more sensitive lIS diogno.<tic tools than many of the major criteria 
such lIS characteristic facie. (Ounuy-Aygun e/ al., 2001). 
This more recent rcscarch has produced additional infonnation On the wide 
runge ofphc:notypie variation found in p""ple diagnosed with PWS, and for this 
reason it has been SIlggestcd thot the existing clinical crite'!'ia may n=1to be 
revised (Ounay-Aygun " al., 2001). 11 has also been recommended that specilic 
features ofPWS should be differentially weighted as diagnostic tools ot different 
singes of life. Fore>tample, during infancy, hypotonia and feeding difficulties DrC 
the most reliable indicators of the syndrome, and it is only after the first two or 
three years of life thol hypcrphngin, global developmental delay nnd obesity 
become prominenl diagnostic traits (Gunny_Aygon el al., 2001; Whittington el al., 
2002). 
5.4 Physical charactcristlCII 
5.4.1 Angelmnnsynd,ame 
The compll/lltively high pro]HIrtion of AS cases with hy]HItonia in this 
study (Table 5.1, p. 76) may be a conscquence of clinicians hecoming 
Increasingly aware of the value Df "]HIrting such clinical delails. Truncal 
hypotonia and limb hypertonia have previously been described as wlde"Pread in 
AS (Lnnn ela/., 19%; Smith el al., 1996; Cassidy & Schwnrtz, 1998). As this 
fcatufl: was not included in the diagnostic criteria, it seems improbable that all 
physicians would have recognised the benefit of including the specific 1<,,:at;on of 
any hypotonia nnd hypertonia in client files. At the present time, however, the 
DSe "Pccialist disability clinicians routinely include this type of detailed 
infonnation in their re]HIrts. 
Earlier reports have suggested frequencies of obesity in AS p.lticnts of I S­
SO%, and individuals with UBEJA mutations are usually reported to be more 
78 
prone \0 becoming overweight than those with other AS di= genotypes {Laan 
cl al., 1996; Monclad a/., 19998; Monela e/ aI., 1999b). More Lhan one-third of 
the AS tohort in the present study wcre obese at some period prior to the time of 
sampling (Tuble S.I. p. 76). which was within the expected nmge for AS 
populations. There Was onc individual with AS who was originally thought to 
have PWS due to obesity and hyperphagia, but who had no ataxia or inappropriate 
laughter. This was similar \0 0 potieT1t described by Dupont el a/. (l999), who 
showed also features of both AS and PWS and had, In addition \0 paternal UPO, a 
SMC 15 which was lotated outside the PWSIAS crilital region. 
Up \0 64% of adults Md 26% of adoles«nts with ID ilIC obese or 
overweight (Beang. & Lennox, 1998; Fisher, 2004), and 0 study from the U.K. 
described 4.S-6.8% of adults with ID as severely obese (Cooper, 1998b). Obesity 
Is estimated to lessen the life-span by 6-7 y= at oge 40. Hypertension, Type 11 
diabetes, coronary heart di=. dyslipidacmla, and gaU bladder disease ore all 
malO COmmOn in thuse who are obese, compared \0 people with 0 nonnal body 
mass index, regardlcSi of their level of Intellectual function (Cooper, 1998b: 
Labib, 2003; Marshall e/ aI., 2003; St-Onge & Hcymsfield, 2003). This means 
tho\ Ihe obese and overweight members of the AS group would benefit from 
regular physical nsscssment with the aim of minimising the risk of these adverse 
health effects ns they become older. 
Strabismus (47%) was present in the study cohort at a similar rIIIe to other 
AS patient groups (Buntilll( el al., 1995: Lann el al., 1996; SlUldlUlatn �t al., 
1997), and the frcqueT1cy was much higher thlUl the 1 1-13% noted for the geneml 
populotion of people wWt lD (Roid & Ballingcr, 1995: Thompson & Reid, 2002). 
An cslimated 25-70% of AS patients have been described lIS presenting 
with scoliosis (Laan et a/., 1996; Sandanam elal .• 1997; Monela et al., 19990; 
Cloyton-Smith, 200l), and the perccntnge of sooliosis cases in this study (43.5% 
of those:> I S years old) fell within this range (Table 5.1. p. 76). None of thi, 
cohort of palicnli had received surgery fOT scoliosis prior to the collection of data, 
Wld none were reoolded lIS having scvere scoliosis. Follow_up at a later date may 
Indicate that the level of severity inorcases in ""me cases, leading to possible 
surgical intervention. 
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Rates of osteoporosis i�=ase with age in both the ID population IIIld the 
general population, IIIld the condition oflen loads to increased frequencies of 
fractures in people with ID (Beangc & Lcnnox, 1998; Center./ al., 1998). None 
of the AS cases Were reported to have osteoporosis, even though individuals 
receiving anli-epileplic medicalion arc at 0 higher risk of developing osteoporosis, 
due 10 abnormalities in bone mClllbollsm (MurchiSlln e/ at., 1975; Prestwood, 
1997). An investigation into the correlation between epilepsy nnd bone frnctures 
WIlong people with ID showed thot 26% o f  the epileptic ID population suffered 
from one or more frncturc, but only 15% of those without epilepsy (Jancar & 
Jancar, 1998). Among Ibe AS patients in this study, 17% of those with n history 
of epilepsy bad bone flllClures, but then: Were no reports of fractures in the four 
individuals wilD had no ""izurcs. The sample sizes were \00 small for any finn 
""nelusions to be drown, bal the direction of the correlation was in keeping with 
previous reports. 
5.4.2 PnuIe".Wili/ $Ji/fdrom� 
Then: was stronS similarity between the frequencies of phy .. lcal 
eh"",cteristics found in the PWS group nnd the literature, with the exception of 
the relBtively high numberofpntients (n = 15) with hypopigmcntation (fable 5.2, 
p. 78) among the 20 cases in whom this feature was recorded. There is, bowever, 
considerable disparity in the prevalence of hypopigmentation reported by other 
authors as the trait is asscs""d in a subjective manner, IIlId comparison with family 
members may be influenoed by the commonly ob!ierved darkening of hair IIlId 
skin which tends to OCCUr lIS children age. In sevCIlII studies it was noted thul the 
hair colour of both AS and PWS children with hypnpigmentntion be<.:ame darker 
as they aged (Buntinx el 01., 1995; Sandllllam el al., 1997). 
The very high rate of obesity in the PWS patients WIIS as expected (Table 
5.2, p. 78). There was a distinct age difference between individuals who were 
overweight or obese and those whu were not (23.5 years for overweigb� 
compnred with 4.3 years for non...,bese cases: / � -4.033, P � 0.001), indicating 
that younger potionts generally fell within the normal weight range. The 
administration of growth hormone therapy to four children with PWS may IISsi,t 
the retention of a normal weight range into adolescence in these individWlIs, lIS 
has been repol1ed elsewhere (Lindgren & Ritzen, 1999; Carrel 01 al., 2002; 
Hoybye cl aI., 2003; l'lI!CJSon & Donaldson, 2003). 
In general, people wIth ID \end to be signifieanlly less II.I,ltivc, eVen when 
able·bodied, thon pe<lple in the wider popul.lion, which may contribute to U1C 
weight problems exhibited by so mnny ID individuals (Rober1SOn ot al., 2ill10; 
Fisher, 20M). Their increasing obesity levels In rum lend to increase the 
incidence of secondary conditions such Il.'i Type 11 diabetes and Clll'diovascular 
disease (Turner & Moss, 1996; van SchrojcnSlCin Lantman-dc Valkelo1., t997). 
Comparable health problems are likely to beset overweight PWS p�tienLS, 
especially lIS they become older, In the U.S.A� rates of obe'ity for the general 
population have been increasing over the lll.'it 50 years. The proportion of adults 
who were obese in 1960.62 Wll.'i 13.4%. however by 1999·2000, itwllS 30.9% (St· 
Onge & Heymsfield, 2003). It is estimated that the direct cost of obesity in the 
United States is 3·8% of the total health cxpaldirure ond, worldwide, there Is 
considerable loss of productivity due 10 sickness or =Iy denth wnong the obe,e 
population (Labib, 2003). Similarly, obese PWS patlenlS arc likely to require 
greater level. of health care for weight.related morbidities . 
. Scolio,is hllS becn repol1ed in 32.75% ofPWS subjects aged 15 year,; or 
older (laurancc el al, 1981: But!crel 0/" 2002; Whittinglon .1 01., 2002). Some 
37% of the PWS subjects older than 15 years in this study showed signs of 
scoliosis, and IWO had been surgically treated for the problem. There were, 
how .... er, 40%ofthe ,tudy group for whom no data on scoliosis were available, so 
that no finn estimate of its pn:valencc could be mad. for the study Sllmple (Table 
S.2, p. 78). 11 is possible that scoliosis will become less of a problem In those 
individuals who are treated with growth honnonc, lIS the lenn body to fat mll5s 
ratio and the degree of weight control move closer 10 the nonnal range, thus 
pl.cing les, strain on the developing ,pine. 
Relatively high mtes ofosteoporo'is (21%) nnd 05toopo""lo (58%), i.e., a 
bene mass density ofbelWcen ·1.0 and ·2.5 SO, have been found In PWS patients 
(Hoybye �I m., 2002). However, only two of the 30 PWS cases OVcT IS years of 
age were repol1ed to have astooporosis. AJ; noted in Section 5.4.1, osteoporo,is 
may be associated with the relatively high numbers of fnl(;\ures reported in the 
PWS and/o, 10 population, as a single 5tandard deviation decrease in bone 
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mineral density is estimated to increase the risk ofbrcaking a bone by n fnclor of 
two (Marshall el al., [996; Center el al., 1998; Butler el aI., 2002). Not 
surprisingly, females are more likely 10 experience m.ctures at some time of life, 
11$ young women gencrnlly reach n lower peak bone mass than men (Prestwood, 
1997). After menopause, changes 10 honnomil leve!s cause an increase in the rate 
of bone density loss, leading to higher mtes of osteoporosis (Ahlborg cl al., 200l). 
The reduced level of physical exercise and [imiled mobility which are bQth more 
common in PWS patients tend 10 decrense bone density (Bennge & Lennol(, 
1998), thus placing persons of either gender with PWS at sreater risk of 
oslooporosis and bone frncture. 
Among the PWS p"pulotion studied by Butler el al. (2002), approximately 
30% had sustained one or more fmetured bones, with n comparable figure of 2 [% 
omong those loilS than 1 8  years of uge. The number of PWS patients with 
fractures was significantly lower in this study group, i.e., 14% overall, and 4% 
among those persons less than 18 years old. However, the data on froctures Were 
only derived from dota linkage 10 the Hospital Morbidity system. Hence any 
fractures that did not require hospital admission were nol recorded, and there may 
have oo.n more instances thot were trealed at an outpatient department or by 
General Practitioner.;. Given Ihe small numl>er of patienlS with osteoporosis 
recorded in the study, the low incidence ofbroK(n bones may not be unusual. 
As in previous studies, cryptorchism/genital hYP"plnsia WIlS present in a 
majority or males (9[%) from this cohort (CllS.Sidy & Schwmtt, 1998; NichoUs el 
al., 1998; CllS.Sidy cl al., 2000; Fridmllll el al., 2000b; Slate & Dykens, 2000). 
However female genital hypopl l$ia, as evidenced by absent or delayed menses, 
was reported in only 58% ofth. 19 female subject.s over 15 years old (Table 5.2, 
p. 78). ThIs was significantly lower than figures from the U.K. which ranged 
between 76-100"/0 (Lnurance el al., 1981; Webb el al., 2002: Whittington et al., 
2002; Crinu el al., 2003). 
Within the su\>.group ofadull female cases from the present study with an 
identified deletion, 011 had absent or delayed menses. The remaining eight female 
subjects, none of whom had confirmed genital hypoplasia, were compo;ed offonr 
cases with nonnal menses (including unc who had three children), three who 
exhibited precocious puberty with early meoses, and One for whom no relevant 
data hod been recorded. None of the eighl individllJlls hwl received a genelic 
confl1nUll on of PWS. therefore stallslics rel810d to these CIISeS should be 
interpreted with appropriale caulion. However, both precocious puberty and 
fertility have bCl:n reported in Individuals with ge:nelica1ly-confirmed PWS 
(Akefeldl et al .• 1999; Schulzc er al., 2001: Crino cl al., 2003). 50 lbal diagnosis 
ofPWS cannot be excluded for llIIy of the eight women discussed above. 
S.S Bebavloural ... pocb 
Up 10 69% of intelleclually discbled individuals aged over 65 years 
experiencc a comorbid psychi"tri� disordcr (Cooper, 1998.; Bowley & Km, 
2000). Of these cases, 40% have been described as suffering from seVere 
emotional or behavioural disturbancc (King er al.  1997). 11 has been suggested 
that the challenging behaviours often shown by people with ID may be related \0 
the nbnormally high anxiety levels they experience in situations which would nOI 
be perecivcd as stressful by persons with normal lnlellectual funclion (Jansscn er 
01" 2002). The limited social networks and poor so1f-estecm frequently exhibited 
by people with inlellectual disabilities can also havc a neg81ive imp,cl on their 
behaviour and menllll health (Walsh, 2002). In edditton, the presence ofcpUepsy 
has been linked 10 a variety of psychiatric disorders, maladuptive bebn.viours, and 
sleep disturbances, although il is not clear if epilepsy cnuses these conditions or is 
D """morbid feature (Bowlcy &Kerr, 2000). 
SS.1 Ang�/""'n :;yndf(J� 
The majority of AS subjects were reported In bave the chamcll:rislic bappy 
disposilion associated with the syndrome, although S<lme individuals occasionally 
had II:mpcr tantrums or periods of withdrawal. It seems probable that these 
episodes may have been relaled 10 the frustration ol\cn experienced by persons 
who arc unnble 10 communicate their wants or .10-00;\; effectively. The rew 
individuals from the cohort who hod attended psychiatric clinics wen: not 
recorded as having specific psychiatric disorders; rather their admissions were " 
consequence of the devclopmcntnl delay and inlellectual disability associated wid1 
the syndrome. There Were only limill:d data on theprcscm:. ofsl".,p distnrbances 
among the AS group, which previously had been described as a minor 
consequence of the syndrome. 
" 
5.5.2 Pnule,..WllJI syndrome 
Although no member of the srudy ""hort wns over 51} years old, eight 
individuals (l7.4%) had some level of contact witJo the State p5)'chiatric servIces 
by the time of dota collecllon. Seven of these people were over 15 years old, IIlId 
onc was 12 yC/ll'S si� months at fif!t contact with p5)'chinlric services. The adult 
patient who had attended mor: than one thousand outpatient sessions suffered 
from !1 combinnlion ofbchavioUnll lll1d emotional disordcrs (Section 4.3.7). The 
majority of the cases were being nssessed IIlId treated by the menial h""lth 
specialists for ID er developmental delay. rather thlll1 for psychotic episodes. 
The behnvlourIll traits exhibited by the PWS study group proved to be 
particu1arly problematic in tcnns of the administration of routine care. Temper 
tantrums, violent outbursts III1d stealing, commonly of food or money to buy food, 
were reported for a number of the PWS individual!. However, the diagnostic 
criteria require that five or more of the ehnructeriS'N behaviour symptoms ore 
present before they un: accepted as a significant diagnostic feature (Holm ., al., 
199�). On this basis, there was insufficient informallon to state the real 
prevole�ce of the characteristic bchoviourIll real\rres in the study sample. 
5.6 Neurolngicnl findings 
5.6./ Angelmansyndro1ll4 
Seiwrcs were reported at some stage of life for 88% orth. AS cases in the 
study. This was ""mpamble to the prevalence statistics given In other srudles 
(rabIc 5.1, p. 76}, lIlId almost double the mean frequency of seizures present in 
the wider ID population (Rdd & Bollinger, t995; Leitner & Smith. 1996; Smith et 
aI., 1996; Clayton·Smith & Lnan. 21}1}3). Seizures and epilepsy arc more frequent 
in people with intcllccrunl disabilities compared to the general popUlation, and the 
presence of seiwre disorders tends to correlate positively with the degree of 
intellectual hlll1dicap. vlU)'ing from 14% of individuals with mild 10 to 44% of 
those with severe 10 (McQrother el al., 1996; Beange &; l.cnno1<, 1998; Bowley &; 
Kcrr. 2000; van SchrojcnSlein Lantman·De Yolk el 01., 2000; Fisher. 2004). 
Some previous reports have stated that epilepsy In AS decreases in 
frequency and severity with advancing agll (Buntinx ., 01., 1995). However, there 
WII.'i little evidence of any reduction in the OCCUrmlce of seizures within the AS 
.. 
study group. A sampl� of 100 individuals with seVere or profound ID were 
fonowed by researchers in the U.K. over n 26_yenr period, and similar proportions 
of the group were epileptic at all data collection times (2&-32%), indicative of the 
persistence of seizure nctivity throughout the lifc-coursc of many individuals 
(Reid & Ballinger, 1995; Thompson & Rcid, 2002). Conversely, the incidence of 
epitepsy h"" been reported to decline among older intellectually disabled people 
in The Netherlands and the U.K. when compared to younger adults. This finding 
Is possibly a sign of the healthy survivor effect, since the presence of seizures 
significantly lowers life expectancy (van Schrojenstcln Lnnlmnn-de Valk el al., 
1997; Chnney & EymWl, 2000: Patjael al., 21100: Morgnn et al., 2001). 
Around n quarter (26%) of the seizure activity among the AS study group 
was reported to be difficult to control andlor of frequent occurrence, lJUlking 
epllepS)' onc of the mo51 significant health problems for indivldll!lls with AS and 
their families on1 enrers (Bowley & KelT, 2000). The eldenslve EUTlount of 
hospital care needed for treatment of epilepsy attests to the severity of the 
condition within this group (Table 4.4, p. 59). In nddition, one of the two deaths 
in the AS group was attributed to epilepsy. 
Tho majority of AS patients have specific abuonnal EEG patterns (Leill1er 
& Smith, 1996, Smith el al., 1996, Monela el al., 1999a; Clayton-Smith & LtIIUl, 
2003). Among the AS cohort, abnonnalities were evident in 25 of the 27 
individuals who had at least one EEG perfonned (TDble 4.2, p. S5). Of the 
individuals tested, three hrul no recorded epileptic episodes, even though two of 
these three people demonstrnted the chorneteristic EEG patterns of AS. It has 
been proposcd that the presence of suggestive EEG pallems, cven in the nbscnce 
of seizure IICtivity, could be used to assist in differentiating between AS and some 
mimicking conditions, ond forthe eonfinnation of AS in those individuals lacking 
an identifiable genetic mcchlll1ism (Yalente el al., 2003). The results of the 
present study provide elenr support for the potential application of this proposal. 
5.6.2 Prade,...WlIII If/lldro_ 
Epilepsy bas be"" previonsly reported in n significant proportion (34-42%) 
ofPWS cases (Butler.' al., 2002), which is n slightly higher mte than the 21% 
given for the oVClll l intellcctuulIy dis"bled populntion (Reid & Bnllinger, 1995, 
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Coopc:r, 1998b: Thompson &. Rdd, 2002). Approximately 28% of the present 
cohort had nt least one episode of epilepsy or convulsions throughout life (Table 
5.2, p. 78). In fact, at 4.3% of total admissions, epilepsy was one of the more 
common rea5Oll5 for hospital admission within the PWS group (Toble 4.7, p. 67). 
It Is possible thot hnploinsufficiency, i.e., low dosage due to the lo,s of one allele 
ofa gcne Or genes within the PWSIAS critit:II.' region, moy COIU.., the development 
ofcpUcpsy in patients with PWS, although the ,�izuros were genernUy in n milder 
fonn than those ruffere<! by individuals with AS. 
5.7 Laboratory diagnosis 
There appeared to be some lack of effective testing to dctennine the 
specific ge:netic mcchanism(,) in�oIved in the aetiology of AS in a con,idernble 
number of cases. More thon a third orth. AS group had either n klU)'otype or 
banding test only, orno diagnostic test at all. 10 addition, 111= had becn no tests 
undertake:n for le defocts, and only one (which was negntive) for an UBEJA 
mutation, even though eight of the 34 subjects showed biparental methylation 
(Table 4.2, p. 55). Many of the patients had been offered the most recent 
laboratory diagnostic tests os they became nnilable, but the take-up rate wo> 
exceptionally low. Further qualitative research would be needed to invcstigote the 
mtionale for this apparent reluctance to take advantage of the newest diagnostic 
ICchniques, although much ofth. lack of motivation may be simnar to that related 
to the limited use ofscrccning tests by ID persons in the U.K., and the lowcrrntes 
of mammography �; conducted on women with 10 compared to 1110 general 
population in WA (Pearson el al., 1998; Djuretic el aI., 1999; Whitmore, 1999; 
Sullivan el al., 2003). 
There seems to be a perception by some physicians and/or carors that such 
tests are UDIlecesswy, or that tile patients will be markedly upset by the procedure. 
This �iew i!! supported by the fact 1I1at severely ID individuals may become 
cxcessi�ely "gilnted when undergoing phlebotomy or oth�r mcdical procedures 
(pearson <I al" 1998; Asprny el aI., 1999; Djuretlc el al., 1999; Whitmore, 1999). 
Monetnry comiderutions may also play a role in the unwillingness of fwoilies and 
carcrs to agree to comprohen,i�e genetic testing, and almosl20% of1l1e cases in 
tIlis study li�ed in more romote region!! of the State wb= SIIlIlpling is more 
difficult to IImIIlge. In addition, infonnation about the new tests may not be freely 
available, er, In some cases, comprehensible te many laY·p"rscns. These could 
well be additional factors affecting the poor uptnkc ef laboralory tests. 
It ls apparent that the avcrngc age at diagnosis for AS is continuing to fall. 
following al. inc""",ed understanding and appreciation of the phenotype Md 
improved genetic testing (Leitner&. Smith. 1996; Loan 0/ al., 1999a; Smith 0/ ,,/., 
2003). The absence ofumunbiguous clinioal signs in young AS patients may be 
the major reason for the meDII age of diagnosis for the study group remaining III 5 
or 6 years, even though there has been u rise in the numbers of AS cases identified 
before the age of2 years during the COIUSC of the IllS! decode. As with most ether 
reports, no gender bias was IlPJl'lf"nt in the group of AS patients (Leilner &. �mith, 
1996; Smith et ,,/., 1997). The numbers of AS cases diagnosed per five-year 
period rose steadily until 1995, but there had been no individuals diagnosed with 
AS and registered with DSC after that time. 
Substantial numbers of PWS patients also had not undertaken 
comprehensive diagnostic testing. However, nil but one of the 14 cases added to 
DSC files since ]993 had a positive genetic diagnosis. The smg]e indiv!dll!ll who 
had not nndergone genetic testing was clinically diagnosed al 6 months of age and 
wllS only 1 I  months old DI the time of data analysis. Therefore. it seems probable 
that the requisite genetic tests had yet to be conducted. OfL�e 32 clients added to 
the mes prior to 1994. six had not been tested, five had a karyotype examination 
enly. nine were tested by banding. and the remainder were positive on FISH or 
melbylation testing. 
As was Ihe case with AIlgelman s}'Ildromc, the issue of diagnostic tesling 
for established clients is interesting in that, although specific new tests have 
[,.o-r,o!nc available over the course of the last decade. there are still mllIly 
indi',idunls who have nol partidpated in genetic an.lyses which could provide 
confirmation of their genetic abnormality. If parental Or carer inertia is the main 
reason For lbe lack of diagnostic testing. then a campaign efieltelS IUld inter;iews 
may be �ffective in helping te procure consent for these procedures. This strategy 
would need to explain the importance to future generalions of improving lbe 
understanding of the mechanisms involved in the development of the syndrome. 
and the =0. risks within thd families concerned. 
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The presence of two distinct peak5 in Ihe rate of di�snosis of PWS per 
live-year period Is an interesting p�enomcnon (Figure 4.3, p. 54). The fir.;! peak, 
in 1980-19&4, coincided with the movement oflD in�iYidunls from Swanboumc 
Hospilal lo either I'yr!on Trnining Centre or to one of the new hostels for people 
with ID. DUMg the movement process, each person WIIS reassessed at Jrrabecnn, 
which may have resulted in the larger number.; of diagnoS<ls during thot time 
period (SI.Iin, 1996). The ,eccod peak, which oc:culrod over the yews ]995· 
1999, could be nssoc;nl!:d with the prior publication of the clinical criteria in 
1993, and the development of l�borntcry \ests fOT genetic diagnosis. It is, 
however, difficull to understand why no complll1lblc peaks were ob,::n'cd in the 
diagnosis of AS. 
n •• definitive identification ofPWS has become .... ieT in the last decade 
since the devclopml.'llt of a comprehensive I1lIlge of laboratory tests and, lIS n 
"" ult, Ihe age at diagnosis has been falling oonslstenlly. OYer the I!I.<I four years. 
nine of the elevCII PWS cases added 10 the DSC database wen: diagnosed before 
the age of onC year. This was similar 10 the results of 11/1 Austrnlasill/1 survey that 
found 71% of new diagnoSC5 were being made before the firsl birthday (Smith el 
nl .• 2003). These figures an: in shatp oonlrasl lo 11/1 earlier report in whieh 36% of 
PWS cases were nOI diagnosed unlil afler 16 years of age (G",enswag. 1987). 
The oldest age al which a memher of Ihe preSC1lI study group Was diagnosed was 
17 years (in 1982). 
5.8 Morbidity 
S.B.l Angl!lman syndrome 
Epilepsy, ",spirlltory inH:clio!l5, Helicobacler pylori Infections, Md gastric 
renux, all of which can I..,d 10 oe:;ophagcal disease Md/or "",,,phagcnl 
c:nn:inomas, !!<:Cur ot higher frequencies among peopl. with intellectual 
disnbilities thDll in the general populalian (Turner & Moss, 1996). In this study, 
respiratory system disorders oomprised a significanl proportion of the primary 
grounds for hospitaliUllion (Toble 4.4. p. 59). Oesophagitis was a'so found In a 
significant number of those admitted for gastroinlestinal prohlems, similar to the 
results observed by ClaytOn-Smith (lOOI), who dcscriboo oc"'phageal ",nux as 
one nfth. main mooicn! problems found in 28 individuals with AS (aged 16-40 
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years). Epilepsy was also onc of the most cemmen reasons for hespi"'l admissIon 
among theprcsentstudy group (T"bl.4.4, p. 59). 
As summarised in Section 4.1.7, " disproportion"te numbor of the total 
hospital admissions for dentnl work were for AS cases with severclprofound ID. 
Much of the dental work cenducted on the AS patients involved tooth filling. 
cleMing and scaling, which an:: normally cen.lidered to bo minor procedures 
within the geneml population. However, many pcrs!!ns with severe ID require a 
general Ma""thetic 10 a!low any inll1lSlve medical procedure to bo CWTied out, 
including venesection, injections, end dental work (Bujok & KnDpik, 2004), 
which would explain the high rotes ofhospito.lization for these procedures. 
People with intcllectual disabilities huve a higher prevalence of particular 
health problems thllll the genernl popuMion. These include thyroid diseases, 
visual and hCllling abnonnalities. deficiencies in oml heatth, Md cardiovascular 
disease (Beange & Lcnnox, ]998; KDpcll el 01.. 1998; How]ey & KelT, 2000; 
Fisher, 10(4). nU of which an:: especially prevalent in Down syndrome patienls 
(Pmsher, ]996; VM Sehrojenstoin l..antman·de Valk el al., 1997; Saxena, 200]). 
Almost half of the AS group had visu,] problems, mesl]y strnbismus, but there 
was very lil\le information available on the presencc of thyroId diseasc. h.,..ing 
difficulties, or eordlovascular disease. 
5.8.2 Pratltr-Willl syntlrolnl!! 
Re:;piratory disorders were prevlous]y noted in 46% of PWS patients 
(Butler el 01 .. 2002), and in the p=t study a similar propor1ion of.ubject.! had 
boen diagnosed with "t ]east o�e �pisode of I15thmll, pneumonia or respiratory 
di.ease over their lifetime (Table 4.7, p. 64). Many of these illnesses required 
hospilll]ization, making rcspimtory problems the mo,t COmmOn primwy reaso� for 
hospital admission within the patient group, RespimlOry diseases arc /lmong the 
most frequent Ciluses ofdcath for peop]e with My form of inteUoctual disability 
(Beans. & LennOx, 1998; Janicki et m., ]999; Patja el al., 2001). R�,pimtory 
infcetior.5, hepatitis B, C IrIld D, and tubereulosis arc also found mOre often in 
institutionalised POPUllllion, (Turner & Moss, 1996), and Illere were two PWS 
pntients in this study wbo had tontrncted bepatitls at some stage of their life. 
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As with Angelman syndrome, many of the PWS JIlItients attended hospilal 
for denial procedures (n � 14), and a significant numbe:rofthe males (n - 9) also 
required lfealment for undescendod tcsles (foble4.7, p. 64). The former problem 
was probably associated with their intcllectUIII disability, while the 1.ller disorder 
is more specific to l'rlIder-Wil1l syndrome. 
Three carcinomas were rerorded for the PWS Stoup. Two were 
malignant, but nil were treatod successfully. Althougb the reported rates of 
cancer.; ore relatively low, carcinomas may present a UIlique threat to those with 
intellectual disability, as there have been reports from the U.K. and Australla of a 
poor uptake of the nvailable screening programs by individuals with ID, chiefiy 
women (P=n el al., 1998; Aspray et 01., 1999: Djuretic el dl., 1999: Whibnore, 
1999: Pntja el a/., 2001: Sullivan el 01., 2003). There appear to be: n variety of 
ralionales for this under-utmsntion ofl/>� available programs. Some membc:rs of 
the target groups may be dismissed by their doctor as not needing the tests, due to 
a presumption that there arc fewer environmental risk factorn associated "'ith the 
lifestyles of the ID population, Or to the assumption th.t people with ID an: nol 
sexually active (in the tII5C of cervical smears). Some individuals arc difficult to 
\cst because of behavioural or cooperation problems, and yet othCTS refuse 
consent, or have consent refuscd on their behalfby care.-:", for unidentified reasons 
(pearson el 0/., 1998; Djuretic el 01., 1999; Hall & Ward, 1999; Whitmore, 1999). 
Although two of the Cl!.SCs of carcinoma had been made before the inception of the 
Cancer Regist:y, the pruticulars of the diagnoses Md tn:alment were available 
through the DSC JIlIJICl" files, which strengthenod the likelihood that nil the data 
pertaining to CfII1Cers within thi. group Were IICccssiblc. 
The positive heulth consequences of screening tall be eonsldemble, as was 
found in New Zealand when: compreneru;ive health screening of most oHlle ID 
populatiou in a single region resulted in almost thrcc:-quartcrs of the people tcsled 
requiring furlller actions, e.g., vaccinations, optical work, blood tests, dental work, 
and ear, nose and throat consultations. If these interventions had not taken place 
the quality of life of the individuals may have been greatly impaired (Webb & 
Rog=. 1999). Other researchern have nlso found relatively high rates of 
unsuspected but treatable disorders among those with ID (Sutherland et al., 2002). 
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s,� PWS-lIke dl!order coml'utd 10 true PWS 
Ccmpari�cn cf the phomotypic featun:5 of the small group of PWS-likc 
palients with Ihe PWS group re'/caled some features that were common 10 or 
differed between the two groups (Tohle 4_5, p. 61; Table 4.8, p. 66). The 
Incidence of obesity, hypogonadism, hyperphagia, and speech defects was not 
significantly different between the two groups. Neither was the level of 
developmental delay. However, feeding difficulties, short stature, and skin 
pIcking were 011 no\.Qbly less prevalent In the PWS-like group than in the PWS 
group_ Epilep:;y was reported somewhat more frequently in this group (4U%) than 
in those with PWS (28%), although the small sample size meant that 'he 
differencc was not statisticaUy significanL There was no discernable pottem 10 
the yeors in which the diagnoses of PWS were made for the people in this group. 
In gem'l'lIl, the
'
,
PWS-likC group showed many of the characteristics 
reported in a U.K. stu�y of individuals who hod a supertlumermy inverse 
duplication(15) mnrker chromosome (Wcbb et al., 1998). In that study, 011 ten 
probands who ellhibited a maternally-derived inverse duplicate SMCI5 had some 
level of phcnotypic abnormality. All showed de'/clopmenllll delay, hypotonia, 
and ID, and most had SOme history of seizure activity, autistic charncteristi", 
undlor behavioural abnormalily (Webb el al., 1998). TherewllS nO record that any 
of the present PWS-like study gmup hod been tested for autism. Six of the ten 
pntients in the U.K_ SMC study had three rr more copies of the DlJSll locu. on 
the mnrker chromosome, and all of them possessed four oopies or the PWSIAS 
critical region (Figure 2.1, p_ 20). Ifth. D1JS/J site is present on aSMC, then on 
abnolillal phenotype, nOI m,ecssarily PWS or AS, generally results (Cotter e/ aI., 
J<}99). 
It could be helpful if cnscs with clini""Uy diDgIlosed PWS but nonn.1 
methylation patterns were reviewed, with special attention paid to the presenc<: or 
nbscnc<: of mnrker chromosomes. Where no chrl5qll-q13 mutotion is found 
associated with the PWS-type phenotype, several other disorders could be 
considered as potenlial explanations for the clinical profile of the PWS-like group 
(Sec:tion 2.3.3.5). 
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5.10 MGrtalUy 
In the pllSl, the mGl1IIlity ",tes for institutionalised persons with ID were 
cornidembly higher than those: found In the gcnCI'D1 population. For instanoe, the 
mortality TIlt. for people with ID in a Greek institution between 1965 and 1995 
equated to 59.2 d""thsllOOO JICI'SOn-years, whioh WIlS 20-150 times hicher than 
age/sex-specific rotes for the rest of Greece at that time (J'emkis d 0/" 1995). 
0-,. ... the thirty-year study period, 22% of patienLS died within One year of 
admIssion to the institution. The dcnth mte WM marc f""lucnt in the a!;c range 1-
4 years than for older pcople in the study, possibly due 10 the pnrticulur need of 
children with ID for high levels ofCDJ"e, which Were unmel in those circumstances 
(Pernki. er 0/" 1995). 
In Finlnnd, disease mortality mtes for people with ID have fa!!en 10 similur 
levels to Ihose in the gen=l population after the age of 411 years, but they still 
tend 10 be somewhal higher prior 10 that ll8c, suggestive of the healthy survivor 
effect (Palja eta/., 20()[); Poljad 01., 20(1). A study in the U.S.A. fOUlld thal men 
with ID who survived 10 90 y= or older arc likely 10 hove higher levd, of 
cognilive funclion than either middle-aged ID men or ID women, which WM 
accepted II.'i further evidence of the differenlinl survivnl of less severely affe::led 
individuals (Perls cl 01., 1993). 
The presence of epilepsy al any lim� of life hos been shown 10 incrcnse the 
relallve risk of death 10 My person, irrespective of the level oflD of the Individual 
(Palja e/ a/., 2000). However, Dutch ohildren who fU/lctioned within the normal 
range of IQ had no incrcnscd mortality ratc in conneotion 10 epilepsy (Collenb.ch 
e/ 01., 2001). Epilepsy increases !he standardised mortaE�J' ratio (SMR) of those 
wIll! ID from 1.6 times the mte for the general population la 5.0 times, lID!! 
cerebral palsy increases the SMR S.4·fold (Slrauss e/ 0/., [999; MOrgM e/ 0/., 
2001). Antistic individuals nonnally have lID overall SMR of 2.4, but autistic 
people who olso suffer from epilepsy hove a SMR of 33-38, OS the combination of 
the two disordel3 seems 10 greatly magnify the adverse effects of both conditions 
(Shavellee/al.,2001), 
Among individuals with ID, deaths from cpil'psy M a primary or 
secondary cnus<: are found to occur at yonnger agcs (mean age at death � 29.8 
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year,;) than those who die from causes other lhIIn epilepsy (m",," age at death >50 
years) (Potjo el al., 2001). However, over the last half century there has been n 
d� in the proportion of [0 individuals who die from slaJlLJ epilepliCU.J, as 
improved medication has increased the degree of conlro! of their seizures (Chaney 
& Eyman, 2000; O'Cal[agilan el al., 2004). Only one AS patient from the present 
study cohort had died ofepi[eJ1'Y. In Au,trn[ia, individuals with severe cerebml 
palsy are much more likely to also have severc ID and epilepsy, both of which are 
associated with greatly increased mortality, �omparcd to those with a modernte or 
mild phenotype (Strnuss el al., 1999; Reddihough el al., 2001; Camficld el 0/., 
2002). This i. particularly evident in persons from younger age groups. 
Respiratory complaints are regarded as significant prinl.llry cauSes of death 
among individual5 with ID, lIS are diseases ofth. circulatory system (Beangc & 
Lenno", 1998; lnnioki el 0/., 1999; Strnuss el al., 1999; Chnney & Eyman, 2000; 
Potjo el a/., 2001; Reddihough el al., 2001). One person with PWS nnd one with 
AS from the present study cohort had died of pneumonia, nnd two PWS 
individuals died from cardiovascular failure. Both a Finnish nnd a U.S.A. ,tudy 
have found that CW'diovascular disord= arc the mo,t frequent caUse of death 
among pcoplewith ID in those countries (lnnicki el al., 1999; Patja el a/., 2001). 
The same rcsoarch groups found thot cancers of all types are slightly less 
likely to be the primary causc of de.th in poople with ID, regnrdless of .ge or 
level of handicap, than in the general population (lanicki cl a/., 1999; Potjo Cl a/., 
2001). This is in concurrence with the present study in whieh none of the 
Individuals died from Cilm:er, with at! three ""rdoom .... being successfully treated. 
However, 15% of 4028 people with cercbml palsy in a Californian study died 
from carcinoma, often in infancy or adolescence, and cancers mised the SMRs of 
auti,ti" individuals in the """,e stnte to 1.9-2.9 times th.t of the genernl population 
(Strnuss cl al., 1999; Shavelle et a/., 2001). Older cerebral palsy patients in the 
Californian study population appeared not to have any incrensed susceptibility to 
canccrs, which may be a rellection of the lifestyles of poop le with ID, who are 
expected to have lower levels of exposurc 10 carcinogenic agents over their 
lifetimes than the general population. For e)(l!J1lplc, both smoking and 81collol 
consumption are much less widespread among individuols with ID, and 
wcrkplaccs for those with ID are less likely to contain chemicals, dust or other 
cardnogens (Robertson e/ al., 2000). Some carcinomas an: not associated with 
home- or wolk-based carcinogenic agents. Then:ron:, then: may be some degree 
of unde.-.diagnosis of cancers in th� ID populat!on due to lack of =nlng, as 
5IIggestcd by SUlliVM el 01. (2003). PrevloU.!lly reported low rates or cancers 
could also have been influenced by the reduced life-span of ID individual, in 
earlier generations. 
•• FUTURE ni'RECTlONS 
The study has seJ'\'ed [0 highlight different genetic and clillical 8Spct:ts of 
Angclman syndrome, Prad.,..WilIi s}'Il<irome, and the Pnulcr-WilIi.likc disorder 
diagnosed in a minority of the patients investigated. In this concluding section, 
direction.s for rubIn: work will be considered. 
6.1 ellre requlremfnts 
The runS!! of physical, neurological and behnvioul'IIi problems experienced 
by individuals with ID suggest thnt the vast majority need some degre. of 
supervision or carer attendance. The extent ofcnrer involvement is varied !lIld 
dependi On many facton;, e.g" level of ID, physical health, mental health, 
adeptive skill level, Md degree of sooialisalion (McGrotbcr e/ nl., 1996). 
Individuals who have relalively high functional nbility may not require continuous 
supervision, but there is likely 10 be some need for occasional help with non­
stnndanl matters, such as financial or legal business. Fonn.! guardillll5hip 
arrangements also may be ncceSSlll)' lIS the person age:;, or if they become 
incapable of managing their own affairs and no appropriate family member is 
available (Milano & Nanba, 2003). 
The majority of Individual� In the present study were living in home 
envlronmenls. However, the average agc of the individuals in residential care Wll.'i 
much higher than that ofpaticnls staying at home. Thus it must be supposed that 
there will be an increased need for sheltered accommodation when parents or 
other CDrers become unable to provide home care through age or other incapacity. 
Thiswill increase the burden On the State Disability Services budget IIIld available 
I'llsources. In addition, currently there Drc limited numbers of the h'lIlned support 
staff who would be needed to equip the greater future numbers of hostels Md 
group homes (Megahc/, 1996). 
MIIIlY health issues Drc specific to the elderly, even those within the 
nonnlll range of intellectual function, and lIS individuals nge they oflen become 
mOI'll reliant on carerS for a number of functions. The need for assistance with 
medication management is very common, and an estimated 82% of persons of 
avelllge intellectual capacity living in a personal care environment, Le., n level of 
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care between living at home and a nursing home, need this type of aid (Quinn el 
0/" 1999). Other = where support Is often required arc: personal hygiene 
(69%), viSllllI (42%) Md hearing (60%) impairment, arthritis and rheumatism 
(43%). Incontinence (42%), mental health conditions (43%), mobility limitations 
(39%), and hypertension (30"10). Most of these difficulties require assistance from 
carers to prevent further deterio!'ll ion of the health of the patient (Quinn el al .• 
1999). As these conditions arc found at similar or higher !'lIles in the ID 
population (Reid & Ballinger, 1995; Thompson & Reid, 2002), the consequent 
need for""'" assistance is even greater among the disabled. 
Hearing Md visual impairments are liable to be under-dingnoscd in the 
Intellectually disabled populalion, of\cn due 10 the failure of the individual andfor 
their = to recognise the signs of impairment. Unusual l>ehovlours, such lIS 
imu:tivity, irritability, self-injury, Or autism-like symploms may be indicative of 
sensory impairmenl (Nngalzmun & Vink, 1998). Up to half of all Down 
syndrome individuals have been fOUIld, 10 have SOme degree of h=ing 
impairment, and many also sufTer from visual disorders (Kapell et Ill., 1998; 
S!lXenll, 2001; Harvey, 2004). In lhe U_K., 1 1-13% oflD pcople followed over a 
26-ycar period were visually impaired. The numbers of individllll s from this 
study who were hearing impaired, incontinent, andlor had mobility problems all 
Increased overtime (Rcid & Bollinger, 1995; Cooper, 1998b; Thompson & Reid, 
2002). 
Progressive loss of mobility with lIgeing i!l common to both the gencml 
populalion and those with ID, lIS are incontinence and chronic constipation 
(Evenhuis. 1997). In addition, lIS individunls grow older they are likely to recover 
mOre slowly and less completely from freclures, resulting in permanent loss of 
mobility in many cases and a concomilllnl increase in the level of care required 
(Beange & LennoK, 1998; Centerel al., 1998). 
Although 11 range of mental health problems are common in the elderly, 
dementia is found in less than 6% of the generel population over 65 years old, 
however it is present in ppproximnlely 25% ofpemms who nn: between 80 and 85 
years old. In individualo; with ID. 15%ofthosc aged belween 65 and 74 years and 
70% of those older than 85 yearn have been reported to have signs of dementia 
(Cooper, 1997; van Scruojenstcin Lantman-de Valk el 0/" 1997; Cooper, 1998a). 
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When compDred to those without dcmentlD, Individuals with dementia arc more 
likely to be older, female, non-smokers, with poorly controlled epilepsy, andlor 
.with a higher number of additional physical disorders (Coop"r, ]9980). Down 
syndrome CllITies 0 disproportionate risk for early OIl5C! dementia, especially 
AlUJelmcr's disease (van Schrojenstein Lnnbnnn-dc Yalk et 0/., 1997; Beange & 
Lenno)(, 1998; BillIes & Glasson, 201>4). 
None of the present study group had evidence of dementia. However, the 
oldest member of the cohort was 48 years 4 months cfage, which prob.bly wns 
not old enough for elItly onset dementi. to become manife,';L There were no 
reports in the patient files of increased rutes of early onset dementia in the 
individuals with either Prader_Wil!i or AnBelman syndrome, such as is found in 
p"ople with Down syndrome. 
6.2 Where to from bere? 
As discussed previously (Section S.2) there Were . number of limitations 
associated with the data collection for this study, in particulll1" th� quality and 
quantity of data recorded in many potienls' file,';. To produce a comprehensive 
overview of the phenotypes and ageing charoc\eristics of individuals with AS or 
PWS, it would be necessary to expnnd the scope of the projcctto include access to 
Medical Practitioners' files, Medicare dali!, and hospital outpatient records. 
As noted by Hollt1llJl el 0/. (1999), General PnlCtitioner re<:ords and 
MedIcare details are held by the Australian Commonwealth Govemment, and 
during the study period il wns not possible \0 link the .. data to the WA Data 
Linlrnge VniL The Hnlmge ofWA residents with the Medl= Benefils Schedule 
(MBS) and the Pharmaceutical Benefils Schedule (PBS) was approved in mid· 
2004. Any future project clUImining the two syndromes would benefit grently 
from this odditional data lin1rngc, a9 all visits to Geneml PIlICtitioners and 
specialist physicians, and all mediClltions prescribed (since 1984 for the MBS, and 
1990 for the PBS) will be recorded in these datasels, thus allowing a significant 
expansion of detailed information on the morbidllies assocIated with each 
syndrome. 
The usc of comprehensive questionnaires and/or interviews, aimed al the 
familie,'; and carers or the clienls themselves, would also be n valuable ancillary 
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resource to extend the /'!illge of information available On individuals with AS or 
PWS. Specific instroments such lIS the Functional Independence Me= for 
Children or WeeFIM (Msall .1 al., 1994), the Food-Related Problems 
Questionnaire (Russell & Olivel, 2003), and the Quolily of Life Questionnaire 
(Schalock el al., 2002) could be use; to lIS5ess pnrticulnr aspects of the lifestyle 
""d care needs �fper.ons with Angelman or Proder-Willi syndromes. There nre 
also questionnaires designed to elicit information on levels of carer stress Md the 
elTeels, both positive and negative, of having a fll/llily member with an ID, such as 
the Fnmily Stress and Coping Interview (Nnchshen e/ al., 2003), the Cnrers 
Assessment ofDif icul!ies Index (Nolan cl 01., 1990) , and the Carer.; Assessment 
of Satisfaction Index (Grant ., al., 1998). 
Specific dalll on the influence of a pnrticulnr genotype on the preSCIlting 
phenotype would requir'! that the majorily of AS and PWS patients undergo 
comprehensive genetic testing. At prosent there are substantial numbers of 
patients who have not pnrtidpated in this testing, and so their status with regnrd to 
spedfic mutations within ehrlSqll..q13 ,lmnins unknown. Personal approaches, 
including home visits, stressing the benefits to the family in terms of accurate 
recurrence forecasting, nnd to the individuals with respect to morbidities which 
might be avoided or mitigated by early intervention, could encourage groater 
participation in the testing process. There is also some evidence that diagnostic 
certaInty is of psychological benefit to mothers of cbildren with Down syndrome, 
enabling better use of coping strategies and improved emotionol stress levels 
(l.enhard er al., 2004). Future cases could also potentinlly benefit via neonatal 
thC/Dpy or other early treatment to alleviate the variOll.'i manifesllltions of the 
syndromes. 
The abilily to gain access 10 lndividunls who !!l"e not registered with DSC. 
partloularly intellectually able persons with PWS, would broaden the = 
ascertainment and give a more accurate picture of the complete phenolypic range 
of beth syndromes. The relcvnnt AS nnd PWS Support Ass""i"tio"" both 
Nationnl and SllIte, are excellent potential sollrCes of case ascertainment, ru; are 
the WA Educntlon Department, Catholic Education and the Association of 
Independent Schools (l.eonard cl al., 2003). 
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Western Australian n'ld intersl.1lc moiecular and cytogenetic lobcmtorie.l 
CIluld similarly be of assistance in identifYing people who had undergone gCIletic 
tests for chromosome 15 abnormolities, regnrdh:ss of the outcome. The ability to 
track DSC cl!ents who had moved out ofWA would nssist the extension of the 
database, especially In tenns of information on deaths and morbidities, but this is 
no! currently nvailable. In addition to the continuing enlargement of the database 
as records become nvailable, any .!<Ira information from such sources would be 
very nelpful in providing a clearer and more CIlmpreilcnsive per:spective on the 
phenotypic variation and ageing issues associated with Pmdcr-Willi or Angelman 
syndromes In Western Australia. 
" 
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INITIAL PIIYSICAL EXAMINA nON 
DOB-I-I_ (Ag< __ v.... Moolhs Pay.) 
H<fgh! __ CJJl> (P _)Wdgh! __ KglI(P----.JHtadCln: __ �e -' 
General Appeannco 
M.jo:Dtf_ 
•• 
, 
Minor D'fO<!s/Dy>",orphlo P..tures 
.. 
, 
, . 
•• 
Skull,. 
". 
"" 
PenInl"",ditlOll 
I!NTTonguc 
E� 
LytnpbNod .. 
Peripheral Cin:ulation 
Resp1 .... olY System 
'"-
Oenilnl Dovelopm",! 
Nail. 
Spin, 
" 
'''''', 
13. 
PEDIGREE 
Consacguinlty YIN 
Annolalion 
Oll":r Family History (o.Il< sensory or mOlOr d.roctl, epilepsy, inlcilectwil hzndiClljl, congenll,l 
molfornwl.n) 
Condi�on R.lotIonshlp I. 011"'1 Sex ICD Cod. ,., 
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File number 
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LcvelorID Age at dingo",i. 
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Heberl Hebcrlv 
Heherl Hebcrlv 
Heher3 Hebcr3v 
Dcccascdlnot Date of death 
DSC region Last entry dale 
Gender Date ofbinh 
Age cawgnry Age to ceru:Jr date or doath 
Country orbinh Residence 
Indigenous/not Hypotonia present 
Degree of hypotonia Obesity present 
Age obesity noted HYP"lJ'hagin 
Sucking reflex Crying character 
Age at sitting Age 8t walking 
SpeeI,b development Presence of eye derect 
Type of eye defect Presence of diabetes 
Development secondary sex MellB .. 
Stalure compared to relatives Molecuhll" wsts done 
Type oftes! done Methylation negative 
Deletion positive Test results 
Skin lesions/skin picking Presence/degree ofsooliosis 
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Temper/aggression Epilepsy 
" 
ControlofepUepsy EEG 
Ataxia La�ghlcT/5miJing 
Hypr.:IlIc1ivity Family history 
Medical information Genem! notes 
Number of hospital admissiOll5 DIagnoses on admission 
Furthcrdiagnose, on admission Psych outpatient number visits 
Psych outpatient diagnosis Psych admissioll3 no. days 
Psych admissions diagnosis Hospirnl procc:dures 
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App"odll: IX: Record Iheet for AS clinical crileriB 
ANGELMAN SYNDROME 
N=, 
Fileno 
DO. 
Region MO 
DIAGNOSTIC FEATURES 
l'sycholDolor dcveloplOenl 
Feeding prohlems In Infancy 
Delayed psychomotor development 
Sat unsupported __ months 
Able to walk withoul ps,i,tance 
Walked alone months 
Absent speech or use of <6 words 
Able to use sign language 
Severe mental retardalion 
IQ (ifknown> __ _ 
Regression (Io,s ofacquircd skills) 
Neurological features I movelOeol dlsordel!l 
Seizures 
Truncal ataxia I hypotonia 
Limb hJIPCnonia 
Jelky I ntaxic movement 
Tongue thrusting 
Hand /lapping 
Bebavionr 
YES {NO I DON'T KNOW 
YES INO I DON'T KNOW 
YES INOI DON'T KNOW 
YES INOI DON'T KNOW 
YES/NOlDON'TKNOW 
YES/NO /DON'TKNOW 
YES I NO I DON'T KNOW 
YES I NO I DON'T KNOW 
YES I NO I DON'T KNOW 
YES I NO I DON'T KNOW 
YES I NO I DON'T KNOW 
YES I NO I DON'T KNOW 
YES I NO I DON'T KNOW 
Happy disposition YES I NO I DON'T KNOW 
Easily provoked I Inappropriate laughter YES I NO I DON'T KNOW 
Pby.icai fenCores 
Osymorphic focles 
Promincnljaw I mandible 
Widely spaced tec:th 
Largemouth 
YES/NO/DON'TKNOW 
YES/NO/DON'TKNOW 
YES I NO I DON'T KNOW 
'" 
Deep se! eyes 
Small bead (<25'" percentile) 
HypopigmentntiGn (foir hair I ,kin ccmpUCd 
YESINO/DON'TKNOW 
YES/NO/DON'T KNOW 
to other family mcmbcrll) YES INO I DON'T KNOW 
OTI:lER STUDIES IRESULTS 
EEG YES INO I DON'T KNOW 
Rcsult' _______ _ 
Cyto&enetic studies 
Daleoft..,t I I 
Laboratory where t.iSi)ierfonned'-_______ _ 
Test result: 
"",."" 
FISH studies 
Molec ular studies 
Methylation studies 
Uniparental disomy 
Otberlovestlgallons _____________ _ 
Additional commcnb or information (including ..,I""aol family bllitory) 
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Appelldll:X: Record .hoe! for PWS cllnlcal criteria 
PRADER-WJLLISYNDROME 
N�. 
File No_ 
DOB 
Region MO 
CLASSICAL FEATURES 
Infantile hypotonia 
I point each 
YES {NO I DON'T KNOW 
Infantile feeding problems: YES {NOI DON'T KNOW 
tuOOfed YES/NOIOON'TKNOW 
• Hypogonadism: YES/NO/DON'TKNOW 
genilal hypoplnsinlpubertal deficiency 
• Rapid weighl gain 1-6 year.; YES I NO I DON'T KNOW 
-" -- percentile 
Characteristic focial features YES I NO I DON'T KNOW 
Developmental delay I intolloelu,,! disability YES I NO I DON'T KNOW 
.g,-- MILD I MODERATE I SEVERE 
MINOR CRITERIA y, point each 
Decreased felnl movements YES I NO I DON'T KNOW 
Typieal behaviour problems YESINOIDDN'TKNOW 
Sleep dislUrbll1lce I sleep apnoea YESINO/DON'TKNOW 
Short stature for family by age 15 YESINO/DON'TKNOW 
",-- percentile 
• Hypopigmcnllllion YESINO/OON'TKNQW 
• Characteristic fol di,tribulion YES/NO/DON'TKNOW 
• Small hands and reet for height & age YES/NO/OON'TKNOW 
-g'--
Narrow hands wiLh straight ulnar border YES I NO I DON'T KNOW 
Estropla I myopia YES/NO/OON'TKNOW 
Thick viscous saliva YES/NOIDON'TKNOW 
Specch IllIiculation derecls YESfNOIDON'TKNOW 
Skin picking YES fNO I OON'T KNOW 
Su pportivecriteria 
High pain Lhroshold, decreased vomiting, temperature control problems, 
scoiiOBiSikyphosis, early adrcnDrChe, ostoeporosis, unusual skill with jigsaws, 
normal neuromuscular studies. 
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I1 
Poor motor eoordinDlion 
Head size 
YESlNOIDON'T KNOW 
M1CROCEPHAL Y/NORMAU MACROCEPHALY 
Head circumference __ ." __ pcrocnti!e __ 
Seizures YESlWOIOON'TKNOW 
"". 
DIAGNOSTIC TESTS 
Cytogenetics Perfomed Rcsults, 
Standard kaJyotypc YES/NO 
Exp8J\dr.:d kaJyotype YES/NO 
FISH YES/NO 
Mol .. n"'r 
Uniparental disomy YES/NO 
Expression / methylation YES/NO " 
